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SUMMARY
Pseudomonas aeruginosa is an opportunistic pathogen that causes infection
mainly in immuno-compromised patients, such as AIDS patients, cystic fibrosis patients
and severe burn victims. Various virulence factors have been identified and
experimentally evaluated, among which a conserved secretion system, the Type III
Secretion System (T3SS), holds particular interests to the scientists studying host-
pathogen interactions. By utilizing this system, the pathogen is able to directly inject its
protein effectors into host cells, where they manipulate host cellular functions.
Expression of T3SS genes is under the tight control of its master regulator ExsA and
other regulatory proteins encoded by the exsCEBA operon and induced by calcium
depletion and contact with host cells. However, the molecular mechanism by which host
cells induce T3SS expression remains elusive.
By generating a chromosomal integrated reporter strain PAO1pClacZ, transposon
mutagenesis was conducted, which led to identification of a range of mutants defective in
T3SS expression under calcium-depletion conditions, including the mutants of spuE,
spuF and spuG, As the spuDEFGH genes encode a major uptake system for spermidine,
which is abundant in host cells, this transporter system has thus become the focus of this
study. Genomic and biochemical analysis showed that mutation of the transporter
substantially reduced the expression of most T3SS genes, including the exsCEBA operon,
and impaired the secretion of effector ExoS, under calcium-depletion conditions. The
mutation also decreased the host cell extract-dependent induction of T3SS expression and
attenuated bacterial cytotoxicity towards HeLa cells. Consistently, exogenous addition of
spermidine to the wild type strain PAO1 enhanced the expression of exsCEBA and
IX
induced the secretion of the effector ExoS, demonstrating that a spermidine transporter-
dependent signaling pathway is involved in T3SS regulation.
By deletion analysis of the genes up-regulated in spu transporter mutants, a LysR
type transcriptional regulator TsrA that controls T3SS expression was identified. Further
analysis showed that TsrA negatively regulates T3SS expression through down-
regulating the expression of vfr, which encodes a known positive regulator of T3SS, by
binding to its promoter Pvfr. Addition of spermidine activates T3SS expression by
interfering with the interaction of the suppressor TsrA with Pvfr. Cumulatively, these data
have depicted a novel spermidine transporter-dependent regulation cascade, which plays
an essential role in signal modulation of T3SS expression in P. aeruginosa.
To evaluate the biological significance of this newly identified signaling pathway,
an acute murine pulmonary infection model was established. By using wild type strain
PAO1 as a control, it was found that mutation of the transporter compromised the ability
of the pathogen to incite the production of cytokines in FVB/N mice, in particular, TNF?,
IL-6 and KC, and significantly reduced mice mortality. Moreover, active immunization
of mice with the transporter substrate-binding protein SpuD significantly boosted mice
survival rate against P. aeruginosa pulmonary infection. These findings highlight a
promising potential application in treating P. aeruginosa infections by generating
antibodies against the spermidine transporter.
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1Chapter 1 Literature Review
1.1 Pseudomonas aeruginosa and clinical importance
1.1.1 Taxonomy, description and distribution
The genus Pseudomonas was designated and described in late 1890s (Migula,
1894; Migula, 1895). However, the biological identity of the genus Pseudomonas has
changed dramatically in recent years during the transition between artificial classification
based on phenotypic properties and revisionist classification based on genotypic
(phylogenetic) properties. Palleroni et al. presented  a  historical  account  showing  the
importance of DNA hybridization and of the value of conserved regions of the genome,
particularly the rRNA genes, which has led to identification of five major groups
(Palleroni et al.,  1973).  In  this  new  classification,  the  rRNA  homology  group  I  is  the
“true pseudomonads”, and other groups were reassigned to new genera. The rRNA
homology groups II and III (?-proteobacteria) were described as Acidovorax and
Burkholderia, and the group IV (?-proteobacteria) and the group V (?-proteobacteria)
were designated Brevundimonas and Stenotrophomonas (Holloway, 1996).
The members of the genus Pseudomonas are Gram-negative, non-spore forming
small rod shaped cells of approximately 0.5 to 0.8 µm in diameter by 1 to 3 µm in length.
They have one or more polar flagella to provide them motility in aqueous environments
(Todar, 2004). Metabolism of this genus is aerobic and non-fermentative, although some
species, such as Pseudomonas aeruginosa, are known to be facultative anaerobes.
2The genus Pseudomonas consists of a large number of species, including
fluorescent species, such as P. aeruginosa, P. fluorescens, and P. syringae, as well as
several nonfluorescent species, such as P. stutzeri and P. mendocina (Palleroni, 1992).
Among them, P. aeruginosa is the type species of the genus Pseudomonas. This
bacterium is commonly found in various environmental niches, such as soil, water and on
the  surfaces  in  contact  with  soil  or  water. P. aeruginosa possesses diverse metabolic
capabilities, as it can utilize more than 70 organic compounds as nutrition or energy
sources (Ramos et al., 2002). Moreover, it is renowned for its tolerance to different harsh
physical conditions, such as high temperature, high concentration of salts, and other very
simple nutritional conditions (Govan and Harris, 1986). Even in distilled water, its
growth has been observed (Favero et al., 1971). The complete genome sequence of a P.
aeruginosa wild type strain PAO1 was published in year 2000 (Stover et al., 2000). The
strain possesses 6.3 million base pairs and 5570 predicted open reading frames (ORFs).
Impressively, it contains large numbers of regulatory genes, with 9.3% of the predicted
ORFs encoding regulatory proteins. Among them, 403 ORFs (7.2%) encode
transcriptional regulators and 118 ORFs (2.1%) encode two-component regulatory
systems. In addition, a huge amount of genes involved in catabolism, protein secretion,
motility systems and efflux pumps of different organic compounds have also been
identified  in  its  genome.  The  abundance  of  regulatory  components  and  various  types  of
metabolic and virulence genes may account for the diversity in P. aeruginosa metabolism
and its superb survival ability in various environmental conditions (Stover et al., 2000).
31.1.2 Clinical importance of P. aeruginosa
P. aeruginosa is an opportunistic human pathogen, which is usually harmless to
healthy individuals but mostly affects immuno-compromised individuals, such as cancer
and AIDS patients (Mandell et al., 1995). This bacterium can cause life threatening
infections in patients suffering from the genetic disease cystic  fibrosis (CF) and patients
with burn wounds (Campodonico et al., 2008). In addition, P. aeruginosa is associated
with urinary tract infections, nosocomial pneumonia and severe eye disease due to the use
of contact lenses in healthy individuals. This pathogen is also easily found in clinics and
hospitals, leading to infections in patients through colonization of respiratory tubes and
intravascular catheters (Pollack et al., 1995).
1.1.2.1 P. aeruginosa infections in CF patients
CF, which is found predominantly in Caucasian populations of European
ancestry, manifests as a disease characterized by chronic pulmonary infections as well as
by gastrointestinal, nutritional, and other abnormalities. In 1989, CF was found to be an
autosomal recessive disorder due to mutations in the cystic  fibrosis transmembrane
conductance regulator (CFTR) gene (Riordan et al., 1989), This discovery has led to an
explosion of research efforts, which increased our understanding of the molecular
mechanisms underlying the various symptoms of this disease. CFTR belongs to the ABC-
family  transporters  and  consists  of  a  tandem  repeat  of  ATP  binding cassettes (ABC-
motif), which are separated by a regulatory domain (R). Each motif consists of a
membrane-spanning domain, which is composed of six transmembrane stretches, and a
nucleotide binding domain (NBD) (Lyczak et al., 2002). The membrane-spanning
4domain of CFTR determines the diameter of the pore for the chloride ion (Sheppard et
al., 1996). The NBD is responsible for the binding and hydrolysis of ATP to provide
energy  as  well  as  for  the  regulation  of  the  opening  and  closing  of  the  ion  channel  pore
(Anderson et al., 1991; Gadsby and Nairn, 1999). In addition, CFTR contains the third
domain, a regulatory (R) domain, which provides a further regulation of the channel
function by phosphorylation of the serine residues in this domain (Ma et al., 1997).
CF patients are hyper-susceptive to chronic lung infections, and their lungs are
usually colonized by pathogens in an age-dependent sequence. In infant and toddler CF
patients, the pathogens found during the early colonization of CF airways mostly are
Staphylococcus aureus and non-typeable Haemophilus influenzae. Subsequently, P.
aeruginosa and Burkholderia cepacia take over and become the dominant pathogens in
the airways of older CF patients (Campodonico et al., 2008). Among these pathogens, P.
aeruginosa is the most clinically important species in CF lung disease. The prevalence of
this pathogen in CF airways increases from 10 to 30% at ages 0-5 years to 80% at ages ?
18 years (Treggiari et al., 2007). Its presence in the respiratory tract and the inflammatory
responses it elicits usually cause fast deterioration of lung functions, which is responsible
for most of the morbidity and mortality in CF patients (Li et al., 2005).
P. aeruginosa isolates from young CF patients are usually non-mucoid, motile
and susceptible to antibiotic treatments (Treggiari et al., 2007). However, with the time
going, P. aeruginosa in  CF  airways  undergoes  genotypic  changes  and  becomes  the
mucoid P. aeruginosa, which overproduces a surface polysaccharide known as alginate
and loses the ability to produce lipopolysaccharide (LPS) O side chains (Henry et al.,
1992; Parad et al., 1999). These genetic changes in mucoid isolates confer increased
5resistance to the innate and acquired host immune defenses to antibiotic treatments,
which leads to most profound increases in the rate of CF lung function decline as well as
the failure in eradication of mucoid P. aeruginosa from CF lungs (Lyczak et al., 2002; Li
et al., 2005; Treggiari et al., 2007). Multiple virulence factors are known to contribute to
P. aeruginosa infections in CF lungs, which will be discussed in detail in the Section 1.2.
The primary function of CFTR is to transport chloride and other ions, such as
potassium and sodium, as well as to regulate conductance of ions in and out of cells and
intracellular vacuoles under the regulation of cyclic adenosine monophosphate (cAMP).
Mutations in CFTR commonly result in deficiency in chloride transport, which
consequently affects the ionic composition of epithelial cell secretions and biosynthesis
of mucus. These alterations result in changes in pH, ion concentration and hydration in
airway surface layer. The dehydrated airway surface liquid in CF decreases mucociliary
clearance of P. aeruginosa from the airway and allows the retention of organisms within
the airway lumen (Worlitzsch et al., 2002).
In  addition  to  be  a  chloride  channel,  CFTR  has  also  been  identified  as  an
important epithelial cell receptor for clearance of P. aeruginosa from lungs. In healthy
individuals, CFTR recognizes P. aeruginosa through specific binding of the amino acids
108-117 to the conserved bacterial outer core LPS and elicites a coordinated, rapid and
self-limiting inflammatory responses, which lead to a fast elimination of the pathogenic
cells from the airway (Pier et al., 1996; Pier et al., 1997; Schroeder et al., 2002).
However, lack of a functional CFTR slows down these inflammatory responses in the CF
airways against P. aeruginosa infection (Kowalski and Pier, 2004). The diminished
binding between bacterium and CF epithelium leads to a reduced initial clearance, which
6gives this pathogen the opportunity to remain within the airway lumen by binding to
mucins via the bacterial FliD protein (Arora et al., 1998). Thereafter, P. aeruginosa
survives within a hypoxic environment, which induces production of alginate, further
protecting the bacterium from host innate immunity (Worlitzsch et al., 2002).
Toll-like receptors (TLRs) and the MyD88 adaptor protein are the other
components associated with the P. aeruginosa-epithelial cell interaction. In vitro studies
suggest that TLR2 (which recognizes peptidoglycan), TLR4 (which recognizes LPS),
TLR5 (which recognizes flagellin) and TLR9 (which recognizes DNA with a high CpG
content) mediate cellular responses to P. aeruginosa (Power et al., 2004; Feuillet et al.,
2006). However, in vivo studies showed that a single TLR-deficiency in transgenic mice
does not lead to a compromised inflammatory response in P. aeruginosa lung infections
(Ramphal et al., 2005; Feuillet et al., 2006). Nevertheless, deficiency in both TLR4 and
TLR5 in multi-transgenic mice results in alterations in cytokine responses and leads to a
modest enhancement of lethality (Feuillet et al., 2006). Such a phenomenon that host
response to P. aeruginosa is not dependent on a single TLR is likely due to the
redundancy of TLRs in the host innate immune system. In addition, MyD88 adaptor
protein  has  been  shown  to  be  important  in  modulating  host  inflammatory  responses
through recruitment of neutrophils (Power et al., 2004).
1.1.2.2 P. aeruginosa infections in burn wounds
In healthy individuals, the intact skin forms a barrier to protect against bacterial
infections. Yet, extensive breaches in the skin barrier caused by burn injury provide the
7opportunities for microorganisms (Lyczak et al., 2000). Although infections with various
bacterial species are predisposed to be present in the wounds, only a few bacterial
species, including P. aeruginosa, have been isolated from infected sites (Bowen-Jones et
al., 1990). The defects in random migration and chemotaxis of PMNs at burn wound sites
have been found to be caused by local deficiencies in protective immunoglobulin (Felts et
al., 1999), complement proteins (Deitch et al., 1985), and PMN Fc receptors (Jeyapaul et
al., 1984). The compromised host immune system provides a chance for P. aeruginosa to
out compete other bacterial species as it can produce a variety of important virulence
factors, such as elastase and other protease (Bejarano et al., 1989), phospholipase C
(Ostroff and Vasil, 1987), ferripyochelin-binding protein (Sokol, 1987), LPS and the
effector proteins secreted by the type III secretion system (Nicas and Iglewski, 1985;
Sokol, 1987; Goldberg et al., 1995), which promote its own dissemination throughout the
host.
1.1.2.3 P. aeruginosa infections in cornea diseases
P. aeruginosa causes severe eye infections even in healthy individuals.
Previously, eye infections with P. aeruginosa were  thought  to  be  associated  with  acute
injury to cornea. However, it has been noticed that such infections also affect the users of
soft contact lenses (Ehrlich et al., 1989). This eye disease, named as ulcerative keratitis
(UK), has been considered as the most destructive bacterial disease of human cornea and
manifests a severe inflammatory response to bacterial infection of cornea (Lyczak et al.,
2000). The direct exposure of cornea to environment determines its dependence on
several mechanisms to prevent bacterial infections. For example, production of tears and
8physical blinking of eyelid remove bacteria from the cornea. More importantly, the
innermost portion of the tear lay is comprised of mucus which traps P. aeruginosa and
prevents further adherence bacterial cells to corneal epithelium (Fleiszig et al., 1994).
However, alterations in mucus compositions have been detected in contact lens wearers,
leading to the loss of ocular mucus adherence to the bacterium and facilitating initiation
of infection (Versura et al., 1987). On the other hand, P. aeruginosa elaborates various
virulence factors, such as glycocalyx, endotoxin (LPS), exotoxins, proteases, flagella and
pili, which contribute to the initiation and development of corneal infection (Lyczak et
al., 2000). Among them, LPS plays special roles in pseudomonal corneal disease. LPS is
well known to initiate inflammation in host cornea by activating PMN chemotaxis
(Mondino et al., 1977). Recently, LPS of P. aeruginosa has  also  been  identified  as  an
important ligand for the host cell receptor CFTR to promote infection of cornea, which is
contrary to what has been observed in lung infections as discussed in subsection 1.1.2.1
(Fleiszig et  al., 1995; Zaidi et al., 1999). It has been proposed that the different
architectures of the two host tissues as well as the altered expression patterns of CFTR in
each tissue give rise to the contradictory functions of this receptor. In the airways, only
one layer of epithelium cells, where CFTR is highly expressed is present. The receptor
CFTR binds to P. aeruginosa LPS and allows the internalization of this bacterium on the
surface, which initiates the rapid inflammatory responses and finally leads to the
clearance of the bacterium.  However, the epithelial cells in the cornea are arranged in
multiple layers, where only basal epithelial cells have the strongest expression of CFTR.
Therefore, the internalization of bacterial cells on the basal cell layer takes place when
corneal injury happens. In this case, instead of clearing the bacterial cells, the CFTR-
9expressing epithelial cells function as a reservoir for P. aeruginosa since the bacteria-
laden cell layer is buried beneath several epithelial cell layers (Fleiszig et al., 1995; Zaidi
et al., 1999).
1.2 The major virulence factors of Pseudomonas aeruginosa
P. aeruginosa employs a range of virulence determinants as its anti-immune and
survival strategies to establish infections in different hosts. To date, extensive knowledge
has accumulated with regard to the roles of these bacterial virulence factors in its
infection processes. In this section, the literature dealing with the characterization and
biologic activity of the major virulence determinants in P. aeruginosa will be reviewed.
1.2.1 Bacterial cell membrane-associated virulence factors
The ability to adhere and invade is essential for P. aeruginosa to establish the
foothold in host tissue and it is supported by its membrane-associated structures, such as
flagellum, type IV pili and LPS (Hahn, 1997), which will be discussed separately in
following subsections.
1.2.1.1 Flagellum
P. aeruginosa possesses  a  single  polar  flagellum,  a  rotary  structure  driven  by  a
motor  at  the  base,  with  the  filament  acting  as  a  propeller.  The  flagellum  is  built  up  by
three major structures: the filament, the hook and the basal body (Bardy et al., 2003). The
filament is built from thousands of flagellin (FliC) monomers that are transported through
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the structure and added at the distal tip of the filament with the help of the capping
protein (FliD) (Arora et al., 1998). The hook region connects the filament and the basal
body. The primary function of flagellum is to provide swimming motility. Additionally,
P. aeruginosa also exhibits swarming motility on soft agar. Swarming motility refers to a
group behavior that promotes flagellum-dependent motility on surface (Murray and
Kazmierczak, 2006). For many pathogenic bacterial species, such as P. aeruginosa and
Vibrio cholerae,  the flagellum-dependent motility allows bacterial  cells  to reach the site
of infection to establish infection (Dasgupta et al., 2003). It has been demonstrated that
non-flagellated P. aeruginosa mutants are defective in virulence in a burned mouse
model of infection (Montie et al., 1982). Additionally, the flagellum is also involved in P.
aeruginosa biofilm maturation, although it is not required for the initial attachment of
cells for biofilm formation (Klausen et al., 2003; Barken et al., 2008). It has been shown
recently that the non-flagellated P. aeruginosa fliM mutant could not form normal
mushroom-shaped caps in biofilms (Barken et al., 2008). On the other hand, during the
infection process, flagellin, the major component of bacterial flagellum, is recognized by
Toll-like receptor 5 (TLR5); the event leads to activation of the MyD88-dependent
signaling pathway and is subsequently provoking the innate inflammatory response
(Feuillet et al., 2006).
1.2.1.2 Type IV Pilus
Type IV pili are strong and flexible filaments that mediate diverse cellular
functions in P. aeruginosa. First of all, type IV pili are the major adhesins in P.
aeruginosa acting by binding to the glycolipids asialo-GM1 and asialo-GM2 on the
epithelial cell surfaces (Woods et  al., 1980; Doig et al., 1988; Krivan et al., 1988a;
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Krivan et al., 1988b). For example, The type IV pili account for about 90% of adherence
capability of P. aeruginosa to human lung pneumocyte A549 cells (Hahn, 1997). Second,
the type IV pili are required for the flagellum-independent twitching motility on semi-
solid surfaces, such as the mucosal epithelia. (Craig et al., 2004). Twitch motility
involves pilus retraction, where the pili attach non-specifically to mucosal surface and are
then retracted into the bacterium to pull the cells along (Bradley, 1980; Merz et al.,
2000). Third, aggregation of the type IV pili leads to autoaggregation of P. aeruginosa
cells and the formation of microcolony, which can effectively concentrate the cells and
the toxins produced by the pathogen at the infection site and protect bacterial cell from
host immune response (Craig et al., 2004). Type IV pili-mediated twitching motility
together with the formation of microcolonies are required for the maturation of biofilms,
which also can protect bacterial cells from host immune responses or antibiotics and lead
to persistent infections (O'Toole and Kolter, 1998). Additionally, the type IV pili in P.
aeruginosa function  as  receptors  for  bacteriophages,  and  probably  play  a  role  in
apoptosis signaling during infection processes since a reduced level of apoptosis of
epithelial cells has been observed when they were infected with non-piliated bacterial
mutants (Craig et al., 2004).
1.2.1.3 Lipopolysaccharide (LPS)
The P. aeruginosa lipopolysaccharide (LPS) has long been known as a major
factor mediating both bacterial virulence and host responses. LPS molecules are located
in  the  outer  membrane  of  Gram-negative  bacteria  with  a  unique  chemical  structure,
which is essential for its virulence. The P. aeruginosa LPS  molecule  consists  of  three
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parts: a hydrophobic lipid A region containing an N- and O-acylated diglucosamine
bisphosphate backbone, a central core oligosaccharide region, and a repeating
polysaccharide portion, which is known as O-antigen. The lipid A region is integrated
among the phospholipids in the outer membrane, while the core oligosaccharide links the
lipid A region to the O-antigen (Rocchetta et al., 1999; Pier, 2007). Two LPS phenotypes
have been described according to the presence of O-antigen. The “smooth” LPS has the
O-antigen attached to core-lipid A; while the “rough” LPS lacks O-antigen (Rocchetta et
al., 1999). It has been demonstrated in different animal model systems that smooth LPS
plays essential roles in full-fledged virulence in acute infection. For example, it has been
shown that a wild-type strain of P. aeruginosa with smooth LPS was more virulent than
the isogenic mutant with rough LPS in a burned-mouse infection model (Cryz, Jr. et al.,
1984). Recently, it has been further confirmed that intact smooth LPS is required for P.
aeruginosa virulence in a mouse cornea infection model as well as a neonatal-mouse
challenge model (Preston et al., 1995; Tang et al., 1996). However, P. aeruginosa
isolates in the lungs of chronically infected CF patients have been found predominately to
be  rough LPS,  as  the  pathogens  are  unable  to  produce  O-antigen.  It  has  been  proposed
that LPS O-antigens are needed for systemic spread of P. aeruginosa cells  as the rough
LPS producing strain, the galU mutant, was unable to spread systemically in mice
following intranasal inoculation, which is probably caused by the killing by serum
complement (Pier and Ames, 1984; Priebe et al., 2004).
In recent years, two major advances regarding the interaction between LPS and
host cells have been achieved. Firstly, it has been found that Toll-like receptor 4 (TLR4)
is  essential  for  the  recognition  of  the  lipid  A portion  of  bacterial  LPS and  subsequently
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mediates  host  immune responses  to  infection  (Fitzgerald  and  Chen,  2006).  Moreover,  it
has been shown that TLR4 mediated inflammatory responses are also related to the level
of acylation of the P. aeruginosa lipid A. Production of a fully hexa-acylated lipid A
leads to more vigorous inflammatory responses during P. aeruginosa infection whereas
production of lipid A with lower levels of acylation gives rise to reduced production of
cytokines (Ernst et al., 2003). Secondly, it was found that the conserved outer-core
oligosaccharide of the P. aeruginosa LPS  is  the  bacterial  ligand  directly  binding  to
CFTR, which mediates entry of P. aeruginosa into lung and corneal epithelial cells (Pier
et al., 1996; Zaidi et al., 1996; Pier et al., 1997). Such interaction between P. aeruginosa
LPS and CFTR promotes internalization of bacterial cells, which subsequently activates
NF-?B nuclear translocation in airway epithelial cells (Schroeder et al., 2002). It has been
shown that the effects downstream of NF-?B nuclear translocation, such as the
production of IL-6, IL-8, CXC1 and intercellular adhesion molecule-1, are present in
reduced levels in CF patients. Such a lag in innate immune responses in CF patients is
likely an opportunity for P. aeruginosa to establish a niche within the CF lungs (Reiniger
et al., 2005).
1.2.2 Extracellular virulence factors
1.2.2.1 Exopolysaccharide (EPS)
It has been widely recognized that P. aeruginosa infection persists in CF patients.
Such persistence of P. aeruginosa during  CF  infections  is  related  to  its  ability  to  form
biofilms (Singh et al., 2000). Biofilms are communities of microorganisms that are
attached to a surface and they play a significant role in bacterial infections (Costerton et
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al., 1999). One characteristic feature of bacterial biofilms is that bacterial cells are
usually embedded within a matrix, the architecture made of protein, exopolysaccharides
(EPS) and nucleic acid. Four steps are involved in biofilm formation, including initial
attachment to a surface by planktonic bacteria, microcolony formation, biofilm
maturation and release of planktonic bacteria to begin the cycle anew (O'Toole et al.,
2000). The secretion of EPS occurs after initial attachment and continues throughout the
biofilm formation and maturation processes (Ramsey and Wozniak, 2005). EPS is an
important component of the microbial biofilm extracellular matrix, which contributes to
overall biofilm architecture and protects bacterial cells from drugs and host inflammatory
responses (Hentzer et al., 2001; Sutherland, 2001; Leid et al., 2005; Branda et al., 2005;
Ramsey and Wozniak, 2005) Two major types of EPS, alginate and Pel/Psl
polysaccharides, have been described in P. aeruginosa, which will be reviewed in
following paragraphs.
Alginate, an important component of EPS in mucoid biofilm, is one of the best
studied virulence factors that confer selective advantages for P. aeruginosa in  the  CF
airways. P. aeruginosa alginate is an acetylated polymer composed of non-repetitive
monomers of ?-1,4 linked L-guluronic and D-mannuronic acids (Ryder et al., 2007). Over-
production of alginate causes the mucoid phenotype for P. aeruginosa. The CF patients
carrying the mucoid P. aeruginosa strains  have  a  worse  prognosis  than  those  colonized
with non-mucoid strains (Govan and Deretic, 1996). Overproduction of alginate
(especially in its O-acetylated form) leads to significant architectural and morphological
changes in P. aeruginosa biofilm (Hentzer et al., 2001; Nivens et al., 2001; Stapper et al.,
2004; Tielen et al., 2005). Moreover, alginate appears to protect P. aeruginosa from the
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consequences of host inflammatory responses which are induced during bacterial
infection of CF lungs as it scavenges free radicals released by activated macrophages in
vitro (Simpson et al., 1989). Alginate also functions as a physical and chemical barrier to
P. aeruginosa cells and therefore protects this organism from phagocytic clearance and
defensins (Govan and Deretic, 1996).
Recent studies suggest that alginate expression is not required for in vitro biofilm
formation by non-mucoid strains, such as PAO1 or PA14 (Hentzer et al., 2001; Nivens et
al., 2001; Stapper et al., 2004). In these non-mucoid strains, some other polysaccharides
have been identified to be essential for biofilm development. Two loci, designated as pel
(pellicle formation) and psl (polysaccharide synthesis locus), harboring alternative
polysaccharide encoding genes have been identified (Jackson et  al., 2004; Matsukawa
and Greenberg, 2004; Parsek and Fuqua, 2004; Friedman and Kolter, 2004a; Friedman
and Kolter, 2004c). The first, the pel operon, contains 7 genes (pelA-G) whose products
are essential for pellicle formation and biofilm structure in P. aeruginosa strains PA14.
Mutations of the pel genes in PA14 affects the colony morphology and the ability of
bacterial cells to bind to Congo red (Friedman and Kolter, 2004a). Similarly, the
nopiliated pel mutants of P. aeruginosa strain PAK shows significantly reduced biofilm
initiation (Vasseur et al., 2005b). Carbohydrate and linkage analysis have shown that the
Pel polysaccharides are glucose rich EPS polymer (Friedman and Kolter, 2004a;
Friedman and Kolter, 2004c). However, the nature of the Pel polysaccharides is still
elusive. The second locus psl is an operon composed of 15 genes (pslA-O) encoding the
Psl polysaccharide biosynthetic machinery. It has been found to be essential for cell-
surface and cell-cell interactions in P. aeruginosa strains PAO1 and ZK2870 (Jackson et
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al., 2004; Matsukawa and Greenberg, 2004; Friedman and Kolter, 2004c; Ma et al.,
2006). Furthermore, psl is also required to maintain the biofilm structure post attachment,
which suggests that Psl polysaccharide functions as scaffold to hold biofilm cells together
in the matrix (Ma et al., 2006). Importantly, this study used biotic surfaces, including
mucin-coated surfaces and airway epithelial cells, to show that Psl polysaccharide is
required for the initial attachment of bacterial cells and thereafter for biofilm maturation
(Ma et al., 2006). These discoveries have provided critical evidence that production of
alternative polysaccarides leads to initiation of colonization by non-mucoid strains, which
implies that during initial infection, biofilm formation may precede the switch to
mucoidy (Ryder et al., 2007). Similar to the Pel polysaccharides, the structure of Psl
polysaccharide is still not known. The results obtained from carbohydrate and lectin
staining assays suggest that it is a mannose-rich and galactose-rich polysaccharide
(Matsukawa and Greenberg, 2004; Friedman and Kolter, 2004c; Ma et al., 2007).
1.2.2.2 Extracellular enzymes
P. aeruginosa is able to secrete several toxins and destructive enzymes into host
to promote colonization and dissemination during infection processes. Exotoxin A is one
of the most toxic extracellular enzymes produced by this pathogen (Liu, 1974). The
biochemical activity of exotoxin A has been determined to be an ADP-ribosyltransferase
(Liu and Hsieh, 1973). The ADP-ribosylation of protein elongation factor-2 by this
exotoxin leads to a cessation of protein synthesis within the host cells (Gray et al., 1984;
Mozola et al., 1984). Administration of purified exotoxin A results in rapid destruction of
corneal epithelial cells within 24 hours, which subsequently brings PMNs to the site of
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infection and leads to corneal ulceration (Iglewski et al., 1977). This study further
confirms that exotoxin A is one of the prime determinants of pseudomonal virulence.
A number of proteases are produced and secreted by P. aeruginosa to damage
host tissues. First, alkaline protease (AprA) is a metalloprotease which functions as an
immunomodulatory agent, digesting complement component C1q and C3, cytokines and
chemokines (Horvat and Parmely, 1988; Parmely et al., 1990; Kharazmi, 1991; Hong and
Ghebrehiwet, 1992; Leidal et  al., 2003). Moreover, AprA also cleaves soluble laminin
releasing immunoreactive laminin which is required from both tissue invasion and
hemorrhagic tissue necrosis during infection (Heck et al., 1986a). Second, pseudomonal
LasA protease has been identified to be important for P. aeruginosa pathogenesis. LasA
protease is a metalloendopeptidase which acts synergistically with LasB elastase to
degrade elastin, an important component of connective tissues, blood vessels, and lung
tissues (Peters and Galloway, 1990; Kessler et  al., 1997). LasA protease also enhances
bacterial virulence by facilitating the shedding of syndecan-1 of epithelial cells (Park et
al., 1997; Park et  al., 2000). Additionally, it lyses Staphylococcus aureus cells by
cleaving peptide bonds within the pentaglycine crossbridges, which likely confers P.
aeruginosa ab advabtage over S. aureus during colonization of CF lungs (Kessler et al.,
1993; Barequet et  al., 2004). Third, the LasB elastase is the most abundant secreted
protease of P. aeruginosa (McIver et al., 2004). It is initially synthesized as a precursor
with a molecular mass of 53.6 kDa. This preproelastase is autocatalytically cleaved,
giving rise to a proelastase (50kDa), which is further cleaved into two proteins (33 and 17
kDa) within the periplasm. The 33-kDa elastase is inactive due to the noncovalently
association  with  the  17-kDa peptide  in  the  periplasm.  Upon the  secretion  of  elastase  to
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the environment, the 17-kDa peptide is removed, giving rise to an enzymatically active
extracellular elastase. However, to reach the full elastolytic activity, LasB elastase needs
a functional LasA protease for post-translational modification (Iglewski et al., 1990).
LasB elastase is produced during the course of clinical infections (Doring et al., 1985).
This enzyme is capable of degrading or inactivating immune system components as well
as biologic tissues, including immunoglobulin (Heck et al., 1990), serum complement
factors (Hong and Ghebrehiwet, 1992), collagen (Heck et al., 1986b), fibrin (Morihara,
1964), ?1-proteinase inhibitor (Morihara et al., 1984), and elastin (Morihara, 1964).
Moreover, it acts synergistically with alkaline protease to inactivate the human cytokines
gamma interferon and tumor necrosis factor alpha (TNF?) (Parmely et al., 1990). Last,
protease IV is the only protease produced by P. aeruginosa strain PA103 (O'Callaghan et
al.,  1996),  yet  it  is  conserved  in  other  strains  of P. aeruginosa, but not in other
Pseudomonas species (Caballero et al., 2004). Purified protease IV has specific activity
for the carboxyl side of lysine-containing peptides and it is able to digest various
important proteins, including immunoglobulin, complement factors, fibrinogen, and
plasminogen (Engel et al., 1998).
Apart from exotoxin A and various proteases, P. aeruginosa also  produces  and
secretes lipase and phospholipase to facilitate infection. P. aeruginosa lipase has a broad
substrate specificity accepting triglyceride substrates with fatty acyl chain lengths varying
from  C6 to  C18, yet it also catalyses the formation of long-chain acylglycerols. Two
genes, lipA and lif, are required for enzymatical activity of the lipase. LipA is the
structural gene encoding the lipase and lif encodes a lipase-specific foldase protein. The
Lif protein anchors to the cytoplasmic membrane, assisting the folding of LipA lipase in
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the periplasm (Jaeger et al., 1996). Lipase is commonly produced and secreted by clinical
P. aeruginosa strains. Furthermore, bronchoalveolar lavage fluid from CF patients
contains higher lipase levels when compared with those of normal volunteers (Konig et
al., 1996). In vitro studies show that purified lipase completely inhibits the monocyte
chemotaxis and strongly inhibits the monocyte chemiluminescence. These findings
suggest that lipase contributes to the pathogenesis of P. aeruginosa infections, as
phagocytes, including monocytes, belong to the first line of defense against invading
microorganisms (Jaeger et al., 1991).  Besides, P. aeruginosa also carries two, non-
tandem genes encoding phospholipase  C (PLC). One PLC (PLC-H) lyses human and
sheep erythrocytes; while the other one (PLC-N) has no haemolytic activity (Shoriridge
et al., 1992). Studies have shown that P. aeruginosa PLC  is  an  inflammatory  agent,
which can induce the release of inflammatory mediators and cause marked inflammation
in mouse models (Meyers and Berk, 1990). PLC is also a potent stimulus for generation
of oxygen metabolites. Additionally, PLC and lipase act synergistically to enhance 12-
hydroxyeicosatetraenoic acid (12-HETE) and leukotriene B4 (LTB4) generation from
human platelets and neutrophils. Collectively, these results suggest that PLC and lipase
are critical components in the pathogenesis of P. aeruginosa infections (Konig et al.,
1996).
1.2.2.3 Extracellular chemical toxins
P. aeruginosa generates several diffusible toxic secondary chemical metabolites,
such as phenazines, siderophones and rhamnolipids, which are critical for its virulence
and cytotoxicity. P. aeruginosa produces a specific phenazine, named pyocyanin, which
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plays a crucial role in the infection process, and importantly, it is the only organism that
produces this specific phenazine (Turner and Messenger, 1986). Pyocyanin is a low
molecular weight zwitterion showing bluish-green color that can easily penetrate
biological membranes and it determines the characteristic color of infected pus and
sputum (Lau et  al., 2004; Prince et al., 2008).  It is a major virulence determinant
responsible for oxidant-dependent killing of C. elegans by P. aeruginosa due to its ability
to undergo redox cycling to cause superoxide generation (Hassan and Fridovich, 1980;
Britigan et al., 1992). Moreover, pyocyanin is readily recovered in large quantities form
the sputum of CF patients with P. aeruginosa infection (Wilson et al., 1988). The in vitro
studies using cell culture systems have revealed that pyocyanin causes a wide spectrum
of cellular damages, such as the inhibition of cell respiration, ciliary function, epidermal
cell grown and prostacyclin release (Sorensen and Klinger, 1987; Kamath et al., 1995).
Pyocyanin also modulates glutathione redox cycling in lung epithelial and endothelial
cells (Muller, 2002; O'Malley et al., 2004). Physiologically relevant concentrations of
pyocyanin from the sputum of CF patients have been shown to induce and accelerate
apoptosis in neutrophils and impair clearance of P. aeruginosa from the lung, which is
crucial for lung infections (Usher et al., 2002; Allen et al., 2005; Prince et al., 2008).
P. aeruginosa produces rhamnolipids biosurfactant, which are amphiphilic
molecules composed of a hydrophobic fatty acid moiety and a hydrophilic portion
consisting one or two rhamnose (Jarvis and Johnson, 1949). Production of rhamnolipids
serves as an essential aid for swarming motility by acting as a wetting agent to overcome
the surface tension of water and facilitating movement across the moist surface, which is
important for biofilm formation (Koch et al., 1991; Harshey, 2003; Caiazza et al., 2005).
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They  also  exhibit  several  effects  on  mammalian  cells,  such  as  disruption  of  the
polymorphonuclear leukocyte chemotactic responses (Shryock et al., 1984), rapid
necrotic killing of polymorphonuclear leukocytes (Jensen et  al., 2007), inhibition of
normal macrophage function (McClure and Schiller, 1992), stimulation of cytokine
release from airways epithelial cells (Bedard et al., 1993), and interference with normal
ciliary functions (Kanthakumar et al., 1996). Additionally, due to their detergent-like
properties,  rhamnolipids  solubilize  phospholipids  of  lung  surfactant  to  make  them
accessible to cleavage by phospholipase C (Kurioka and Liu, 1967), as well as solubilize
the quorum sensing signal PQS to facilitate the regulation of expression of various
virulence factors (Calfee et al., 2005).
P. aeruginosa is able to produce two siderophores, pyochelin and pyoverdine to
aquire iron from environment to support its growth (Cox, 1980; Cox and Adams, 1985).
Pyoverdine is characterized by a conserved hydroxyquinoline moiety (the chromophore)
and an amino acid tail of variable length and composition (Budzikiewicz, 1993). It is
highly water soluble, binds iron in a 1:1 stoichiometry with high affinity and is able to
remove transferring-bound iron in vitro, which contributes to the ability of P. aeruginosa
to grow in the presence of serum (Meyer and Abdallah, 1978; Ankenbauer et al., 1985;
Sriyosachati and Cox, 1986). Pyoverdine production correlates with enhanced virulence
in burned mouse model as well as the rat lung model (Meyer et al., 1996), which suggests
that it plays important roles in iron acquisition for in vivo growth and thus contributes to
pathogenesis of chronic pulmonary P. aeruginosa infections seen in CF patients
(McCubbin and Fick, 1993). The other siderophore is pyochelin, a phenolate siderophore
of  low  molecular  mass  and  low  solubility  in  water.  Pyochelin  binds  iron  in  a  2:1
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stoichiometry (Cox and Graham, 1979; Cox et al., 1981). Unlike pyoverdine, it exhibits a
low affinity to iron in vitro; yet its production is still correlated with increased virulence
and in vivo bacterial growth (Cox, 1982). The role of pyoverdine in pathogenesis may not
be related to iron acquisition, but could be associated with its ability to promote free-
radical formation and damage of endothelial and epithelial cells (Britigan et  al., 1992;
Britigan et al., 1997; DeWitte et al., 2001).
1.2.3 Type III Secretion System (T3SS)
The bacterial type III secretion system (T3SS) is a conserved injection apparatus,
allowing both plant and animal pathogens to deliver its effector proteins directly into
eukaryotic host cells to initiate a sophisticated “biochemical cross-talk” between
pathogen and host (Hueck, 1998). Homologous T3SSs have been described for many
Gram-negative bacterial species, including pathogens (predominantly), such as Yersinia
pestis, Shigella flexneri, Bordetella pertussis, P. aeruginosa and Vibrio Cholerae, and the
commensals of mammals, plants and insects (Troisfontaines and Cornelis, 2005).
1.2.3.1 Structure of T3SS and the effectors
The T3SS secretion apparatus is a supramolecular complex known as the needle
complex made up of approximately 20 proteins, which mediates the passage of the
secreted proteins through bacterial inner and outer membranes, including the
peptidoglycan layer (Galan and Wolf-Watz, 2006). This apparatus complex consists of
two rings on the two layers of membrane. The inner membrane ring is the larger one
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between the two coaxial rings, and the protein components that make up the inner ring
have been found to be homologous to those of flagella biosynthesis apparatus of both
Gram-negative and Gram-positive bacteria (Hueck, 1998; Coburn et al., 2007). The outer
membrane ring is composed of the secretin protein family. A needle-like structure, with
various lengths among different bacterial species, associates with the outer membrane
ring and projects from bacterial surface. In addition to the proteins that make up the T3SS
apparatus, the proteins called “translocators” are also required to translocate the effector
proteins into host cell cytoplasm (Ghosh, 2004).
The effector proteins of T3SS are the virulence factors that manipulate or interfere
host cell biological functions. A common theme of virulence caused by T3SS effectors is
subversion of the host cytoskeleton through direct or indirect manipulation of small Rho
GTPases or direct interactions with filamentous (F-actin) or globular (G-actin) (Coburn et
al.,  2007).  As  a  result,  injection  of  T3SS  effectors  commonly  leads  to  bacterial
internalization in mammalian cells (Hayward and Koronakis, 1999; Zhou et al., 1999),
induction of macrophage apoptosis (Mills et al., 1997), inhibition of phagocytosis by
changing macrophage actin structures (Frithz-Lindsten et al., 1997), and generation of
pores in host cells (Lee et al., 2001), which consequently facilitate pathogens to colonize,
multiply, and sometimes chronically persist in the host (Coburn et al., 2007).
T3SS, including gene organization (Fig. 1-2) as well as individual genes (Fig. 1-
1), is highly conserved various bacterial species. The genes encoding the type III
secretion apparatus have been found in clusters with a conserved gene order and often on
potentially mobilisable plasmids or flanked by insertion elements. These discoveries
indicate that the genes encoding T3SS have been spread by horizontal gene transfer
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(Hueck, 1998). On the other hand, the effector proteins secreted by T3SSs of different
bacterial species vary greatly in size, structure, and function, which account for the
species-specific pathogenicity phenotypes associated with type III secretion (Hueck,
1998).
1.2.3.2 T3SS in P. aeruginosa
Similar to other bacterial pathogens, the T3SS of P. aeruginosa (Fig.  1-3)  is
composed of three classes of gene products including secretory apparatus components
(PscB-L, and PscN-U), the proteins mediating the effector translocation (PopB and
PopD), and the effectors (ExoS, ExoT, ExoU, ExoY) and their  chaperones (Yahr et  al.,
1996a; Yahr et al., 1996b; Finck-Barbancon et al., 1997; Frank, 1997; Yahr et al., 1998;
Coburn et al., 2007). ExoS and ExoT have distinct functional domains. The N-terminal
portion is homologous to GTPase-activating proteins and the GTPase-activating activity
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Fig. 1-1 Genetic organization of the P. aeruginosa exoenzyme S regulon. P. aeruginosa
genes required for secretion, translocation and regulation are located contiguously on the
chromosome within five operons; while genes encoding the effectors and associated
chaperones (indicated by white boxes) are located somewhere else on the chromosome.
ExsA-binding sites (red ovals) are located upstream of all the T3SS related genes. ExsA
protein is indicated by the red circle. The inversion of three P. aeruginosa operons




Fig. 1-2 Occurrence of the protein homologues of T3SS genes in Pseudomonas and other
bacterial families. The presence or absence of protein in an organism is marked with a
quantitative color scale, showing the amount of sequence conservation between the input
protein and its best hit in the other species. The results were generated by an on-line tool
STRING (Search Tool for the Retrieval of Interacting Gene/Proteins,
http://string.embl.de/).
29
Fig. 1-3 Schematic model of the Type III Secretion System (T3SS) in P. aeruginosa. The
T3SS is assembled by large multisubunit complexes crossing the whole bacterial cell
envelope and its four effectors are directly translocated to host cells (modified from Yahr,
T.L., http://www.healthcare.uiowa.edu/labs/yahr/projects.htm).
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towards Pho family GTPases was demonstrated in vitro and in vivo (Goehring et al.,
1999; Henriksson et al., 2002; Krall et al., 2002). The physiological consequence is
disruption of actin cytoskeleton, cell rounding, inhibition of wound migration and
healing, and prevention of bacterial uptake into epithelial cells and macrophages (Sundin
et al., 2001; Sun and Barbieri, 2004). The C-terminal domain of ExoS has ADP-
ribosylase activity directed towards Ras and likely other small GTPases, which is
important for phagocytic functions (Barbieri and Sun, 2004; DiNovo et al., 2006). ExoY
is an adenylate cyclase which is activated by a eukaryotic factor distinct from calmodulin
(Yahr et al., 1998). Translocation of ExoY to eukaryotic host cells results in elevated
intracellular cAMP levels and morphological changes in epithelial cells (Vallis et al.,
1999a). ExoU has phospholipase activity that is responsible for acute cytotoxicity of P.
aeruginosa toward epithelial cells and macrophages (Sato and Frank, 2004).
Translocation of these effectors facilitates the successful evasion of phagocytosis and
enhances bacterial dissemination by causing host tissue damages, which has been
demonstrated through various approaches, such as cell culture and animal infection
experiments, as well as epidemiological studies (Apodaca et al., 1995; Sawa et al., 1998;
Roy-Burman et al., 2001; Holder et al., 2001b).
1.2.3.3 Clinical importance of T3SS in P. aeruginosa
It  has  been  shown  that  type  III  secretion  genes  are  prevalent  in P. aeruginosa
isolates from patients and non-hospital environments (Feltman et al., 2001). Moreover,
antibodies against secreted components of TTSS have been detected in CF patients
suffering from P. aeruginosa infections, which indicates that TTSS is expressed in the
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lungs of CF patients (Moss et  al., 2001; Banwart et al., 2002). In addition, active
secretion of type III proteins by clinical P. aeruginosa isolates is associated with poor
clinical outcomes in patients suffering from pneumonia (Hauser et al., 2002). As an
important virulence determinant, T3SS is not uniquely identified in P. aeruginosa strains
collected from humans; environmental isolates also harbor the genes involved in the
T3SS, suggesting it is a common secretion system among this bacterial species.
Comprehensive understanding of T3SS regulation might provide a theoretical basis for
developing new strategies to control P. aeruginosa infections.
1.3 Regulation of virulence factor production in P. aeruginosa
P. aeruginosa deploys a large number of virulence factors to facilitate its
infection and survival in host. The expression and production of these virulence factors
are subjected to tight regulation in response to environmental changes, which involves
transcriptional regulators, two component systems, sigma factors, quorum sensing
systems and other proteins.  In the following subsections, the mechanisms of virulence
regulation will be reviewed in detail.
1.3.1 Regulation of bacterial membrane associated virulence factors
1.3.1.1 Regulation of flagellar biogenesis
More than 40 genes have been identified to encode structural/assembly or
regulatory components of the flagellar organelle in the genome of P. aeruginosa, which
indicates that expression of flagellar is likely to be energetically expensive. Therefore, the
32
transcription of the flagellar genes is tightly regulated. A four-tiered transcriptional
regulatory circuit has been reported to control flagellar biogenesis (Dasgupta et al.,
2003). Class I genes are constitutively expressed, which include the transcriptional
activator FleQ and the alternative sigma factor FliA (?28).  Synthesis  of  FleQ  is  ?70-
dependent and is inhibited by the cAMP receptor protein Vfr (Dasgupta et al., 2002). The
activity  of  FleQ  is  also  prosttranslationally  inhibited  by  a  direct  interaction  of  FleN
(Dasgupta and Ramphal, 2001b). The other Class I factor, FliA, is required for the
transcriptional expression of the class IV genes, including fliC (encoding flagellin) (Frisk
et al., 2002). Class II genes include those encoding the motor, basal body export
apparatus and the fleSR gene, encoding a two-component regulatory system. Activation
of  class  II  genes  requires  both  FleQ  and  RpoN  (?54). Class III genes encode hook
proteins, whose expression requires FleR, FleQ and RpoN (Dasgupta et al., 2003).
1.3.1.2 Regulation of type IV pili biogenesis
Over 30 genes are required for the biosynthesis and function of type IV pili,
which can be divided into four groups: the biosynthesis genes (pilA-F, pilM-Q, pilV-Z,
fimT-V), the genes encoding chemotactic-like proteins (pilG-L, chpA-E), the genes
encoding transcriptional regulators (pilSR, fimS, algR, algU, vfr and rpoN) and the genes
required  for  the  function  of  pilus  (pilTU) (Alm and Mattick, 1997; Mattick, 2002).
Transcription of pilA in P. aeruginosa is tightly controlled by a classical RpoN-
dependent, two-component sensor-regulator pair, PilS/PilR (Hobbs et al., 1993; Strom
and Lory, 1993). The transmembrane sensor PilS is polarizedly located at the pole of the
bacterial cell for sensing unknown environmental signal(s) (Boyd, 2000). The other
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atypical sensor regulator pair FimS/AlgR is also required for pili biogenesis as both fimS
and algR mutants lack extracellular pili (Whitchurch et al., 1996). In addition, the type IV
pili dependend twitching motility is also controlled by Vfr and the chemosensory
phosphotransfer signal transduction system chp (Alm and Mattick, 1997; Beatson et al.,
2002). The chp gene cluster in P. aeruginosa contains three CheY-like response receiver
domains (pilG, pilH and chpA) (Darzins, 1993; Darzins, 1994; Alm and Mattick, 1997).
The  ChpA  protein  appears  to  be  one  of  the  most  sophisticated  signal  transduction
proteins, which contains seven histidine phosphotransfer (Hpt) domains, suggesting that
this protein is receiving and integrating multiple inputs and/or transmitting multiple
outputs (Alm and Mattick, 1997; Mattick, 2002). The environmental signals that control
type IV pili dependend twitching motility are not well understood. Nutritional
composition as well as cell density have been shown to influence twitching motility
(Wall and Kaiser, 1999).
1.3.2 Regulation of extracellular virulence factors
1.3.2.1 Regulation of EPS biosynthesis
Biosynthesis of alginate involves more than 10 genes including the genes within
the algD-algA operon and algC. In addition, alginate biosynthesis is under the control of
complicated regulation mechanisms that involve a number of genes encoding
transcriptional regulators and sigma factors (Ramsey and Wozniak, 2005). Expression
from the alginate biosynthetic operon (algD-algA)  is  under  the  control  of  the algD
promoter, whose activity is tightly controlled by multiple regulatory elements. The
alternative sigma factor AlgT (AlgU) is one key regulator which induces the expression
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of algD as well as other regulatory proteins that enhance algD transcription (Govan and
Deretic, 1996). The activity of AlgT is negatively regulated by the anti-sigma factor
MucA and its partner MucB, a periplasmic protein. Inactivation of mucA or mucB leads
to deregulation of AlgT and conversion to mucoid phenotype (Martin et al., 1993;
Mathee et al., 1997). In fact, it has been reported that over 80% of mucoid P. aeruginosa
isolates from CF patients harbour mutations in mucA, suggesting that this region is a hot-
spot for mutagenesis (Boucher et al., 1997). However, AlgT is not the only sigma factor
that regulating the algD promoter. Under certain conditions, the alternative sigma factor
RpoN (?54) is required for algD expression (Boucher et al., 2000). Additionally,
expression of the algD-algA operon is also regulated by some other elements, such as the
response regulators AlgR and AlgB, the DNA-binding protein AlgZ, the histone-like
proteins IHF and AlgP, and the activator AlgQ (Ramsey and Wozniak, 2005). Such
regulation network by multiple regulatory proteins in algD expression suggests that
alginate production is under tight control and takes place only under specific
environmental  conditions.  Besides  the  regulation  of  the algD-algA operon,  the  other
independent alginate gene algC is also controlled by the response regulator AlgR, which
binds three regions positioned upstream and downstream of the transcription start site
(Fujiwara et al., 1993).
The regulation mechanism of Psl and Pel polysaccharide production is not clearly
understood yet. To date, two regulatory systems have been identified that control pel and
psl expression.  The  first  system is  the  Wsp chemosensory  system together  with  cellular
levels of cyclic di-GMP (c-di-GMP). Mutation of wspF increases the expression level of
psl and pel (Hickman et al., 2005). WspF controls the methylation state of WspA, which
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subsequently controls WspR (Spiers et al., 2002). WspR displays diguanylate cyclase
activity and generates c-di-GMP, a small signaling molecule involved in many cellular
processes. The constitutive activation of WspR results in high levels of cellular c-di-
GMP, which increases the transcriptional levels of psl and pel and thereafter activates
biofilm formation (Hickman et al., 2005). More recently, FleQ has also been identified as
a c-di-GMP-responsive transcriptional factor that suppresses psl and pel expression but
activates fleSR expression when cellular c-di-GMP level is low. However, the interaction
between the N-terminal domain of FleQ and c-di-GMP occurs when the level of c-di-
GMP increases, which leads to dissociation of FleQ from pelA promoter and thereby
causes derepression of pel transcription (Hickman and Harwood, 2008). Collectively,
these findings suggest that the signaling molecule, c-di-GMP, plays important roles in
controlling Pel and Psl polysaccharide production. The GacS/GacA/rsmZ signal
transduction pathway is the other regulatory system. GacS and GacA is a sensor-regulator
two-component pair (Parkins et al., 2001). RsmZ is the GacA-dependent small regulatory
RNA and it mediates gene regulation by sequestering posttranscriptional regulatory
protein RsmA, which consequently relieves target transcripts from RsmA-mediated
translational control (Heurlier et al., 2004). Recently, it has been identified that this
GacS/GacA/RsmZ pathway under the regulation of two sensor kinase-response regulators
RetS (RtsM) and LadS. Moreover, the two sensors, together with the GacS/GacA/RsmZ
pathway form a signaling network reciprocally regulating the genes required for
colonization and acute infection and those associated with biofilm formation including
pel and psl (Goodman et al., 2004; Laskowski et al., 2004; Ventre et al., 2006).
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1.3.2.2 Regulation of exotoxin and extracellular enzyme production
Studies have shown that many of the known virulence factors, including elastase,
LasA protease, alkaline protease, phospholipase C, lipase, exotoxin A, rhamnolipids, and
pyocyanin, are all coordinately controlled by the cell density-dependent quorum sensing
systems in P. aeruginosa (Passador et al., 1993; de Kievit and Iglewski, 2000; Rumbaugh
et al., 2000; Smith and Iglewski, 2003). Quorum sensing is a process for bacteria to
communicate  within  a  group  to  coordinate  their  behavior  to  function  as  a  multicellular
organism (Fuqua et al., 2001). In P .aeruginosa, two distinct AHL-based quorum-sensing
systems, LasR/I and RhlR/I, have been identified. In the LasR/I system, LasI synthesizes
the extracellular autoinducer N-3-oxododecanoyl homoserine lactone (3-oxo-C12-HSL),
which  acts  together  with  the  regulator  protein  LasR in  a  complex  to  activate  or  repress
expression of target genes (Pesci et al., 1997b). The second system is the RhlR/I system
and it is under the regulation of the LasR/I system (de Kievit et al., 2002). RhlI produces
the second autoinducer, N-butanoyl-L-homoserine lactone (C4-HSL), which acts together
with the regulator RhlR to control expression of different genes (Pesci et  al., 1997a).
Additionally, P. aeruginosa also produces a third signaling molecule, the Pseudomonas
quinolone  signal (PQS), which is integrated in the AHL quorum sensing response
governed by the LasR/I and RhlR/I systems (Pesci et al., 1999; McKnight et  al., 2000).
The  synthesis  and  activity  of  PQS  is  also  required  for  virulence  factor  production,
particularly, for rhl-dependent exoproducts, such as pyocyanin (Diggle et al., 2003).
Apart from quorum sensing systems, the other important regulatory factor for the
expression of alkaline protease and siderophores is the availability of iron. The negative
regulation of the expression of alkaline protease and pyoverdine by iron is mediated by
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the Fur repressor through the interaction with the Fur repressor binding motif at their
promoter regions (Litwin and Calderwood, 1993; Prince et al., 1993). In addition to the
Fur system, the production of pyoverdine and alkaline protease also requires a
transcriptional activator PvdS (Cunliffe et al., 1995; Shigematsu et al., 2001). It has been
shown that pvdS expression is repressed by the Fur repressor (Cunliffe et al., 1995;
Miyazaki et al., 1995). In a high-iron containing environment, iron represses pvdS
expression but activates the production of the repressor Fur, and therefore shuts down the
expression of aprA and pvd genes, which encode pyoverdine and alkaline protease
respectively (Fukushima et al., 1996).
1.3.3 Regulation of T3SS
A functional T3SS requires the energy-consuming expression of 20 or more
proteins, which is restricted for bacterial pathogens in most environments. Generally,
transcription of type III secretion genes is controlled by multicomponent regulatory
networks which integrate a diverse set of environmental signals to make sure T3SS genes
are expressed when they are needed. Moreover, expression of several T3SSs is also
controlled by unidentified host factors and is activated by contact with host cells (Hueck,
1998). Different bacterial species have developed diverse regulatory systems to sense the
environment clues and control T3SS expression with two-component response regulators
and AraC-like transcriptional activators being the common themes. Besides these, some
pathogens regulate T3SS expression in response to temperature and osmolarity by
histone-like proteins; while some others require alternative sigma factors (Hueck, 1998).
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In the following subsections, the regulatory networks controlling P. aeruginosa T3SS
expression will be elaborated in detail.
1.3.3.1 Environmental cues and host signals
As described in section 1.2.4, the T3SS in P. aeruginosa involves more than 40
gene products. Expression of the T3SS genes is under tight regulations and is finely tuned
to environmental signals (Fig. 1-4). So far, three potent T3SS inducing signals have been
described: i) contact of P. aeruginosa with eukaryotic host cells, ii) presence of serum.
and iii) low extracellular concentrations of calcium (in the micromolar range) (Frank,
1997; Vallis et al., 1999b). The first two conditions are known as tissue culture
conditions; while the third one is called bacterial growth condition, which is generally
achieved by supplementing the medium with nitrilotriacetic acid (NTA), a chelator of
calcium and zinc ions. It has been reported that cocultivation in the presence or absence
of serum during infection lead to two patterns of the ExoS effector secretion. In the
absence of serum, ExoS is specifically transclocated in to eukaryotic cells. While in the
presence of serum, ExoS is translocated to the host cells as well as medium (Vallis et al.,
1999b). Additionally, it has been noticed that ExoS production by P. aeruginosa grown
in low Ca2+ bacteriological  medium  also  differs  from  the  pathogen  grown  under  tissue
culture  conditions  when  using  type  III  secretory  (psc)  mutants.  Under  the  low  Ca2+
condition, ExoS production is not detectable from the psc mutants; while grown in tissue
culture  medium,  ExoS  is  produced  but  not  secreted,  confirming  the  requirement  of  the
Psc Proteins for the secretion of ExoS (Vallis et al., 1999b). Other than these three
inducing signals, some other signals that repress expression of P. aeruginosa T3SS genes
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Fig. 1-4 The environmental signals and regulatory systems which regulate the expression
of the P. aeruginosa T3SS. Solid lines show the regulatory connections that have been
demonstrated experimentally; while dashed lines indicate hypothetical regulatory
connections.  Details  of  each  system  are  explained  in  text  (modified  from  Yahr  and
Wolfgang, 2006).
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also have been described in recent years. For example, conditions like metabolic stress,
DNA  damage,  high  levels  of  Cu2+, and low osmolarity have been reported to repress
T3SS.  However,  the  response  to  these  signals  appears  to  be  stochastic  since  only  a
subpopulation of bacteria express the T3SS genes under inducing conditions (Hornef et
al., 2000; Rietsch and Mekalanos, 2006; Yahr and Wolfgang, 2006).
1.3.3.2 The exoenzyme S regulon
The production of exoenzyme S by P. aeruginosa was first reported in 1978
(Iglewski et al., 1978). Later on, the exoenzyme S trans-regulatory locus required for
induction of ExoS production was cloned (Frank and Iglewski, 1991). Extensive efforts
have been devoted to understand the roles of this genetic locus. It has become clear that
this locus on the chromosome harbors five operons, pscUTSRQPON, popN-pcr1234DR,
pcrGVH-popBD, exsCEBA and exsD-pscBCDEFGHIJKL, which encodes proteins
involved in T3SS secretion, translocation and regulation (Frank, 1997). Moreover, the
genes encoding the type III effectors and associated chaperones have been identified to
be located at separate sites on the chromosome somewhere else, or in the case of exoU,
on a pathogenicity island (Kulasekara et al., 2006; Yahr and Wolfgang, 2006). Up to
now, 43 T3SS genes have been identified in P. aeruginosa (Fig. 1-1), which are
coordinately regulated by its master regulator ExsA, a member of the AraC family
transcriptional activators. Therefore, a member of the exoenzyme S regulon is defined as
the one being coordinately regulated by the master transcriptional factor ExsA (Frank,
1997). The DNA binding properties of ExsA and ExsA-dependent promoters were
characterized in detail in 2008. ExsA-dependent promoters lie upstream of exoS, exoT,
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exoY, exoU, pscU, popN, pcrG, exsC and exsD. The core consensus sequence in these
promoters is AaAAAnwnMygrCynnnmYTGayAK spanning from -57 to -33 site, which
overlaps the -35 RNA polymerase binding site. In vitro EMSA assay between ExsA and
the promoter of exoT shows two shift products, which suggests that two molecules of
ExsA are likely required to bind to the promoter in order to give rise to the 2nd shift
product (Brutinel et al., 2008). Meanwhile, it has been shown that ExsA auto-regulates its
own expression by activating the transcription of exsCEBA operon.  In addition to its
auto-regulation, the expression of exsCEBA operon is positively regulated by the
transcriptional factor PsrA, which can bind the exsCEBA promoter in vitro. However,
high level of PsrA is required to form the binding complex, which suggests that
regulation by PsrA may not due to direct binding (Shen et al., 2006).
In recent years, it has been noticed that the activity of ExsA is also regulated by
protein ligands. Two anti-activators, ExsD and PtrA, were identified to antagonize ExsA
transcriptional activation through direct binding to ExsA. PtrA was first  identified to be
induced during P. aeruginosa burn wound infections in an IVET screen and later on it
was found to be induced in the presence of Cu2+, which suggests that Cu2+ released from
burn wounds serves as a environmental signal to repress T3SS expression (Ha and Jin,
1999; Ha et al., 2004). ExsD is one of a cascade of interaction proteins which function to
couple the expression of T3SS to the type III secretory activity under low Ca2+ conditions
(Yahr and Wolfgang, 2006). Under this condition, a small T3SS protein ExsE is secreted
through the Type III secretion channel and leaves the anti-antiactivator ExsC free to
interact with ExsD to form an ExsC-ExsD complex, which sets ExsA free to activate the
ExsA-dependent promoters. However, under high Ca2+ conditions, the type III secretion
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channel  is  closed.  As  a  result  ExsE remains  intracellularly  and  associates  with  ExsC to
form an ExsE-ExsC complex, which leaves ExsD to interact ExsA. Formation of the
ExsD-ExsA complex prevents ExsA from activating T3SS transcription (Fig. 1-5)
(McCaw et al., 2002; Dasgupta et al., 2004; Rietsch et al., 2005; Urbanowski et al.,
2005; Yahr and Wolfgang, 2006; Urbanowski et al., 2007).  It is worthwhile to note that
such  a  feedback  mechanism  which  couples  transcription  and  secretion  is  a  common
regulatory feature of T3SSs (Miller, 2002).
Induction of T3SS by host cell contact occurs at the level of transcription.
Generally, both host cell contact and low Ca2+ signals activate the ExsCEDA regulatory
cascade by the secretion of ExsE (Urbanowski et al., 2005; Urbanowski et al., 2007).
However, a recent study focusing on the contribution of ExsC to host contact-dependent
T3SS gene regulation suggests that the regulation of T3SS by cell contact may involve
distinct ExsC-dependent and ExsC-independent pathways (Dasgupta et al., 2006). The
ExsC-dependent pathway likely contributes to the survival of P. aeruginosa outside of
the context of mammalian infections in response to generic cell contact, while the ExsC-
independent pathway might be required for a specific adaptation to maximize T3SS
expression during infections as this pathway only responds to specific mammalian cell
types.
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Fig. 1-5 Schematic model for the coupling of transcription with type III secretory
activity. The right panel presents the interactions between ExsECDA proteins under low
Ca2+ conditions,  or  upon  contact  with  host  cells.  Activated  by  these  T3SS  inducing
signals,  the  type  III  secretion  channel  is  open  and  ExsE is  secreted  or  translocated  into
host  cells  by  the  T3SS,  which  favors  the  formation  of  the  ExsC-ExsD complex  thereby
making ExsA available to activate transcription of the T3SS genes. The left panel
illustrates the interactions between these regulatory proteins under high Ca2+ conditions.
In such environments, ExsE remains intracellular, leading to the formation of the ExsE-
ExsC and ExsD-ExsA complexes. As a result, ExsA-dependent transcription is prevented
(modified from Yahr and Wolfgang, 2006).
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1.3.3.3 Regulation of T3SS through the cAMP-Vfr pathway
Recent studies suggest that the expression and function of ExsA are modulated by
several upstream regulatory proteins, including a cAMP-dependent transcription factor
Vfr (Wolfgang et al., 2003). It has been reported that the conditions favoring the
expression of T3SS, such as low Ca2+ and high salt, also increase bacterial intracellular
cAMP levels (Wolfgang et al., 2003; Rietsch and Mekalanos, 2006). Two adenylate
cyclases,  CyaA  and  CyaB,  are  produced  by P. aeruginosa.  While  both  of  them  are
responsible  for  cAMP  synthesis,  the  contribution  of  CyaB  is  much  greater  than  that  of
CyaA. CyaB has six transmembrane helices that anchor its catalytic domain to the inner
membrane, suggesting its potential role as a sensor for extracellular signals (Wolfgang et
al., 2003).
Intracellular  cAMP in  turn  acts  as  an  allosteric  regulator  of  a  homologue  of  the
cAMP receptor protein, Vfr, which was initially found to be involved in the regulation of
quorum sensing, exotoxin A production and twitching motility (West et al., 1994; Albus
et al., 1997; Beatson et al., 2002; Wolfgang et al., 2003). In 2003 a transcripton analysis
by microarray revealed that T3SS transcription is controlled by Vfr and intracellular
cAMP, which suggests that the global regulator Vfr controls virulence gene expression in
P. aeruginosa.   Genetic  evidence  suggests  that  cAMP,  Vfr  and  ExsA act  on  a  common
pathway to regulate T3SS gene expression as T3SS expression in the vfr and cyaB
mutants can be restored by ExsA overproduction. However, the exsA mutant cannot be
complemented by overproduction of either Vfr or cAMP, suggesting that Vfr and cAMP
probably  act  upstream  of  or  at  the  same  step  as  ExsA  (Wolfgang et al., 2003). Yet,
cAMP-Vfr complex did not seem to regulate exsA expression directly as it failed to
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recognize the exsCEBA promoter  in  EMSA  (Shen et al., 2006). So far, only two Vfr
binding sites have been identified in P. aeruginosa: promoters of lasR, encoding the
regulator of the Las quorum sensing system, and fleQ, encoding the regulator of flagellar
biogenesis (Albus et al., 1997; Dasgupta et al., 2002). However, these two regulators
have no influence on T3SS expression (Dasgupta et al., 2003; Hogardt et al., 2004;
Bleves et al., 2005). As some CRP family members are able to work synergistically with
AraC-like transcriptional regulators, the cAMP-Vfr complex probably enhances ExsA
activity as part of a transcriptional complex (Yahr and Wolfgang, 2006).
1.3.3.4 Reciprocal regulation of T3SS and biofilm
There are two types of P. aeruginosa infections, acute or chronic infections.
Expression of T3SS and other virulence factors regulated by the cAMP-Vfr pathway is
associated with acute infections; while production of EPS, including alginate and the
Pel/Psl polysaccharide, biofilm formation, and quorum sensing are associated with
chronic infections (Yahr and Wolfgang, 2006). Recently, a series of factors contributing
to chronic infections has been found to have negative effects on P. aeruginosa T3SS.
First,  it  was  found  that  expression  of  the  T3SS  genes  is  repressed  in  the mucA mutant
(Wu et al., 2004). MucA is an antisigma factor, which antagonizes the alternative sigma
factor AlgT. As described previously in section 1.2.2.1, AlgT regulates the production of
alginate and mutation of mucA releases  the  antagonization  of  AlgT  and  results  in  a
mucoid phenotype due to overproduction of alginates, which is a clinical indicator for the
onset of chronic P. aeruginosa infection in the CF airways (Martin et al., 1993; Mathee et
al., 1997). Considering the fact that many P. aeruginosa isolates from older CF patients
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are mucoid strains carrying the mucA mutation, this mutation at least partially accounts
for the lack of T3SS gene expression in the mucoid isolates. Second, two sensor kinase-
response regulator hybrid proteins, RetS and LadS have been found to affect T3SS in an
opposite manner (Goodman et al., 2004; Laskowski et al., 2004; Zolfaghar et al., 2005;
Ventre et  al., 2006). RetS activates T3SS but represses pel and psl loci; while LadS
represses T3SS but contributes to biofilm formation. Both proteins contain 7
transmembrane domain, transmembrane associated periplasmic sensing domains, sensor
histidine kinase domain, an ATPase, and a C-terminal region encoding either a single
(LadS) or tandem (RetS) response regulator receiver domains. Their activities are likely
to be mediated through the GacS/GacA/rsmZ pathway (Ventre et al., 2006), which has
been discussed in the previous subsection 1.2.2.2.
Expression of the two quorum sensing systems (LasR/I and RhlR/I) and the
production of the three autoinducers (3-oxo-C12-HSL, C4-HSL and PQS) are growth
dependend and they contribute to P. aeruginosa chronic infections (de Kievit et al., 2001;
Lesprit et al., 2003). Studies on P. aeruginosa quorum sensing systems have shown that
LasR/I system is not involved in the T3SS regulation, but the strains with the mutations
in the RhlR/I system show increased expression of T3SS genes and secretion of ExoS
during exponential growth (Hogardt et al., 2004; Bleves et al., 2005). In addition, the
alternative sigma factor RpoS also exerts a negative effect on T3SS in P. aeruginosa.
Given the fact that RpoS regulates RhlR/I system, the mechanism of regulation by RpoS
is probably through the RhlR/I system (Whiteley et al., 2000; Hogardt et al., 2004).
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1.3.3.5 Regulation of T3SS by stress
As mentioned in the section 1.3.3.1, low Ca2+ and host contact are not the only
signals to affect the expression of T3SS genes. Osmolarity, DNA damage and metabolic
stress also influence the transcription of T3SS genes (Yahr and Wolfgang, 2006). Hyper-
osmotic stress conditions like high salt or sucrose level have been shown to induce T3SS
genes significantly by microarray studies (Rietsch and Mekalanos, 2006; Aspedon et al.,
2006). Moreover, intracellular cAMP level also increases when salt concentration is
elevated, which suggests that regulation of T3SS by osmotic stress is likely through the
cAMP-Vfr pathway (Rietsch and Mekalanos, 2006). Another stress signal, DNA damage,
was found to repress T3SS gene expression (Wu and Jin, 2005). The SOS-induced gene
product PtrB was found to be a repressor of T3SS expression but the mechanism is
unknown. It is likely that the response to DNA damage may redirect energy resources to
the SOS stress responses in bacterial cells. Furthermore, metabolic stresses, which
usually are associated with the overproduction or depletion of specific metabolites, have
been found to influence T3SS gene expression profoundly. For example, a low
expression level of T3SS genes has been observed in the aceA or aceB mutants, lacking
the pyruvate dehydrogenase, or in the glucose transport regulator mutant (gltR) (Dacheux
et al., 2002; Wolfgang et al., 2003). It was also found that overproduction of MDR efflux
pumps MexCD-OprJ and MexEF-OprN or overproduction of genes involved in histidine
transport and metabolism reduces T3SS gene expression (Rietsch et al., 2004; Linares et
al., 2005). Moreover, a recent study indicates that an unidentified metabolite derived
from acetyl-CoA controls T3SS gene expression (Rietsch and Mekalanos, 2006).
However, the mechanisms by which metabolic stress regulates T3SS remain elusive.
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1.4 Treatment and prevention
P. aeruginosa is one of the most worrisome pathogens for the CF patients as well
as the patients with pneumonia, particularly those in intensive care settings (Fleiszig et
al., 1995; Giamarellou, 2000; Garau and Gomez, 2003). One of the biggest challenges to
treat P. aeruginosa infection is its inherent resistance to many antibiotics, which is
largely due to its semi-permeable outer-membrane and possession of efflux systems that
reduce the intracellular drug concentration. Moreover, the rapid mutation rate of the
pathogen also brings difficulties during courses of therapy (Carmeli, 2008). Therefore,
great efforts have been devoted to develop new and improved strategies to prevent and
control infections. Traditionally, treatment for P. aeruginosa infection largely relies on
antibiotics. Empiric use of various combinations of different antibiotics and drugs might
work by inhibiting P. aeruginosa growth to reduce virulence factor production or by anti-
inflammation (Cigana et  al., 2007; Campodonico et al., 2008). Although early
interventions  with  antibiotic  treatments  have  been  under  the  trials  in  some  European
centers and showed promising results, additional work will be required to unambiguously
demonstrate measurable improvements in clinical outcomes for CF patients, especially in
the long term (Frederiksen et al., 1996; Hoiby and Koch, 2000; Wood and Smyth, 2006).
On the other hand, immunotherapy against P. aeruginosa is another method to prevent
initial colonization with non-mucoid strains as well as to limit the infection to those less
pathogenic strains (Henry et al., 1992). Because of the ineffective innate immune system
in CF patients, researches have been focused on the activation of acquired immune
system, whose major effectors are antibodies. Many virulence factors of P. aeruginosa
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have been used for active immunization against this pathogen. For example, a bivalent P.
aeruginosa flagella vaccine has shown to be safe and immunogenic, which reduces the
risk of initial infection with P. aeruginosa strains with the same flagella subtypes
included in the vaccine (Doring et al., 2007). Other approaches targeting the restoration
of CFTR expression or function as well as the consequences of defective CFTR function
in CF patients may be promising but are still far away (Campodonico et al., 2008).
With the increase in the number of clinical P. aeruginosa isolates showing
multiple resistances to conventional antibiotics, the need to speed up research and
development of alternative approaches for treatments of P. aeruginosa infections appears
to be greater than previously appreciated (Norrby et al., 2005). One of the foci is to target
at  the  regulatory  components  of  the  major  virulence  factors.  Since  a  wide  range  of
extracellular virulence factors are coordinately regulated by quorum sensing systems as
reviewed in subsection 1.3.2.2, but not the essential phenotypes for bacterial survival,
inhibition of quorum sensing is not expected to create the harsh selection pressure as seen
with conventional antibiotics. Therefore, the pursuit of quorum sensing blockage or
quorum quenching is presently considered as a possible treatment of a variety of P.
aeruginosa based infection by controlling or interfering with the fundamental microbial
activity (Zhang and Dong, 2004; Bjarnsholt and Givskov, 2007a), Development of
quorum sensing blockages follows two directions. First, scientists have shown a great
interest in searching for quorum quenching enzymes which are able to degrade quorum
sensing signals. Several groups of AHL-degradation enzymes have recently been
identified in different organisms, including eukaryotes and bacteria (Dong and Zhang,
2005). The first quorum quenching enzyme, an AHL-lactonase, encoded by aiiA gene
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was identified from a soil bacterial isolates belonging to a Gram-positive Bacillus species
(Dong et al., 2000; Dong et al., 2001). Subsequently, AHL-degradation enzymes,
including AHL lactonase and AHL acylase, have been identified from a range of other
bacterial isolates and strains (Dong and Zhang, 2005). Moreover, AHL-degradation
enzymes, such as paraoxonases encoded by PON genes, have also been identified in
eukaryotes (Yang et al., 2005; Draganov et al., 2005). However, due to the protein nature
of AHL degrading enzymes, much remains to be studied on the possible methods in
protein delivery, stability, and efficacy. The second direction is to search for quorum
sensing inhibitors in extracts of natural products or through chemical screening. The first
example, the halogenated furanones which are produced by the Australian macroalga,
Delisea pulchra, have been shown to specifically inhibit bacterial quorum sensing in
Serratia liquefaciens (Givskov et al., 1996). However, these natural furanones do not
efficiently block quorum sensing system in P. aeruginosa. Then, the synthetic derivatives
C-30 and C-56, made using natural furanones as the scaffold, have been shown to inhibit
quorum sensing of P. aeruginosa and reduce bacterial virulence in a pulmonary mouse
model (Hentzer et al., 2002; Hentzer et al., 2003). Recently, a number of natural quorum
sensing inhibitors have been identified in food, herbal and fungal sources and tested on in
vitro biofilms and in a pulmonary mouse model of infection, which have given positive
results (Bjarnsholt et al., 2005; Rasmussen et al., 2005a; Rasmussen et al., 2005b). These
findings highlight the potential in the development of future antibacterial treatment
scenarios. In the case of prevention, it is believed that administration of anti-pathogenic
quorum sensing inhibitor drugs combined with conventional antibiotics might prevent the
onset of chronic infections (Bjarnsholt and Givskov, 2007b). However, such plans need
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to be exploited only after the development of pharmacologically relevant quorum sensing
inhibitory drugs followed by successful clinical trials.
1.5 Aims and scope of present study
P. aeruginosa, as an important opportunistic human pathogen, has become an
excellent model for studying microbial pathogenesis and virulence regulation. The
advances in elucidation of virulence regulatory mechanisms are critical for drug design in
the future. The previous studies have not only determined the roles of T3SS in the
pathogenesis during bacterial infections, but also increased the understanding of how
T3SS expression is regulated. However, the exact structure of the signal molecules
released from the host cells remains elusive and the mechanisms of regulation are far
from clear. This study attempts to address these questions, and therefore the aims of this
study are to:
(1) identify the novel genes associated with T3SS regulation;
(2) explore the putative small signal molecules that regulate the expression of
T3SS;
(3) investigate the molecular mechanism of signal modulation of T3SS.
This thesis is divided into 6 chapters. Chapter 1 is the introduction, reviewing
pertinent literatures.
Chapter 2 describes the establishment of a reliable reporter system pC-lacZ that
monitors the expression level of the exsCEBA operon. Based on this reporter, transposon
mutagenesis was conducted. Transposon mutants obtained showing lower expression
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level of exsCEBA than the wild type strain were selected and the disrupted genes in these
mutants were summarized.
Chapter  3  focuses  on  the spuE::Tn mutant obtained from the mutagenesis. It is
demonstrated that regulation of P. aeruginosa T3SS involves a spermidine transporter
(encoded by spuDEFGH) dependend pathway and spermidine is novel small signal
activating T3SS.
Chapter 4 presents the identification of a LysR type transcriptional regulator
TsrA, which represses T3SS gene expression. Genetic and biochemical evidence suggests
that TsrA regulates T3SS via the global regulator Vfr and spermidine is also involved in
the regulation process.
Chapter 5 reports that the ?spuE deletion mutant is less virulent to FVB/N mice
compared with wild type PAO1. In mice pulmonary infection model, immunization of
mice with the recombinant protein SpuD protects the animals from P. aeruginosa
infections.
Chapter 6 summarizes the relevance and significance of the above research
findings.
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Chapter 2 Genetic screening of the novel genes involved in regulation of
T3SS expression in P. aeruginosa
2.1 Introduction
Studies in the past two decades have greatly advanced our understanding on the
type III secretion system (T3SS) of P. aeruginosa. About 43 T3SS genes have been
identified (Yahr and Wolfgang, 2006), but not all isolates contain the same repertoire of
effector genes. For example, cytotoxic P. aeruginosa isolates possess exoU, whereas non-
cytotoxic isolates lack this gene (Frank, 1997). Despite this variation, the general T3SS
regulatory mechanism appears to be highly conserved among P. aeruginosa isolates.
Expression of T3SS can be induced by three types of environmental signals, i.e., (i)
limitation  of  calcium,  (ii)  serum,  and  (iii)  contact  with  eukaryotic  cells  (Frank,  1997;
Vallis et al., 1999b). The transcriptional expression of these T3SS genes are coordinated
by its master regulator ExsA encoded by the exsCEBA operon, which activates the T3SS
system by binding to the promoter motif of T3SS genes, including the promoter of
exsCEBA itself (Yahr and Frank, 1994; Frank 1997).  In addition to its auto-regulation,
expression of the exsCEBA operon seems to be directly regulated by the transcriptional
factor PsrA; in vitro analysis showed that PsrA forms a complex with the exsCEBA
promoter (Shen et  al., 2006). Furthermore, several upstream regulatory proteins,
including the cAMP-dependent transcription factor Vfr (Wolfgang et al., 2003), the two-
component hybrid regulators LadS and RetS (Goodman et al., 2004; Laskowski et al.,
2004; Ventre et al., 2006), are implicated in modulation of the expression and/or function
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of ExsA. Albeit little is known about the underlying mechanisms by which these
regulators respond to environmental cues, it becomes clear that regulation of T3SS is in
general through modulating the activity of the master regulator ExsA whose expression is
under the control of the exsCEBA promoter (Frank, 1997; Yahr and Wolfgang, 2006).
To identify the new genes implicated in T3SS regulation, several groups have
performed large scale transposon mutagenesis and screened for mutants using different
approaches. The first group of genes, such as truA and aceAB,  were  identified  by
examining the T3SS dependent cytotoxicity of the transposon mutants (Dacheux et  al.,
2002; Ahn et al., 2004). However, to screen these cytotoxicity deficient mutants, each
transposon insertion mutant had to be co-cultured with pre-seeded mammalian cells. Such
mutant screening procedure required a huge amount of work, and therefore only a
relatively low number of mutants could be analyzed (~5000) (Dacheux et al., 2002; Ahn
et al., 2004).  Secondly, several groups of scientists initiated primary screenings for
biofilm mutants and subsequently found that the identified genes, including retS, ladS
and sadARS, are not only involved in the biofilm formation but also in the control of
T3SS expression (Goodman et  al., 2004; Kuchma et al., 2005; Ventre et al., 2006).
Lastly, the T3SS regulatory genes prtR and mucA were identified by Jin’s group as
transposon insertion in these genes resulted in decreased expression of exoT, which was
monitored by the pT-lacZ reporter gene harbored in the plasmid pDN19lacZ? (Wu et al.,
2004; Wu and Jin, 2005). To examine expression of T3SS genes represents a direct way
to screen for T3SS regulatory genes. However, due to potential variations in copy number
of the plasmid in bacterial cells during proliferation of each generation, such a plasmid
reporter may lead to artificial results. Therefore, in this chapter, I aimed to set up a
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chromosomal integrated reporter system that stably maintains a single copy of the
reporter gene for accurate reflection of the expression level of exsCEBA in P. aeruginosa,
and with which to screen for T3SS signaling mechanisms by transposon mutagenesis.
2.2 Materials and methods
2.2.1 Bacterial strains, plasmids and growth conditions
The bacterial strains used in this study are listed in Table 2-1. P. aeruginosa and
E. coli strains  were  routinely  maintained  in  Luria  Bertani  broth  (LB,  per  liter  contains
Bacto-tryptone 10 g, yeast extract 5 g, NaCl 10 g, pH 7.0) or on LB agar at 37°C. Stock
cultures of P. aeruginosa and E. coli strains were maintained in LB containing 20% (v/v)
glycerol and stored at -80°C.  Following antibiotics (Sigma, U.S.A.) were added to
medium when necessary: gentamicin (Gm), 30 µg/ml for P. aeruginosa, and 5 µg/ml for
E. coli; tetracycline (Tc), 50 µg/ml for P. aeruginosa, and 10 µg/ml for E. coli;
carbenicillin (Cb), 300 µg/ml for P. aeruginosa, and ampicillin (Ap) 100 µg/ml for E.
coli.  Induction of T3SS expression was achieved by supplementing LB medium with the
chelating reagent nitrilotiracetic acid (NTA, Sigma, U.S.A.) at a final concentration of 7.5
mM or otherwise indicated.
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Table 2-1. Strains and plasmids used in this study*
Strains or plasmid Description Source or
reference
E. coli
DH5???pir F– f80 dlacZDM15 endA1hsdR17 (rk– mk–) supE44 thi-1
gyrA96 D(lacZYA-argF), used for plasmid transformation
Gibco
     S17-1 res- pro mod+ integrated copy of RP4, mob+, used for




PAO1 Prototrophic laboratory strain Laboratory
collection
PAO1pClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the PAO1 chromosome
This study
PAO1pTlacZ lacZ fused to the exoT promoter and integrated at the attB
site of the PAO1 chromosome
This study




pBT20 The mariner transposon mutagenesis vector; GmR & ApR Schweizer HP
pFLP2 Source of Flp recombinase; ApR Schweizer HP
mini-CTX-lacZ Chromosomal integration vector containing a
promoterless lacZ for construction of transcriptional
fusion; TcR
Schweizer HP
mini-CTX-pC-lacZ mini-CTX-lacZ with the exsCEBA promoter fused to
lacZ; TcR
This study
mini-CTX-pT-lacZ mini-CTX-lacZ with the exoT promoter fused to lacZ;
TcR
This study
* Symbol: Gm, gentamicin; Ap, ampicillin; Tc, tetracycline.
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2.2.2 DNA manipulation
Plasmid DNA was prepared by QIAprep® Miniprep column (Qiagen).
Chromosomal DNA was prepared by MasterPureTM DNA Purification Kit (Epicentre).
Restriction enzyme digestion, ligation, and electrophoresis were performed routinely
following standard procedures. The nucleotide sequences of PCR-derived constructs were
determined with ABI PrismTm dRhodamine terminator cycle sequencing ready reaction
kit (Perkin-Elmer) and an ABI Prism 3770 sequencer.
2.2.3 Construction of reporter strains
All the PCR primers used in this study were designed based on the genome
sequence of P. aeruginosa strain  PAO1  (http://www.pseudomonas.com) (Stover et al.,
2000). PCR amplification was carried out with Pfu Turbo polymerase (Promega) using
the  PAO1  genomic  DNA  as  the  template.  The  promoters  of exsCEBA and exoT were
amplified by PCR using the primer pairs pC-F/pC-R (5’-gctctagacggtgatccagtccttc/5’-
ggggcgcctcctaaagctc), and pT-F/pT-R (5’-ctcggccgtcgtgttcaagc/5’-
aggctgaaggtgcggattcc), and cloned into the integration vector mini-CTX-lacZ (Becher
and Schweizer, 2000; Hoang et al., 2000), respectively. These constructs and the vector
control were introduced into E. coli S17-1(?pir), and then integrated into the chromosome
of P. aeruginosa as described previously (Hoang et al.,  2000).  The  resultant  reporter
strains were designated as PAO1pClacZ and PAO1pTlacZ, respectively.
58
2.2.4 Transposon mutagenesis
The marina transposon carried by plasmid pBT20 (Kulasekara et al., 2005) was
used for mutagenesis to screen for the genes involved in regulation of exsCEBA
expression. The plasmid was transferred from E. coli S17-1(?pir) into the recipient
reporter strain PAO1pClacZ by biparental mating at 37°C for 4 hours.  The mutants were
screened on LB agar plates containing Tc and Gm supplemented with 7.5 mM NTA and
50 µg/ml of 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal). The mutants
which showed lighter blue than the parental strain PAO1pClacZ were selected for further
confirmation by quantitative ?-galactosidase analysis, which is described in the next
subsection.  Arbitrary PCR was then used to identify the genes disrupted by transposon
insertion as described previously (Caetano-Annoles, 1993). Briefly, the arbitrary primer
AD2 (5’-cangctwsgtntscaa) and the specific primer Gm447 (5’-
gtgcaagcagattacggtgacgat) matching the right end of transposon were used for the first
round PCR. The primer pair AD2 and the nested specific primer Gm464 (5’-
tgacgatcccgcagtggctctc) was then used for the second round PCR. The PCR products
were purified using the QIAquick Spin PCR purification kit (Qiagen) and sequenced
using the primer Gm487 (5’-atacaaagttgggcatacg).  The DNA sequences flanking the
transposon insertion were analyzed with the NCBI BLAST server
(http://www.ncbi.nlm.nih.gov/blast/) and the Pseudomonas database
(http://www.pseudomonas.com/).
59
2.2.5 Quantitative ?-galactosidase assay
Overnight bacterial cultures were inoculated in 1:100 ratio to fresh LB medium
supplemented with or without NTA or spermidine as indicated. The growth was
continued with shaking at 37°C for desired time as indicated. ?-Galactosidase activity
was measured as described (Sambrook J. et al., 1987).  The data shown were the averages
from at least three independent experiments and given as Miller units (MU).
2.3 Results
2.3.1 The transcriptional fusion reporters pC-lacZ and pT-lacZ monitor the
expression of exsCEBA and exoT respectively
In this study, to set up a chromosomal integrated reporter system that stably
monitors the T3SS gene expression in P. aeruginosa, I constructed two promoter-lacZ
fusion reporter systems by fusing the promoterless reporter gene lacZ to the promoters of
exoT (pT) and exsCEBA (pC) respectively on the chromosomal integration vector mini-
CTX-lacZ (Hoang et al., 2000). The resultant vectors containing fusion genes pC-lacZ or
pT-lacZ were then integrated separately at the attB site of the strain PAO1 to generate the
report strains PAO1pTlacZ and PAO1pClacZ (Fig. 2-1) following a previously described
method (Hoang et al.,  2000).  As  a  control,  the  vector  min-CTX-lacZ  containing  a
promoterless lacZ gene was also integrated into PAO1 chromosome to generate the strain
PAO1lacZ (Fig. 2-1).
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Fig. 2-1 Schematic chromosomal organization of the reporter strains PAO1pClacZ and
PAO1pTlacZ. Promoter of exsCEBA (pC) and promoter of exoT (pT) were fused with the
lacZ gene and the resultant reporters pC-lacZ and pT-lacZ were integrated to the
chromosomal  of  wild  type  strain  PAO1  to  form  PAO1pClacZ  and  PAO1pTlacZ,
respectively. The PAOllacZ is the control strain with the promoterless lacZ integrated in
the chromosome.
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To test the feasibility and reliability, the two reporter strains, PAO1pTlacZ and
PAO1pClacZ, and the control strain PAO1lacZ were inoculated on T3SS inducing plates
(LB agar plates containing 7.5mM of NTA) with 50 µg/ml of X-gal as enzyme substrate
and  allowed to  grow at  37°C for  20  hours.  The  color  of  the  single  colony  of  each  stain
was examined. As shown in Fig. 2-2B, under T3SS inducing conditions, the colonies of
both PAO1pClacZ and PAO1pTlacZ turned blue after 20 hours incubation, while the
colonies  of  the  control  strain  PAO1lacZ  remained  white.  To  confirm  the  result,  the  ?-
galactosidase activity of each strain was quantified by using ONPG as the substrate.
Overnight cultures of three strains were separately inoculated in LB or LB NTA medium
at the ratio of 1:100 and allowed to grown at 37°C for 5 hours until OD600 reached 1.5.
Bacterial cells from each strain were collected and subjected for quantitative ?-
galactosidase assay. The results showed that in the presence of NTA (i.e., calcium is
limited), the expression level of exsCEBA as reported by strain PAO1pClacZ was
increased by about 7 times (Fig. 2-2A). Similarly, analysis of the reporter PAO1pTlacZ
showed that the expression level of exoT was increased by 8 times when NTA was added.
In contrast, in the absence of exsCEBA or exoT promoter, the ?-galactosidase activity
encoded by promoterless lacZ in the control strain PAO1lacZ was negligible with or
without NTA (Fig. 2-2A). The results obtained from the quantitative assays are consistent
with the results from the plate assay, confirming that the two reporter pC-lacZ and pT-
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Fig. 2-2. Activation of pC-lacZ and pT-lacZ in response to calcium limitation condition
(LB NTA medium). (A) Quantitative ?-galactosidase assay for the reporters pC-lacZ and
pT-lacZ using ONPG as substrate. CK indicates the promoterless lacZ control. The
experiment was repeated twice and the data are means of three replicates (B) Plate assay
for the reporters pC-lacZ and pT-lacZ using X-gal as substrate.
CK                   pC-lacZ               pT-lacZ
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2.3.2 Screening the transposon mutants with decreased T3SS expression
Based on the above results, the reporter PAO1pClacZ was used as the parental
strain for transposon mutagenesis analysis. Several rounds of transposon mutagenesis
were conducted and more than 50,000 Tn mutants were obtained based on the ?-
galactosidase plate assay. About 147 mutants showing less blue or white color on the LB
NTA agar plate containing X-gal were selected and they were named sequentially as
pale1 till pale147.  These selected mutants were subjected to quantitative ?-galactosidase
assay using ONPG as substrate to exclude the false positives. Fig. 2-3 showed that 136
mutants had decreased ?-galactosidase activity than the parent strain; 3 mutants (pale35,
37 and 44) had increased ?-galactosidase activity and 8 mutants (pale38, 41, 73, 74, 75,
77, 113 and 130) had a similar level of ?-galactosidase activity as the parent strain
PAO1pC-lacZ.  In general, the results obtained from quantitative ?-galactosidase assay
were consistent with those from plate screening since approximately 92.5% (136/147) of
the mutants showed light blue or white color on the LB NTA X-gal agar plates also
displayed reduced activity in quantitative assay, which again confirms the reliability of
this pC-lacZ reporter and the screening method used in this study.
2.3.3 DNA sequence analysis of the transposon mutants
During the process of mutagenesis, transposon was randomly inserted into the
chromosome of the reporter strain PAO1pClacZ. At least two kinds of insertion sites
should occur among the 136 mutants showing low ?-galactosidase activity. In the first
case, transposon was inserted at the pC-lacZ fusion gene region and the mutants with this
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kind of insertion should be excluded from further study. In the second case, transposon
was inserted at the bacterial genome other than the pC-lacZ fusion gene region and this
kind of mutants would be characterized further.  To exclude the first possibility, PCR
analysis was carried out using the primers pC-F (5’-gctctagacggtgatccagtccttc-3’) and
lacZ-R (5’-ttatttttgacaccagacc-3’), which were designed to amplify the pC-lacZ fusion
gene (~3.5 kb), for all these 136 mutants. As the transposon fragment is about 3.5 kb in
size, insertion in the pC-lacZ fusion gene would increase its size to about 7 kb, which
could not be amplified with the PCR conditions used in this study. Using this method, 48
of the 136 mutants were found to have transposon insertion at the pC-lacZ reporter gene
(Table 2-2), and these mutants were excluded from further study.
Genomic DNA samples of the 88 remaining mutants with low ?-gal activity and
the 3 mutants with high ?-gal activity were prepared. TAIL-PCR and sequencing analysis
were carried out to identify the disrupted genes of these mutants. Table 2-2 lists the 71
identified Tn-inserted genes/loci that are putatively involved in T3SS regulation, which
were assigned to 10 groups according to their annotated functions as shown in Fig.2-4.
Among them,  5  genes  (retS, exsA, vfr, cyaB, and rhlI/rhlR) encode previously reported
T3SS regulators, which re-confirms the feasibility of this mutant screening method. The





Fig. 2-3 Quantitative ?-galactosidase assay for the mutant pale1-147. The mutant pale1-
147 is labelled as P1 – P147. The parent strain PAO1pClacZ is labelled as ‘+ve’ and the
control strain PAO1lacZ is labelled as ‘-ve’. The experiment was repeated twice and the
data are means of three replicates.
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Table 2-2. List of transposon mutants (pale1- pale147)*
Mutant(s) Gene/locus with Tn insertion Description
Mutants showing low ?-galactosidase activity
Pale2 rsaL Regulatory protein RsaL
Pale3 pa3066 Hypothetical protein
Pale4 vfr Transcriptional regulator Vfr
Pale5 metF 5,10-methylenetetrahydrofolate reductase
Pale6, 135 exsA Transcriptional regulator ExsA
Pale7 Between pa3535& pa3536 Pa3535: probable serine protease
Pa3536: hypothetical protein
Pale8, 13 N.A. 16S ribosomal RNA
Pale9 speD S-adenosylmethionine decarboxylase proenzyme
Pale10, 94, 101 Between rluC & rne RluC: ribosomal large subunit pseudouridine
synthase C
Rne: ribonuclease E
Pale11 pa0833 Hypothetical protein
Pale12 ppk Polyphosphate kinase
Pale15, 66, 78,
87, 96, 108, 118,
121
retS (rtsM) RetS (Regulator of Exopolysaccharide and
Type III Secretion)
Pale16 spuE Polyamine transport protein
Pale18 pa3518 Hypothetical protein
Pale19 pa5307 Hypothetical protein
Pale20 Between spuG & spuH SpuG: polyamine transport protein PotH
SpuH: polyamine transport protein PotI
Pale21 potA Polyamine transport protein PotA
Pale22 nusA N utilization substance protein A
Pale24, 26, 79 truB tRNA pseudouridine 55 synthase
Pale25 desA Delta-9 fatty acid desaturase, DesA
Pale29, 40 pgi Glucose-6-phosphate isomerase
Pale36 pa4543 Conserved hypothetical protein
Pale39 Between mucD & lepA MucD: serine protease MucD precursor
LepA: GTP-binding protein LepA
Pale42 Between queA & pa3824.1 QueA: S-adenosylmethionine:trna
ribosyltransferase-isomerase
Pa3824.1: tRNA-Leu
Pale43 pa0620 Probable bacteriophage protein
Pale49 mexH Probable Resistance-Nodulation-Cell Division
(RND) efflux membrane fusion protein
precursor
Pale50 ilvA1 Threonine dehydratase, biosynthetic
Pale52 sahH S-adenosyl-L-homocysteine hydrolase
Pale53 nuoJ NADH dehydrogenase I chain J
Pale56 pa3688 Hypothetical protein
Pale58 algZ Alginate biosynthesis protein AlgZ/FimS
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Pale59 pa0370 Conserved hypothetical protein
Pale61 fimX Phosphodiesterase towards bis-(3'-5')-cyclic
dimeric guanosine monophosphate (c-di-GMP)
Pale63, 85, 92,
109, 132
miaA Delta 2-isopentenylpyrophosphate transferase
Pale64 pa5055 Hypothetical protein
Pale69 pa0405 Conserved hypothetical protein
Pale72, 76 pa4032 Probable two-component response regulator
Pale80 Between argH & pa5264 ArgH: argininosuccinate lyase
Pa5264: hypothetical protein
Pale81 Between ntrC & pa5126 NtrC: two-component response regulator NtrC
Pa5126: hypothetical protein
Pale82, 89 spuF Polyamine transport protein PotG
Pale83 nuoB NADH dehydrogenase I chain B
Pale86, 120 Pa2840 Probable ATP-dependent RNA helicase
Pale88 miaB Conserved hypothetical protein
Pale90 spuG polyamine transport protein PotH
Pale91 tufA Elongation factor Tu
Pale93 pa0041 probable hemagglutinin
Pale98 Pa5405 Hypothetical protein
Pale100 pa3598 Conserved hypothetical protein
Pale102 corA Magnesium/cobalt transport protein
Pale105 pa3010 Hypothetical protein
Pale106 lepA GTP-binding protein LepA
Pale114 lysA Diaminopimelate decarboxylase
Pale115 Between cyaB & pa3218 CyaB: adenylate cyclase
Pa3218: hypothetical protein
Pale116 oprI Outer membrane lipoprotein OprI precursor
Pale117 Between rhlI & rhlR RhlI: autoinducer synthesis protein
RhlR: transcriptional regulator
Pale119 pa2768 Hypothetical protein
Pale122 algC phosphomannomutase AlgC
Pale129 spoT Guanosine-3',5'-bis(diphosphate) 3'-
pyrophosphohydrolase
Pale131 fleN Flagellar synthesis regulator FleN
Pale137 Between pa5412 & ltaA Pa5412: hypothetical protein
Pa5413: low specificity l-threonine aldolase
Pale138 pslA PslA involved in Psl Exopolysaccharide
synthesis
Pale139 wbpM Nucleotide sugar epimerase/dehydratase WbpM
Pale140 pa0317 Hypothetical protein
Pale143 era GTP-binding protein Era
Pale144 pa0769 Hypothetical protein
Pale145 pa1392 Hypothetical protein
Pale146 cca tRNA nucleotidyl transferase
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Pale147 mtr Tryptophan permease
Mutants showing high ?-galactosidase activity
Pale35 pa2624 Hypothetical protein
Pale37 N.A. 23S ribosomal RNA
Pale44 pa0262 Conserved hypothetical protein
Mutants with Tn insertion at the reporter gene pC-lacZ
Pale1, 14, 17, 23, 27, 28, 30-34, 45-48, 51, 54, 55, 57, 60, 62, 65, 67, 68, 70, 71, 84, 95-97, 99, 103,
104, 107, 110-112, 123-128, 133, 134, 136, 141, 142
Mutants showing similar level of ?-galactosidase activity as parental strain
Pale38, 41, 73-75, 77,113, 130
*The  genes  known  to  be  associated  with  T3SS  regulation  or  function  are  indicated  by
bold font.
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Fig. 2-4 Summary of the mutated genes which are potentially associated with T3SS
regulation. The genes/loci with Tn insertion are grouped according to their annotated




2.4.1 The roles of five previously characterized T3SS regulators in modulation of
T3SS
In this chapter, two chromosomal integrated reporter strains PAO1pClacZ and
PAO1pTlacZ were generated to monitor the expression of exsA, which encodes the
master regulator ExsA, and exoT, which encodes the effector ExoT under calcium
limiting conditions. Based on the validated reporter pC-lacZ, several rounds of screening
for novel genes potentially involved in the T3SS regulation were carried out by
transposon mutagenesis. Over 50,000 colonies were screened and 71 genes were
identified to be putative T3SS regulatory genes, among which, 5 genes/loci associated
with T3SS regulation have been characterized in previous studies, including exsA, vfr,
cyaB, retS, and rhlI/rhlR. ExsA, a transcriptional regulator belonging to the AraC family,
is well known as the T3SS master regulator of P. aeruginosa, which coordinately
activates expression of the 43 T3SS genes, including its own expression (Yahr and Frank,
1994; Frank 1997). Vfr and CyaB are the two key regulatory elements involved in
cAMP-signaling. The cyaB gene encodes an adenylate cyclase that is responsible for
cAMP synthesis; vfr encodes a transcriptional regulator, a functional homologue of the E.
coli cAMP receptor protein (Crp). Mutations in these two genes were reported to reduce
expression of nearly 200 genes, including those involved in T3SS, type IV pilus
biogenesis, type II secretion and quorum sensing (Wolfgang et al.,  2003).  RetS  is  a
modular protein containing amino-terminal-transmembrane and 7-transmembrane
associated periplasmic sensing domains, internal domains encoding a sensor histidine
73
kinase and an ATPase, and a carboxy-terminal region encoding tandem response
regulator-like receiver domains, which was found to be required for expression of the
T3SS genes and for repression of the pel and psl loci (Goodman et al., 2004; Laskowski
et al., 2004; Zolfaghar et al., 2005; Ventre et al., 2006). Mutation in retS results in
reduced T3SS-dependent cytotoxicity to mammalian cells and an increased capability to
form biofilms (Goodman et al., 2004; Laskowski et  al., 2004). The RhlR/RhlI quorum
sensing system was reported to negatively control expression of T3SS genes and
secretion of ExoS at an earlier stage during exponential growth (Hogardt et  al., 2004;
Bleves et al., 2005). However, my data showed that the mutant (pale117) with transposon
insertion in the intergenic region between rhlI/rhlR has reduced expression of exsCEBA
(Fig. 2-3), which seems to be contradictory to the previous reports. However, such
discrepancy may be likely due to the polar effect caused by transposon insertion, which
may lead to an increased expression of rhlR and subsequent repression of exsCEBA
expression. This possibility remains to be validated by future studies. Identification of
these known T3SS regulators convinced me that the strategy used in this study to search
for novel T3SS regulatory genes is functional.
2.4.2 Mutants with Tn insertion at the genes functionally or physically related to
T3SS regulators
In addition to the above five genes known to be T3SS regulators, another five
genes/loci (mucD/lepA, lepA, algZ, algC and rsaL) were identified to be either
functionally or physically related to known T3SS regulators. Among them, two genes
(mucD and algZ) are associated with regulation of alginate production and the algC gene
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is an independent alginate synthetic gene. MucD is the last gene in the algT-mucABCD
operon, which encodes a homologue of the E. coli HtrA (DegP), a periplasmic serine
protease that is involved in the proteolysis of abnormal proteins and is required for
resistance to oxidative and heat stress (Boucher et al., 1997). MucD together with MucA
and the two other members of this operon, MucB and MucC, appear to negatively
regulate AlgT activity (Yorgey et  al., 2001; Qiu et  al., 2007; Ciofu et  al., 2008). The
alternative sigma factor AlgT is one key regulator that induces the expression of alginate
biosynthetic operon (algD-algA), as well as other regulatory genes, including AlgR
(Govan and Deretic, 1996), the response regulator of the AlgZ-AlgR two component
system, which also controls the expression of the independent alginate gene algC
(Fujiwara et al., 1993; Yu et al., 1997). This MucA-AlgT-AlgR regulatory cascade is
well known to be essential for controlling alginate production in P. aeruginosa, but also
found to be involved in regulation of T3SS expression reciprocally (Martin et al., 1993;
Wu et al., 2004). The findings that transposon insertion at the algZ or algC gene, or the
intergenic region between mucD and lepA, leads to a reduced expression of exsCEBA are
in agreement with the previously identified role of the MucA-AlgT-AlgR regulatory
pathway in T3SS regulation. Moreover, the reduced exsCEBA expression of the lepA::Tn
mutant is probably caused by a polar effect on the expression of the AlgT-mucABCD
operon since lepA is located adjacent to mucD. RsaL encodes an 11-kDa regulatory
protein, which represses lasI transcription and thereby blocking activation of the P.
aeruginosa quorum sensing cascade (de Kievit et al., 1999). Therefore, RsaL is likely to
modulate T3SS expression through the quorum sensing regulation pathway, and thus
mutation in rsaL leads to reduced expression of T3SS genes.
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2.4.3 Mutants associated with bacterial motility and EPS production
Apart from the above described T3SS regulators, I also identified 3 genes (fleN,
pslA and fimX) associated with bacterial motility and EPS production. Firstly, FleN, a
putative ATP/GTP binding protein, was identified as an antiactivator to the
transcriptional activator FleQ, a multidomain ?54-dependent transcriptional activator that
belongs to the NifA/NtrC enhancer binding protein (EBP) family, which controls many
flagellar genes and operons in P. aeruginosa (Dasgupta et al., 2000; Dasgupta and
Ramphal, 2001a; Dasgupta et al., 2002; Dasgupta et al., 2003). Disruption of fleN results
in multiflagellation of otherwise monoflagellate strains PAK and PAO1 and is associated
with a chemotactic defect (Dasgupta et al., 2000). Recently, FleQ has been shown to be a
new type of c-di-GMP binding protein that reciprocally controls expression of flagella
biosynthesis genes and EPS biosynthesis genes (the pel operon) in P. aeruginosa
(Hickman and Harwood, 2008). C-di-GMP is a small intracellular signaling molecule that
plays a central role in modulating the transition between planktonic and biofilm lifestyles
in a large and growing number of bacterial species including P. aeruginosa (Simm et al.,
2004; Hickman et al., 2005). The second gene, pslA,  is  the first  gene in the psl operon,
which is required for Psl exopolysaccharide biosynthesis (Friedman and Kolter, 2004b;
Vasseur et al., 2005a). The third gene, fimX encodes a phosphodiesterase converting c-di-
GMP into pGpG and thus controls type IV pili dependent twitching motility through
modulating the intracellular level of c-di-GMP (Kazmierczak et al., 2006). In this study,
quantitative assay for the lacZ activity shows that the mutants pale61 (fimX::Tn), pale131
(fleN::Tn), pale138 (pslA::Tn) had decreased expression level of exsCEBA, which
equaled to ~30%, ~15% and <1% of that of the parent strain, respective. These data
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indicate that the intracellular signal molecule c-di-GMP may exert important roles in
regulating  biosynthesis  of  EPS  and  flagella  as  well  as  in  expression  of  T3SS  in P.
aeruginosa. Contradictory to the previous finding that the mutant ?fimX produced and
secreted similar levels of the T3SS effectors ExoU and ExoT, and the translocon
components PopB, PopD and PcrV, as the wild type PA103 did in MinS medium
(Kazmierczak et al., 2006), my data seem to suggest that fimX is required for the full
expression of the exsCEBA operon in LB NTA medium. Whether this discrepancy is due
to strain variation or the polar effect caused by transposon insertion or secondary
mutation or differences in experimental conditions remains to be further investigated.
2.4.4 Mutants associated with metabolic imbalance
Previous findings have shown that metabolic imbalance affects the expression of
T3SS genes (Dacheux et  al., 2002; Rietsch et al., 2004; Linares et al., 2005). Not
surprisingly, among the mutants I identified, 13 mutants were shown to have transposon
insertion in the genes involved in metabolism, among which, 5 genes (ilvA1, sahH,
argHpa5264, lysA and pa5412-13) are involved in amino acid biosynthesis and
metabolism. Moreover, the transcriptional regulator, NtrC, a nitrogen regulatory protein
C, was disrupted in the mutant pale81. NtrC is a bacterial enhancer-binding protein that
activates transcription by ?54, which is required for nitrogen assimilation (Nishijyo et al.,
2001). The ntrC mutant of P. aeruginosa was reported to grow poorly in media with
nitrate or histidine or with a low concentration of ammonia as nitrogen sources, and
likely, amino acid metabolism in P. aeruginosa is  mainly  controlled  by  the  NtrB-NtrC
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two component system (Nishijyo et al., 2001). These data support the idea that metabolic
imbalance, particularly the nitrogen metabolism, plays a role in T3SS regulation.
2.4.5 Transposon insertion mutants with defects in genes involved in transport of
small molecules
I also identified eight genes involved in the transport of small molecules, which
attracted  my interest,  since  I  aimed to  study  the  signal  modulation  of  T3SS expression,
and particularly to identify novel signal molecule to activate T3SS transcription. Among
the  eight  genes,  five  genes/loci  (spuE, spuF, spuG, spuGH and potA) are involved in
polyamine transport; especially, the genes spuE, spuF and spuG, and the intergenic
region between spuG and spuH (spuGH) are located in the spuABCDEFGH operon. The
spuDEFGH genes were reported to encode a major ABC-type transporter system for
spermidine uptake, and knocking out any of these genes significantly reduces the ability
of P. aeruginosa to utilize spermidine as the sole source of carbon and nitrogen in a
defined minimum medium (Lu et  al., 2002). The decreased expression of exsCEBA in
these four spu transposon insertion mutants suggests that this spermidine transporter may
be associated with T3SS activity and this possibility will be further examined in the next
Chapter. The remaining three genes associaated with transport of small molecules are
mexH, corA and mtr.  The  gene mexH encodes a probable Resistant-Nodulation-Cell
Division (RND) efflux membrane fusion protein precursor, one of the components of the
MDR pump MexGHI-OpmD, which is able to extrude an ample range of molecules,
including quorum sensing signals (Aendekerk et  al., 2002; Aendekerk et  al., 2005).
Overexpression of the MDR pumps is associated with reduced virulence of P.
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aeruginosa. Particularly, it was reported that overexpression of the MDR pumps MexCD-
OprJ and MexEF-OprN was associated with low expression of exsA and consequently
reduced expression of the T3SS regulon, which is probably caused by the metabolic
challenge associated with MDR overexpression (Linares et al., 2005). Therefore, reduced
expression of exsCEBA in  the  mutant  pale49  (mexH::Tn)  is  likely  due  to  metabolic
imbalance. The corA gene encodes a homologue to the CorA Mg2+ transport systems of
Salmonella typhimurium and Escherichia coli,  which mediates both influx and efflux of
Mg2+, the most charge dense of all biologically relevant cations (Smith et al., 1993). As
T3SS of P. aeruginosa is activated under the low calcium conditions (Frank, 1997), the
mutation of corA is likely to affect the cationic balance in the environment and therefore
influence T3SS expression. The mutant pale147 has a transposon insertion in the gene
mtr, which is annotate to encode a tryptophan permease, suggesting mutation in mtr may
lead to deficiency in utilization of the amino acid tryptophan and the amino acid
metabolic imbalance is likely to influence T3SS expression.
2.4.6 Other mutants
Among the 71 genes, it was also noted that 5 genes are involved in the post-
translational modification and 4 genes are involved in the post-transcriptional
modification. These gene products may play a role in modulate T3SS regulators
posttranslationally  or  posttranscriptionally,  and  thus  affect  T3SS  expression.   At  last,
there are 20 genes which were identified to encode hypothetical proteins and 8 genes with
other diverse functions, such as non-coding RNA and membrane proteins, which may
suggest that expression of the T3SS master regulator exsA is controlled by multiple
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regulatory pathways, indicating that T3SS is tightly regulated in response to different
environmental conditions.
80
Chapter 3 Modulation of bacterial type III secretion system by a spermidine
transporter-dependent signaling pathway
3.1 Introduction
As  a  critical  virulence  determinant,  T3SS  is  prevalent  in P. aeruginosa isolates
from various ecological niches, including CF patients and non-hospital environments
(Feltman et al., 2001). Expression of T3SS genes is under the tight control of its master
regulator ExsA and other regulatory proteins encoded by the exsCEBA operon (Yahr and
Wolfgang, 2006). The objective of this study is to explore the potential signaling
mechanisms which modulate the expression of exsCEBA. Chapter 2 has described an
engineered reporter strain PAO1pClacZ with a chromosomally integrated T3SS reporter
gene pC-lacZ.  Based  on  this  reporter  system,  several  rounds  of  transposon mutagenesis
were conducted to identify the potential genes implicated in regulation of the T3SS gene
expression. The analysis led to identification of a range of genes potentially implicated in
T3SS regulation. Among them, three genes and one locus, i.e., spuE, spuF, spuG and
spuGH, which are located in the spuABCDEFGH operon, are of particular interesting.
The spuDEFGH genes were reported to encode a major ABC-type transporter system for
spermidine uptake, and mutation in any of these genes significantly reduces the ability of
P. aeruginosa to utilize spermidine as the sole source of carbon and nitrogen in a defined
minimum medium (Lu et al., 2002). In silico analysis has indicated that SpuD and SpuE
are the periplasmic binding protein components, SpuF is the ATPase component, and
SpuG and SpuH are the inner membrane permease components for the ABC-type
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transporter complex. Given that the spu mutants are defective in exsCEBA expression, I
decided to investigate and characterize the roles of the spermidine uptake transporter and
exogenous polyamines in the regulation of T3SS expression with major findings
described in this chapter.
3.2 Materials and methods
3.2.1 Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are listed with details in
Table 3-1. Culture conditions are the same as described in Chapter 2 unless otherwise
indicated.  Phosphate buffered saline (PBS) (per litre contains 123.2 mM NaCl, 10.4 mM
Na2HPO4 and  3.2  mM  KH2PO4, pH 7.2) was used for bacterial washing and re-
suspension. Following antibiotics were added to medium when necessary: gentamicin
(Gm), 30 µg/ml for P. aeruginosa, and 5 µg/ml for E. coli; tetracycline (Tc), 50 µg/ml for
P. aeruginosa, and 10 µg/ml for E. coli; kanamycin (Km), 800 µg/ml for P. aeruginosa,
and 100 µg/ml for E. coli; ampicillin (Ap), 200 µg/ml for E. coli.  The antibiotics and
chemicals used in this study were purchased from Sigma.
3.2.2 Gene cloning and deletion
The PCR primers used in this study were designed based on the genome sequence
of P. aeruginosa strain  PAO1  (http://www.pseudomonas.com) (Stover et  al., 2000),
which  are  listed  in  Table  3-2.  PCR  amplification  was  carried  out  with  Pfu  Turbo
polymerase (Promega)
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Table 3-1. Strains and plasmids used in this study*
Strains or plasmids Description Source or
reference
E. coli
DH5???pir F– f80 dlacZDM15 endA1hsdR17 (rk– mk–) supE44 thi-1
gyrA96 D(lacZYA-argF), used for plasmid transformation
Gibco
     S17-1 res- pro mod+ integrated copy of RP4, mob+, used for
incorporating constructs into P. aeruginosa
Laboratory
collection
BL21 (DE3) F- ompT hsdS(rB- mB-) dcm+ Tetr gal (DE3) endA Stratagene
P. aeruginosa
PAO1 Prototrophic laboratory strain Laboratory
collection
?spuE PAO1 with spuE being deleted in-frame This study
?spuEH PAO1 with spuEFGH being deleted in-frame This study
?speD PAO1 with speD being deleted in-frame This study
?speE PAO1 with speE being deleted in-frame This study
PAO1pClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the PAO1 chromosome
Chapter 2
?spuEpClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?spuE chromosome
This study
?spuEHpClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?spuEH chromosome
This study
?speDpClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?speD chromosome
This study
?speEpClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?speE chromosome
This study
vfr::Tn vfr disrupted by transposon in strain PAO1pClacZ This study
spuE::Tn spuE disrupted by transposon in strain PAO1pClacZ Chapter 2
spuF::Tn spuF disrupted by transposon in strain PAO1pClacZ Chapter 2
spuG::Tn spuG disrupted by transposon in strain PAO1pClacZ Chapter 2
exsA::Tn exsA disrupted by transposon in strain PAO1pClacZ Chapter 2
PAO1pTlacZ lacZ fused to the exoT promoter and integrated at the attB
site of the PAO1 chromosome
Chapter 2
?spuEpTlacZ lacZ fused to the exoT promoter and integrated at the attB
site of the ?spuE chromosome
This study
?spuEHpTlacZ lacZ fused to the exoT promoter and integrated at the attB
site of the ?spuEH chromosome
This study
Plasmids
pDSK519 Broad-host-range cloning vector; IncQ, KmR Laboratory
collection




Strains or plasmids Description Source or
reference
pDSK-exsA pDSK519 containing exsA under the control of lac
promoter
This study
pK18mobsacB Broad-host-range gene replacement vector; sacB, KmR Laboratory
collection
pK18GT pK18mobsacB with GmR cassette inserted at the NcoI
site; GmR
This study
pK18GT-spuEdel pK18GT containing the spuE flanking region with the
gene being deleted in frame
This study
pK18GT-spuEHdel pK18GT containing the spuEFGH flanking region with
the genes being deleted in frame
This study
pK18GT-speDdel pK18GT containing the speD flanking region with the
gene being deleted in frame
This study
pK18GT-speEdel pK18GT containing the speE flanking region with the
gene being deleted in frame
This study
mini-CTX-pC-lacZ mini-CTX-lacZ with the exsCEBA promoter fused to
lacZ; TcR
Chapter 2
mini-CTX-pT-lacZ mini-CTX-lacZ with the exoT promoter fused to lacZ;
TcR
Chapter 2
* Symbol: Gm, gentamicin; Ap, ampicillin; Km, kanamycin; Tc, tetracycline.
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Table 3-2. PCR primers used in this study*
Primer Sequence Note
In frame deletion
spuEdelAF 5’-GGGGATCCCCGGCGAAATG-3’ For amplification
of the 5’-region of
spuEspuEdelAR 5’-CGGGATCCCTGATAATCGCTCATGGG-3’
spuEdelBF 5’-CGGGATCCATCGGCAAGCAGGACAAC-3’ For amplification
of the 3’-region of
spuEspuEdelBR 5’-CCAAGCTTGGCGATGCGGAACACCAG-3’
spuHdelBF 5’-CGGGATCCTGAGCCCTCCGCCGAAAAG-3’ For amplification
of the 3’-region of
spuHspuHdelBR 5’-GCTGCTCAGGCGCCTTCTCAAC-3’
speDdelAF 5’-CGGTGGAGCTGTCGGCGGAGAA-3’ For amplification
of the 5’-region of
speDspeDdelAR 5’-CGGGATCCGTAGCAGATGTCGTAGATG-3’
speDdelBF 5’-CGGGATCCTGATCGCACACGAGGAAGAAAA-3’ For amplification
of the 3’-region of
speDspeDdelBR 5’-CCAAGCTTGATGGCGAACTGAGCGAGGA-3’
speEdelAF 5’-GGGGATCCCCGGCGAAATG-3’ For amplification
of the 5’-region of
speEspeEdelAR 5’-CGGGATCCCTGATAATCGCTCATGGG-3’
speEdelBF 5’-CGGGATCCATCGGCAAGCAGGACAAC-3’ For amplification
of the 3’-region of
speEspeEdelBR 5’-CCAAGCTTGGCGATGCGGAACACCAG-3’
RT-PCR analysis
RT-16SF 5’-GCGGCGGACGGGTGAGTAAT-3’ For RT-PCR
analysis of 16s
rDNA as a controlRT-16SR 5’-CCCGAGGTGCTGGTAACTAAGGAC-3’
RT-exoSF 5’-CTCGGCCGTCGTGTTCAAGC-3’ For RT-PCR
analysis of exoS
expressionRT-exoSR 5’-GCAGAGCGCGATTCAGGTCC-3’
RT-exoTF 5’-CCGCCGAGATCAAGCAGATG-3’ For RT-PCR
analysis of exoT
expressionRT-exoTR 5’-GACGCAGGGACCGATTCAGG-3’





In trans expression of exsA and spuE
ExsA-F 5’-CGGGATCCATGCAAGGAGCCAAATCTC-3’ For construction of
pDSK-exsAExsA-R 5’-GTCAGTTATTTTTAGCCCGGCATTCG-3’
spuE-F 5’-CGGAATTCGAATTTGAACTTATTTGCCG-3’ For construction of
pDSK-spuEspuE-R 5’-GCTCTAGAGGAGTCGGACATGCAACATTC-3’
Cloning aacC1





* Restriction enzyme site is underlined.
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 using  the  PAO1  genomic  DNA  as  the  template.  Plasmid  preparation,  ligation,  cloning
and transformation of E. coli were performed following standard procedures.
To facilitate selection of P. aeruginosa transformants, a new allelic exchange
vector pK18GT was constructed by inserting a gentamicin resistance gene into the NcoI
site of the original pK18mobsacB vector. To generate the suicide plasmid constructs
pK18spuEdel and pK18spuEHdel using the newly generated vector pK18mobsacB-Gm,
three DNA fragments spuEdelA, spuEdelB and spuHdelB were amplified from P.
aeruginosa PAO1 with primer pairs spuEdelAF/R, spuEdelBF/R and spuHdelBF/R,
respectively. After BamHI digestion, the DNA fragment spuEdelA was ligated to
spuEdelB and spuHdelB, respectively. The two ligation mixtures were aliquoted for PCR
amplification using primer pairs spuEdelAF/spuEdelBR and spuEdelAF/spuHdelBR. The
DNA fragments of the expected size were then recovered from 0.8% agarose gel,
digested with restriction enzymes and inserted into vector pK18mobsacB-Gm, which was
treated with the same restriction enzymes. The resultant plasmids pK18GT-spuEdel and
pK18GT-spuHdel were screened by PCR and confirmed by DNA sequencing. Deletion
of the internal sequence of spuE encoding the peptide from 32-aa to 362-aa and that of
spuEFGH encoding the amino acid 32 of SpuE to the last amino acid of SpuH was
carried out by allelic exchange following the methods described previously (Slater et al.,
2000). The transconjugants were screened on MM medium containing gentamicin, and
subjected to further selection on fresh MM agar plates containing 10% sucrose. The
resultant deletion mutants ?spuE containing the spuE in-frame deletion and ?spuEH
containing the spuEFGH in-frame deletion were then identified by the loss of gentamicin
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resistance on LB agar plates with and without antibiotic, and confirmed by PCR analysis
and DNA sequencing.
For construction of pK18GT-speDdel and pK18GT-speEdel, the DNA fragments
speDdelA and speDdelB, and speEdelA and speEdelB from P. aeruginosa PAO1 were
amplified with the primer pairs speDdelAF/R and speDdelBF/R, speEdelAF/R and
speEdelBF/R. After BamHI digestion, ligations were done between the DNA fragments
speDdelA and speDdelB, and speEdelA and speEdelB. The two ligation mixtures were
aliquoted for PCR amplification using primer pairs speDdelAF/speDdelBR and
speEdelAF/speEdelBR respectively. The DNA fragments of expected size were then
recovered from 0.8% agarose gel, digested with restriction enzymes and inserted into
vector pK18mobsacB-Gm, which was treated with the same restriction enzymes. The
resultant plasmids pK18GT-speDdel and pK18GT-speEdel were screened by PCR and
confirmed by DNA sequencing. Deletion of speD and speE was carried out by allelic
exchange following the same method used for deletion of spuE.
For construction of pDSK-exsA and pDSK-spuE, the exsA and spuE genes from
P. aeruginosa PAO1 were amplified with corresponding PCR primers, respectively
(Table 3-2). PCR products were digested with appropriate enzymes and purified using a
QIAquick PCR Purification Kit (Qiagen), then ligated into the enzyme treated plasmid
pDSK519. The resultant constructs were verified by DNA sequencing.
3.2.3 RNA Extraction and microarray analysis
Total RNA samples were isolated from fresh bacterial cultures using the RNeasy
mini kit (Qiagen) according to the manufacturer’s instructions, and digested with DNase I
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(Promega)  to  remove  contaminating  genomic  DNA.  The  enzyme  was  then  removed  by
RNeasy column purification. The quantity and purity of RNA were determined by
agarose gel electrophoresis and spectrometry. cDNA was synthesized from total RNA
samples by using random primers (Invitrogen). SuperScript II (Invitrogen) and biotin-
ddUTP was used to label the product according to the protocol from Affymetrix
(Affymetrix). Target hybridization, washing and staining were performed following the
manufacturer’s instructions. GeneChip arrays were scanned with an Affymetrix probe
array scanner. Each microarray analysis was repeated twice and the data were analyzed
using a statistics software MAS-5.0 from Affymetrix.
3.2.4 Protein isolation and western blotting analysis
Overnight bacterial cultures were inoculated at a 1:2000 ratio to fresh LB medium
supplemented with or without NTA or spermidine.  After incubation at 37°C overnight,
the bacterial cultures were chilled on ice for 10 minutes.  For each bacterial culture, 10 ml
were collected and centrifuged. The supernatants and the bacterial pellets were used for
preparation of extracellular proteins and total cellular proteins, respectively. The
supernatants were filtered with 0.2 µm syringe filter and precipitated with trichloroacetic
acid (TCA) at a final concentration of 10%. The precipitates were pelleted by
centrifugation, washed twice with acetone, dried, and re-suspended in SDS sampling
buffer.  For  isolation  of  total  cellular  proteins,  the  bacterial  pellets  were  resuspended  in
PBS buffer and the cells were broken by sonication. After centrifugation, the supernatants
which contain total cellular proteins were kept for further analysis. The protein samples
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were denatured by boiling for 5 minutes and separated by 10% SDS-PAGE.  Western
blot analysis was performed following the standard protocol (Sambrook J. et al., 1987).
3.2.5 Quantitative ?-galactosidase assay
Overnight bacterial cultures were diluted 1:200 to fresh LB medium
supplemented with or without NTA or spermidine as indicated. The growth was
continued with shaking at 37°C for 4 hours to allow OD600 reaching 1.2. ?-Galactosidase
activity was measured as described (Sambrook J. et al., 1987).  The data presented were
the averages from at least three independent experiments and given as Miller units (MU).
3.2.6 Culture of P. aeruginosa with mouse liver extract
Animals were used following the guidelines of the National Advisory Committee
for Laboratory Animal Research (NACLAR), with protocols approved by the
Institutional Animal Care and Use Committee (IACUC), Singapore. Liver supernatants
were prepared using fresh liver from the wild type mouse FVB/N. About 4g of liver was
placed in 10 ml of the calcium-free minimal medium and homogenized by Ultra-Turrax
(T25). Liver homogenates were centrifuged at 10,000 rpm for 10 minutes and
supernatants were collected. Bacterial cells were prepared by inoculating overnight
bacterial cultures at 1:200 ratio to 20 ml fresh LB medium and incubated with shaking at
37°C for 4 hours to allow OD600 reaching about 1.2. The bacterial cells were collected by
centrifugation and washed twice with minimal medium before resuspending in 10 ml of
minimal medium. The liver supernatants were diluted with minimal medium to desired
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concentrations and then mixed with the bacterial suspension at the ratio of 1:1. After
incubation  at  37°C  for  4  hours,  bacterial  cells  were  harvested  by  centrifugation.  ?-
galactosidase activity was measured as described above.  Results were the averages from
three independent experiments.
3.2.7 HeLa cell culture and cytotoxicity assay
The  cytotoxicity  of  different  bacterial  strains  was  assayed  by  using  HeLa  cells.
HeLa cells were seeded in 24-well tissue culture plates containing Dulbecco’s Modified
Eagle Medium (DMEM) and allowed to grow at 37°C for 16 to 18 hours to obtain 80 to
90% monolayer confluency (5.0 x 105 cells / well). Culture supernatants were removed,
the monolayer was washed once with PBS buffer. For inoculation, the fresh bacterial
cells were resuspended and diluted in DMEM to a concentration about 6 x 107 CFU per
ml. Thereafter, 0.4 ml of the bacterial dilution was applied to the HeLa cell monolayer at
a multiplicity of infection (MOI) of 40-50. Cytotoxicity was determined by measuring the
release of the cytosolic enzyme lactate dehydrogenase (LDH) into supernatants by using
the cytotoxicity detection kit (Roche) at indicated time points post infection. The
percentage cytotoxicity was determined by the following equation: Cytotoxicity (%) =
(experimental value – low control value) / (high control value – low control value) x100.
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3.3 Results
3.3.1 Induction of exsCEBA required the major spermidine uptake transporter
encoded by spuDEFGH
Transposon mutagenesis described in previous Chapter identified 4 genes/loci
spuE, spuF, spuG and spuGH, which together with spuD encode a major spermidine
transporter (Lu et  al., 2002). Quantitative analysis of the lacZ activity showed that the
transcription level of exsCEBA increased by about 8 fold in wild type PAO1 after 4 hours
growth under T3SS-inducible conditions, whereas no obvious increase in exsCEBA
expression was detected in all the three spu transposon mutants, spuE::Tn (pale16),
spuF::Tn (pale89) and spuG::Tn (pale90), upon calcium depletion (Fig. 3-1A). As
expected, mutation of the known T3SS regulatory genes vfr and exsA also abolished the
inducible expression of exsCEBA (Fig. 3-1A).
In  order  to  confirm  the  role  of  the spu genes in T3SS regulation, the spuE and
spuEFGH in-frame deletion mutants were generated in the wild type strain PAO1 (Fig. 3-
2). The transcriptional fusion genes pC-lacZ and pT-lacZ were integrated respectively
into  the  genomes  of  deletion  mutants  ?spuE  and  ?spuEFGH  in  the  same  way  as
described for the strain PAO1pClacZ. Similar to the spu transposon mutants, deletion of
spuE or spuEFGH abrogated the inducible expression of exsCEBA and exoT upon
calcium depletion (Fig. 3-1C, D).  The time course study further confirmed that deletion
of spuE disabled the low-calcium induced exsCEBA expression throughout growth (Fig.
3-1B). Moreover, in trans expression of spuE in the deletion mutant ?spuE restored the
calcium-depletion inducible expression pattern of exsCEBA and exoT (Fig. 3-1C, D).
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Taken together, these data suggest a critical role of spermidine transporter in modulating
the expression of T3SS genes.
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Fig. 3-1 Mutation of the genes encoding the SpuDEFGH transporter decreases the
expression of T3SS genes. (A) The exsCEBA expression patterns of five transposon
mutants under normal and low calcium condition. (B) Time course analysis of the
exsCEBA expression in strain PAO1 and in the spermidine transporter mutants. (C)
Deletion  of  the  transporter  abolishes  the  low  calcium-induced  expression  of exsCEBA.
(D) Deletion of the transporter abolishes the low calcium-induced expression of exoT.
Bacteria were grown in LB medium with or without 7.5 mM NTA, indicated by solid and
open bar/symbol, respectively. The experiment was repeated twice and the data are
means of three replicates.
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Fig. 3-2 Genetic organization of the spuABCDEFGH locus in  wild  type  strain  PAO1
(top), and the corresponding region in the deletion mutants ?spuE (middle) and ?spuEH
(bottom).  The arrow above and the triangle below indicate the direction of transcription
and the location of transposon insertion, respectively.
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3.3.2 Null mutation of the spermidine transporter down-regulated the transcription
of T3SS genes
We next examined the global gene expression profiles of strain PAO1 and the
mutant ?spuE under calcium-depletion conditions using whole genome microarrays. In
P. aeruginosa, thirty six T3SS genes involved in secretion, translocation and regulation
are located in a chromosomal locus about 26 kb in size (Yahr and Wolfgang, 2006).
These T3SS genes constitute five ExsA-dependent operons (Fig. 3-3). The microarray
results showed that transcription of 34 out of the 36 genes at this locus was significantly
decreased (?2-fold) in the deletion mutant (Fig. 3-3). The affected genes include those
encoding the T3SS secretion and translocation (pscNOPQRS, popN-pcr1234DR,
pcrGVH-popBD, pscBCDEFGHIJKL),  and  regulation  (exsCEBA, exsD). The remaining
two less significantly affected T3SS genes at the same locus are pscU and pscT (Fig. 3-
3), which were moderately down-regulated by about 1.6-fold in the mutant. In addition,
the transcriptional expressions of three T3SS effector genes (exoT, exoY, exoS), which
were located elsewhere on the chromosome, are markedly decreased by 7.5-, 4.8- and
8.3-fold, respectively, in the spermidine transporter mutant. The microarray results were
verified by semi-quantitative RT-PCR, which showed a reduced expression level of 3
T3SS  genes  (popN, exoS, and exoT) in the mutant ?spuE under the calcium limitation
conditions (Fig. 3-4). Furthermore, inactivation of the spermidine transporter also
resulted in increased transcription of six uncharacterized genes by about 2.3- to 12.1-fold,
including one probable transcriptional regulator (PA2432, 5.3-fold), two probable
hydrolases (PA1202, 12.1-fold; PA2698, 2.6-fold), and three hypothetical proteins
(PA0572, 3.2-fold; PA1203, 4.3-fold; PA2433, 2.3-fold). Interestingly, this SpuDEFGH
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transporter-dependent signaling system appears to be highly specific for positive
regulation  of  T3SS,  as  the  mutation  did  not  decrease  transcription  of  other  genes  under
the assay conditions used in this study.
3.3.3 Deletion of spuE impaired  the  production  and  secretion  of  the  T3SS  effector
ExoS
Considering that the activator ExsA is required for the secretion of T3SS effectors
(Hovey and Frank, 1995), we further determined the role of the spermidine uptake system
on secretion of the effector ExoS.  No secreted ExoS was detected in the supernatants
from ?spuE and ?spuEH, as well as the two negative controls including mutant exsA::Tn
(pale135) and strain ?spuE(pDSK) containing the plasmid vector pDSK519.  In contrast,
ExoS was easily detectable from the culture supernatant of wild type strain PAO1 and the
complementation strain ?spuE(pDSK-spuE) grown under low-calcium conditions (Fig.
3-5A).
Previous studies have shown that transcription of T3SS genes is coupled to
secretion and could be blocked in the absence of type III secretory activity (Yahr and
Wolfgang, 2006). To determine whether disruption of the spermidine transporter may
have a pleiotropic effect on the type III secretion machinery, the master regulator gene
exsA was cloned under the control of the lac promoter in plasmid vector pDSK519 to
generate the expression construct pDSK-exsA. Abundant ExoS effector proteins were
detected in the culture supernatant of strain ?spuE(pDSK-exsA) (Fig. 3-5A), indicating
that mutation of the transporter did not affect the functionality of the T3SS
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Fig. 3-3 Inactivation of the spermidine transporter leads to decreased transcription of
T3SS genes.  Top panel shows the relative location and size of the genes required for
secretion, translocation and T3SS-related regulatory activities, which are located
contiguously on the chromosome within five operons (based on the genome sequence
data of strain PAO1, http://prodoric.tu-bs.de/gsearch.php). The ExsA-dependent promoter
and transcriptional direction are indicated by diamond and arrow, respectively. Bottom
panel indicates the transcriptional fold changes of these T3SS genes in the deletion
mutant ?spuE in comparison with the wild type strain PAO1. The transcriptional changes
of three effector genes, i.e., exoT, exoY, and exoS, which are located elsewhere on the
chromosome, are described in the text.
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Fig. 3-4 RT-PCR analysis of popN, exoS and exoT transcription in PAO1 and the ?spuE
deletion  mutant.  The  RNA  samples  used  as  the  reaction  templates  were  prepared  at
different concentrations as indicated. The ?spuE deletion mutant (E) shows decreased
transcription  of  these  3  T3SS genes  compare  with  wild  type  PAO1 (P).  16s  rDNA was
used as internal control and showed equal loading of RNA template.
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Fig. 3-5 In trans expression  of exsA restored T3SS gene expression and effector
production  in  the  spermidine  transporter  mutants.  (A)  Inactivation  of  the  spermidine
transporter inhibits the production of the type III effector protein ExoS but the phenotype
is rescued by expression of exsA. Bacterial cultures were grown overnight in LB medium
with or without 7.5 mM NTA and the extra-cellular proteins in supernatants were
collected by trichloroacetic acid precipitation and separated by 10% SDS-PAGE. The
proteins were transferred onto nitrocellulose membrane and blotted with anti-ExoS
antibody. (B) Overexpression of exsA in the transporter mutants results in a high level
expression of the T3SS genes exsCEBA.   Symbol:  “+”  and  “-”  indicate  whether  the
plasmid or expression construct is carried by the bacterial strains.  The data are means of
three replicates.
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Fig. 3-6 Exogenous spermidine induction of the T3SS system requires a functional
SpuDEFGH transporter. (A) The exsCEBA promoter directs ?-galactosidase activity.
Results are means of three replicates. (B) Immunoblotting detection of the effector ExoS.
Bacterial cultures were grown in LB medium supplemented with NTA and spermidine as
indicated. The extra-cellular proteins (ECP) and intra-cellular proteins (ICP) from strains
PAO1 (P) and ?spuE (?E) were separated by 10% SDS-PAGE. The proteins were
transferred onto nitrocellulose membrane and blotted with anti-ExoS antibody. The
experiment was repeated for at least three times with similar results.
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secretion machinery.  In addition, overexpression of exsA in strains ?spuE(pDSK-exsA),
?spuEH(pDSK-exsA), and wild type PAO1 resulted in a similar high level of expression
of exsCEBA with  or  without  NTA (Fig.  3-5B),  which  seems to  preclude  the  possibility
that spermidine may act as a signal ligand of ExsA.
3.3.4 Exogenous addition of spermidine induced the expression of T3SS and
secretion of effector ExoS
Lu et al. (2002) showed that mutation in any of the genes harbored in the
spuDEFGH locus significantly reduced the ability of P. aeruginosa to utilize spermidine
as the sole source of carbon and nitrogen in a defined minimum medium. This finding
and our data seems to indicate that this pathogen may as well use this transport system to
take up exogenous spermidine as a novel T3SS activation signal.  To test this hypothesis,
we added different amounts of spermidine (up to 1 mM) to the LB medium, and
monitored the bacterial growth by measuring absorbance at 600 nm and the expression of
exsCEBA in strains PAO1 and ?spuE by measuring ?-galactosidase activity of a pC-lacZ
transcriptional fusion. Supplementation of spermidine increased T3SS gene expression in
a dosage-dependent manner. In the absence of NTA, addition of 0.1 mM spermidine to
strain PAO1 did not show significant effect, but increasing its concentration to 0.5 or 1
mM enhanced the expression of exsCEBA by  about  2-3  fold  (Fig.  3-6A).  The  calcium
chelator NTA at a final concentration of 1 mM did not have any effect on exsCEBA
expression, however, the maximal effect of spermidine was observed under this
condition. Addition of 0.1, 0.5 and 1 mM spermidine increased the exsCEBA expression
by 2- to 4-fold, respectively (Fig. 3-6A). In contrast, deletion of spuE largely attenuated
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the inducible effect of spermidine (Fig. 3-6A); the low level of induction may suggest
that the mutant could partially take up exogenous spermidine, agreeable with the previous
finding  that  the  SpuDEFGH is  the  major  but  not  the  sole  spermidine  transporter  (Lu et
al., 2002). In the presence of a high concentration of NTA (3.75 and 7 mM), spermidine
was still able to induce T3SS gene expression but became less significant in the presence
of low NTA (Fig. 3-6A).
To further study the effect of exogenous spermidine on secretion of T3SS
effectors, we used ExoS-specific antibody to detect its presence in bacterial cellular and
extracellular fractions. Wild type PAO1 had a readily detectable amount of ExoS in both
supernatant and cellular protein fractions when grown under low calcium conditions, and
addition  of  0.5  or  1  mM  of  spermidine  further  increased  the  ExoS  content  in  both
fractions (Fig. 3-6B). On the contrary, no ExoS was detectable from the deletion mutant
?spuE grown under the same conditions (Fig. 3-6B).
Intrigued by the capability for exogenous spermidine to activate T3SS gene
expression and effector secretion, I started to ask whether endogenous spermidine was
able to activate T3SS in P. aeruginosa. To answer this question, I deleted the speD and
speE genes, which encode the key enzymes for spermidine biosynthesis (Lu et al., 2002),
in the reporter stain PAO1pClacZ background and checked the expression level of
exsCEBA. Quantitative ?-galactosidase assay showed that deletion of the speD and speE
genes had no obvious effect on exsCEBA expression in P. aeruginosa under the assay
conditions used in this study (Fig. 3-7A). Furthermore, secretion of the effector ExoS
remained at the wild type level in the ?speD and ?speE mutants (Fig. 3-7B).
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Fig. 3-7 Deletion of the spermidine synthetic genes speD and speE does not alter the
expression of exsCEBA or  secretion  of  ExoS.  (A)  Bacteria  were  grown  in  LB  medium
(open  bar)  or  in  LB  medium  supplemented  with  7.5  mM  NTA  (grey  bar)  and  the  ?-
galactosidase activity directed by the promoter of exsCEBA was  determined  at  4  hours
after inoculation. The data are means of at least three replicates ± SE. (B) The extra-
cellular proteins from P. aeruginosa grown in LB medium supplemented with 7.5 mM
NTA  were  separated  by  10%  SDS-PAGE.  The  proteins  were  transferred  onto
nitrocellulose membrane and blotted with anti-ExoS antibody.
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3.3.5 Spermidine was the most effective polyamine signal for T3SS induction
To determine the specificity of potential polyamine signal molecules, we
compared the activity of a range of polyamines on induction of exsCEBA expression in
wild type PAO1 using ornithine, the precursor of polyamines, as the negative control.
The results showed that spermidine displayed the strongest relative signaling activity
(100%), followed by spermine (79.0%) and acetyle-spermidine (21.6%), whereas the
remaining polyamines including putrescine, cadaverine, and norspermidine were not able
to induce T3SS genes at a final concentration of 1 mM (Table 2-3).
3.3.6 Mutation of spermidine transporter decreased the host cell extract-induced
expression of T3SS genes and attenuates the T3SS-mediated cytotoxicity
Given that eukaryotic organisms produce abundant spermidine and other polyamines
(Igarashi and Kashiwagi, 2000), we speculated that mutation of spermidine uptake
system may have significant impact on host cell-induced expression of T3SS genes. To
test this hypothesis, we mixed a portion of minimum medium containing various amounts
of liver extract with the same volume of the medium containing fresh bacterial cells and
monitored the expression of exsCEBA. After co-culture for 4 hours with liver extract
equivalent to 10, 40, and 200 mg of liver tissue per ml of culture mixture, exsCEBA
expression in the wild strain PAO1 was increased by about 2.5- to 4.5-fold, in
comparison with the corresponding blank control of bacterial cells growing in minimum
medium without liver extract and the exsA::Tn mutant that was used as a negative control
(Fig. 3-8A). Mutation of the spermidine transporter substantially decreased the liver
extract-induced exsCEBA expression (Fig. 3-8A).
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putrescine NH2(CH2)4NH2 6.0 ± 2.7
cadaverine NH2(CH2)5NH2 5.4 ± 6.6
spermine NH2(CH2)3NH(CH2)4NH(CH2)3NH2 79.0 ± 13.3
spermidine NH2(CH2)3NH(CH2)4NH2 100 ± 3.9
norspermidine (NH2CH2CH2CH2)2NH 4.2 ± 2.0
acetyl spermidine CH3CONH(CH2)4NH(CH2)3NH2 21.6 ± 10.1
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Fig. 3-8 Inactivation of the spermidine transporter reduces the host cell extract-dependent
expression of exsCEBA and attenuated the T3SS-mediated cytotoxicity. (A) The
exsCEBA promoter directs ?-galactosidase activity after culture of the bacterial cells for 4
hours in minimum medium with various amounts of mouse liver extract (indicated as
equivalent  to  liver  tissue  fresh  weight  per  ml  culture).  The  bacteria  grown  in  the  same
minimum medium is used as a blank control. (B) Cytotoxicity was assayed by monitoring
LDH  release  by  the  HeLa  cells  infected  with  a  MOI  of  40-50.  Experiments  were
performed with DMEM medium supplemented with 1% FBS and 2 mM glutamine.  The
data are means of at least three replicates.
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To test the biological significance of the SpuDEFGH transporter, we determined
the cytotoxicity of strain PAO1 and its derivatives on the human epithelial cell line HeLa.
Quantitative determination of lactate dehydrogenase (LDH) release from HeLa cells at 2
hour  and  4  hour  post  infection  showed that  comparing  with  the  wild  type  strain  PAO1,
inactivation of the spermidine transporter by deleting spuE or spuEFGH significantly
decreased the cytotoxicity by up to 60% (Fig. 3-8B).
3.4 Discussion
The work from this chapter presents several lines of evidence to support that the
spermidine transporter encoded by spuDEFGH has a prominent role in modulation of the
T3SS gene expression. First, mutation of any of the spuEFG genes abrogated the calcium
depletion-induced expression of the exsCEBA genes (Fig. 1-1A). Second, deletion of
either spuE or spuEFGH abrogated the induced expression of the exsCEBA and exoT
genes (Fig. 1-1B, C, D). Third, deletion of spuE significantly decreased the expression of
most T3SS genes under inducible conditions and abolished the production of effector
proteins (Fig. 3-3, Fig. 3-4, and Fig. 3-5A). Furthermore, inactivation of the spermidine
transporter decreased the host cell extract-dependent induction of the T3SS system (Fig.
3-8A) and attenuated the bacterial cytotoxicity (Fig. 3-8B).
Among the several polyamines tested, only spermidine and spermine were able to
induce the expression of T3SS genes with spermidine being the strongest inducer (Table
3-3), which is in agreement with the previous report that spermidine is the preferred
ligand  molecule  of  the  SpuDEFGH  transporter  system  (Lu et al., 2002). Consistently,
deletion of the transporter significantly attenuated the spermidine activity on induction of
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T3SS genes (Fig. 3-6A) and abrogated the production of T3SS effector proteins (Fig. 3-
6B). These findings strongly suggest that the SpuDEFGH transporter system is required
for influx of exogenous polyamine signals, in particular, spermidine and spermine, into
the bacterial cell.
Polyamines are ubiquitous polycationic molecules comprising putrescine,
spermidine and spermine, which contain 2, 3 and 4 amino groups, respectively, and they
have been implicated in a wide variety of biological reactions (Fiori and Turecki, 2008a).
Owing to their cationic nature, polyamines interact with nucleic acids (DNA and RNA),
and therefore, they are involved in many aspects of gene expression (Tabor and Tabor,
1984). In addition, polyamines influence the properties of proteins and membranes
(Tabor and Tabor, 1984; Schuber, 1989), and function as antioxidants and scavengers of
reactive oxygen species (Lovaas and Carlin, 1991). In mammals, polyamines have been
shown to play an important role in cell proliferation with pro- and anti-apoptotic effects
(Seiler and Raul, 2005). Additionally, polyamines, especially spermine, make a ternary
complex with ATP-Mg2+ that can affect phosphorylation by protein kinases, which may
play important roles in many signal transduction pathways during the proliferating stage
of eukaryotic cells (Meksuriyen et al., 1998; Igarashi and Kashiwagi, 2000). Polyamines
also interact with specific receptors such as the NMDA receptor (Williams et al., 1991),
and ion channels such as K+ channels (Lopatin et al., 1994). It has been shown that
polyamines cause inward rectification by voltage dependent block of K+ channels and
intracellular polyamine depletion prevents inward rectification (Lopatin et al., 1994).
Moreover, agmatine is believed to act as a neurotransmitter by binding to several
receptors (Reis and Regunathan, 2000), and spermine has been shown to be released from
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synaptic vesicles on depolarization, suggesting that polyamines may function as
neuromodulators (Masuko et al., 2003). It has been proposed that polyamines may play a
role in the neurobiology of major psychiatric disorders and suicide, since they influence
the properties of several neurotransmitter pathways known to be involved in mental
disorders (Fiori and Turecki, 2008b). Recent studies have indicated that arginase, which
converts L-arginine into L-ornithine  and  urea,  may  play  a  role  in  the  pathogenesis  of
various pulmonary disorders (Maarsingh et al., 2008c). Increased arginase activity
detected in asthma, chronic obstructive pulmonary disease and CF may contribute to the
airway remodeling observed in these diseases through increased production of L-proline
and the polyamines converted from L-ornithine (Maarsingh et al., 2008a). The synthesis
of polyamines could be involved in the proliferation of structural cells in the airways by
promoting histone acetyltransferase activity (Hobbs and Gilmour, 2000). Therefore, the
pathogenesis of various pulmonary disorders, including CF, is associated with increased
production of polyamines, which may favor the opportunistic pathogen P. aeruginosa to
activate T3SS as a virulence determinant to establish infection and escape from host
immune system.
It is highly intriguing how the polyamines, spermidine and spermine, could
modulate the expression of T3SS genes.  Previous studies have shown that cationic
polyamines could participate in many cellular processes via binding to DNA, RNA,
nucleotide signals and other acidic substances (Igarashi and Kashiwagi, 2000). Our
finding that disruption of the spermidine transporter exclusively down-regulated the
T3SS genes seems to suggest a rather specific mechanism. Albeit the mechanism is
unknown, several lines of evidence indicate that spermidine functions by modulating the
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transcriptional expression of the master regulator gene exsA. Firstly, mutation of the
spermidine transporter significantly decreased the transcriptional expression of exsA
according to transcriptional gene fusion and microarray data (Fig 3-1, 3-3). Secondly, in
trans expression of exsA in the transporter mutants restored the ExsA-dependent
functions including expression of T3SS genes and production of effector proteins (Fig. 3-
6), which precludes the possibility that null mutation of the transporter may also affect
the functionality of the type III secretory machinery.  It is worth to note that null mutation
of the transporter, in addition to down-regulating about 40 T3SS genes, also increased the
expression of six genes encoding putative enzymes or proteins. The significance of
upregulation and the potential involvement of their gene products in spermidine
modulation of T3SS will be investigated in the next chapter.
 In  conclusion,  this  chapter  has  used  a  combination  of  genetic,  genomic  and
biochemical approaches to elucidate a novel spermidine transporter-dependent signaling
pathway that  controls  the  expression  of  the  T3SS genes  of P. aeruginosa.  Discovery  of
this signaling pathway has added a new dimension to the known complicated T3SS
regulatory networks (Yahr and Wolfgang, 2006), and may also provide interesting
insights into the molecular mechanisms of host-pathogen interactions. Considering that
host body fluid contains millimolar ranges of extracellular calcium (Hueck, 1998), it
becomes highly intriguing how bacterial T3SS is activated under such a high calcium
level during infection. The discovery of this apparent host-pathogen signal
communication pathway and the finding that exogenous spermidine, whose production
increases in the disordered airways, alleviates the repression of calcium on T3SS gene
expression (Fig. 3-5), seem to provide a useful platform to resolve this puzzle.
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Furthermore, given that many bacterial pathogens appear to have T3SS and the
SpuDEFGH-like polyamine transporters (Hueck, 1998; Igarashi and Kashiwagi, 1999b;
Igarashi et al., 2001a; Lu et  al., 2002), this work thus raises an intriguing possibility of
potential functional co-evolution of this new signaling pathway with T3SS in other
bacterial pathogens
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Chapter 4 A novel spermidine-responsive transcriptional regulator TsrA
modulates the expression of T3SS genes in P. aeruginosa
4.1 Introduction
Polyamines, including putrescine, spermidine and spermine, are organic
polycations that are positively charged at physiological pH due to their protonated amine
groups (Tabor and Tabor, 1984). Organic polycationic molecules such as polyamines and
inorganic  cationic  molecules  such  as  magnesium  and  calcium  play  a  crucial  role  in
maintaining optimal conformation of negatively charged nucleic acids. However, unlike
cations, the positive charges on polyamines are found at regularly spaced intervals along
flexible hydrocarbon chains, serving as electrostatic bridges between negative phosphate
charges on nucleic acids and other negatively charged polymers (Tabor and Tabor, 1985).
Putrescine  and  spermidine  are  the  most  common  polyamines  which  are  essential  for
normal cellular growth and multiplication of both prokaryotic and eukaryotic cells. The
intracellular  content  of  spermidine  (1-3  mM) is  generally  higher  than  that  of  putrescine
(0.1-0.2 mM) in most bacteria, with some exceptions like E. coli. Spermine is present in
many living organisms, yet its presence in bacterial cells is not well established. So far,
spermine is only found in bacterial cells when exogenous spermine is present in the
medium (Cohen, 1997; Shah and Swiatlo, 2008). Polyamines are primarily found to form
complexes with RNA to stabilize higher orders of structure and might cause unique
structural changes that are different from those induced by magnesium (Igarashi et al.,
1974). Polyamines also bind to ribosomes and increase translation fidelity during protein
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synthesis (Ito and Igarashi, 1986), facilitate translational read-through of mRNAs with a
UAA stop codon (Higashi et al., 2006), and increase the efficiency of nonsense mutation
suppression in T4 phage (Tabor and Tabor, 1982). Additionally, binding of spermidine to
a GC-rich double-stranded region near the Shine-Dalgarno (SD) sequence of the oppA
mRNA appears to cause a conformational change and consequently enhances the
translation of the oppA mRNA in E. coli (Yoshida et al., 1999). Besides interacting with
RNA, polyamines also play a crucial role in outer membrane functions, especially in the
production and function of porins (Dela Vega and Delcour, 1996). For example,
putrescine and spermidine bind to aspartic acid residues of OmpF and OmpC of E. coli,
altering the charge and pore size, resulting in channel closure and subsequently
decreasing outer membrane permeability (Iyer et al., 2000).
In recent years, an increasing number of reports showed that polyamines and their
transport mechanisms are associated with bacterial pathogenesis. Microbial pathogens
face physiological stresses in vivo and as a consequence initiate adaptive responses (Shah
and Swiatlo, 2008). Evidence suggests that in response to oxidative stress, bacterial cells
could synthesis or import spermine and spermidine, which function as free radical
scavengers in conjunction with superoxide dismutase (SOD) to reduce DNA strand
breakage caused by oxygen radicals (Khan et  al., 1992; Ha et al., 1998).  In addition,
survival in an acidic environment is essential for intestinal pathogens and polyamines are
the key mediators in response to acid stress in bacteria (Park et al., 1996; Jung and Kim,
2003). Furthermore, polyamine transporter systems, which allow uptake of extracellular
polyamines, seem to provide a significant adaptive and/or survival advantage to microbial
pathogens (Shah and Swiatlo, 2008). Polyamine transporters have been primarily
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characterized in E. coli, and subsequent analysis of microbial genome sequences shows
that they are likely to be universal in many Gram-positive and Gram-negative human
pathogens, including Bacillus anthracis, Heamophilus influenzae, Legionella
pneumophila, Mycoplasma pneumoniea, Streptococcus pneumoniae (pneumococcus),
Vibrio cholerae and P. aeruginosa (Shah and Swiatlo, 2008). The genes encoding
polyamine ABC transporters in many pathogens are organized as four-gene operons and
designated as potABCD (spermidine uptake) and potFGHI (putrescine uptake). In S.
pneumoniae, potD transcription is increased in response to oxidative and temperature
stress, choline limitation and more importantly during murine bactereamia, which
suggests that polyamine uptake from the environment may potentially help pneumococci
to survive in various host microenvironments (Shah and Swiatlo, 2008). Polyamines have
also been implicated in modulation of biofilm formation in several bacterial pathogens. In
V. cholerae, a PotD homolog, NspS has been shown to mediate biofilm formation and the
polyamine norspermidine has been found to activate biofilm formation in an NspS- and
MbaA-dependent manner (Karatan et al., 2005).  However, the molecular mechanism
with which polyamines regulates biofilm formation remains unclear.
In the previous chapter, we identified a spermidine transporter dependent pathway
that modulates expression of T3SS in P. aeruginosa (Zhou et al., 2007) (Chapter 3),
which for the first time has unveiled the role of the polyamine uptake system and
polyamines in modulation of T3SS expression. In brief, disruption of the major
spermidine uptake transporter encoded by spuDEFGH leads to down-regulation of T3SS
gene transcription, which consequently results in an attenuated T3SS-mediated
cytotoxicity. Moreover, evidence indicates that spermidine is a novel host signal that
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specifically activates T3SS gene expression. However, it is unclear how the polyamine
signal induces T3SS expression. In this chapter, I have examined the spermidine
transporter dependent pathway with the aim to identify key regulatory elements in this
signaling pathway and to investigate the molecular mechanism with which the
spermidine signal acts on modulation of T3SS gene expression.
4.2 Materials and methods
4.2.1 Strains and culture conditions
The bacterial strains and plasmids used in this study are listed in Table 4-1. The
culture conditions used in this study were the same as described in Chapter 2 unless
otherwise indicated.  Antibiotics were added to medium when necessary following the
dosages indicated in Chapter 3.
4.2.2 Gene cloning and deletion
The PCR primers listed in Table 4-2 were designed based on the genome
sequence of P. aeruginosa strain  PAO1  (http://www.pseudomonas.com) (Stover et al.,
2000). The methods used for PCR amplification, plasmid preparation, ligation, cloning
and transformation of E. coli were the same as described in Chapter 3.
P. aeruginosa PAO1  was  used  as  a  parental  strain  for  generation  of  reporter
strains and subsequent deletion mutants. To generate the integration vector mini-CTX-
PtsrA-lacZ, the promoter of tsrA (PtsrA) was amplified by PCR using the primer pair
ptsrA-F/ptsrA-R, and cloned into the integration vector mini-CTX-lacZ. The resultant
116
Table 4-1. The strains and plasmids used in this study*
Strains or plasmid Description Source or
reference
E. coli
DH5???pir F– f80 dlacZDM15 endA1hsdR17 (rk– mk–) supE44 thi-1
gyrA96 D(lacZYA-argF), used for plasmid transformation
Gibco
     S17-1 res- pro mod+ integrated copy of RP4, mob+, used for
incorporating constructs into P. aeruginosa
Laboratory
collection
BL21(DE3) F- ompT hsdS(rB- mB-) dcm+ Tetr gal (DE3) endA Stratagene
P. aeruginosa
PAO1 Prototrophic laboratory strain Laboratory
collection
?spuE PAO1 with spuE being deleted in-frame Chapter 3
?tsrA PAO1 with tsrA being deleted in-frame This study
?spuE?tsrA PAO1 with spuE  and tsrA  being deleted in-frame This study
?tsrA?vfr PAO1 with tsrA  and vfr  being deleted in-frame This study
?vfr PAO1 with vfr  being deleted in-frame This study
PAO1pClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the PAO1 chromosome
Chapter 3
?spuEpClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?spuE chromosome
Chapter 3
?tsrApClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?tsrA chromosome
This study
?spuE?tsrApClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?spuE?tsrA chromosome
This study
?vfrpClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?vfr chromosome
This study
?tsrA?vfrpClacZ lacZ fused to the exsCEBA promoter and integrated at the
attB site of the ?tsrA?vfr chromosome
This study
exsA::Tn  (pale135) exsA disrupted by transposon in strain PAO1pClacZ Chapter 2
vfr::Tn  (pale4) vfr disrupted by transposon in strain PAO1pClacZ Chapter 2
PAO1pTsrAlacZ lacZ fused to the tsrA promoter and integrated at the attB
site of the PAO1 chromosome
This study
?spuEpTsrAlacZ lacZ fused to the tsrA promoter and integrated at the attB
site of the ?spuE chromosome
This study
?tsrApTsrAlacZ lacZ fused to the tsrA promoter and integrated at the attB
site of the ??tsrA chromosome
This study
Plasmids
pDSK519 Broad-host-range cloning vector; IncQ, KmR Laboratory
collection
pDSK-tsrA pDSK519 containing tsrA under the control of lac promoter This study
pDSK-vfr pDSK519 containing vfr under the control of lac promoter This study
pGEX-6p-1 Cloning vector to generate GST gene fusion, ApR GE
Healthcare
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Strains or plasmid Description Source or
reference
pGEX-tsrA pGEX-6p-1 vector harboring the encoding region of tsrA
for protein purification, ApR
This study
pK18GT pK18mobsacB with GmR cassette inserted at the NcoI site;
GmR
Chapter 3
pK18GT-tsrAdel pK18GT containing the spuE flanking region with the gene
being deleted in frame
This study
pK18GT-vfrdel pK18GT containing the spuEFGH flanking region with the
genes being deleted in frame
This study
mini-CTX-lacZ Chromosomal integration vector containing a promoterless
lacZ for construction of transcriptional fusion; TcR
Schweizer
HP
Mini-CTX-PtsrA-lacZ mini-CTX-lacZ with the tsrA  promoter fused to lacZ; TcR This study
mini-CTX-pC-lacZ mini-CTX-lacZ with the exsCEBA promoter fused to lacZ;
TcR
Chapter 2
* Symbol: Gm, gentamicin; Ap, ampicillin; Km, kanamycin; Tc, tetracycline.
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Table 4-2. The PCR primers used in this study*
Primer Sequence Note
In frame deletion
tsrAdelAF 5’-CAGAGCAAGCGGGCGTAGAA-3’ For amplification of
the 5’-region of tsrAtsrAdelAR 5’-CGGGATCCCTTGCTGATCACCGACTTG-3’
tsrAdelBF 5’-CGGGATCCCCCTGGGGCAACGGCTG-3’ For amplification of
the 3’-region of tsrAtsrAdelBR 5’-CAGAGCGGGCAGGCAGTGAAC-3’
vfrdelAF 5’-CGGAATTCCTTCTTCAGGATGCTGACC-3’ For amplification of
the 5’-region of vfrvfrdelAR 5’-CGGGATCCACAGTGTGCGAGCAGCTTG-3’
vfrdelBF 5’-CGGGATCCATGGTGGTCTTCGGCAC-3’ For amplification of




of 16s rDNA as a
controlRT-16SR 5’-CCCGAGGTGCTGGTAACTAAGGAC-3’
RT-vfrF 5’-CGCTGTTCTTCATCATCAAGG-3’ For RT-PCR analysis
of vfr expressionRT-vfrR 5’-GCTCCTCCAGGCTCTTCAG-3’
RT-popNF 5’-CGTTTCCGTTTCGCAGTCG-3’ For RT-PCR analysis
of popN expressionRT-popNR 5’-GACAGGCCCCGGTAGTCAAG-3’
RT-exoSF 5’-CTCGGCCGTCGTGTTCAAGC-3’ For RT-PCR analysis
of exoS expressionRT-exoSR 5’-GCAGAGCGCGATTCAGGTCC-3’
RT-exoTF 5’-CCGCCGAGATCAAGCAGATG-3’ For RT-PCR analysis
of exoT expressionRT-exoTR 5’-GACGCAGGGACCGATTCAGG-3’
RT-tsrAF 5’-GCGTCCGCCTGCTCTATCG-3’ For RT-PCR analysis
of tsrA expressionRT-tsrAR 5’-GGCTCGGCGTGGCGTTGTTG-3’
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Primer Sequence Note
In trans expression of vfr and tsrA
pDSK-vfr-F 5’-CGGGATCCGGGACTCGGGCATGGTA-3’ For construction of
pDSK-vfrpDSK-vfr-R 5’-CGGAATTCATGGGTGCTGTTCAG-3’
pDSK-tsrA-F 5’-GCTCTAGAGCGTCGAGCGATTGCCACTG-3’ For construction of
pDSK-tsrApDSK-tsrA-R 5’-CGGAATTCAGTCTTCTCCGCATGCCCA-3’
Amplification of promoters








promoter (445 bps)Biotin-pvfr-R 5’-Biotin-CATGCCCGAGTCCCGAAA-3’
ptsrA-F 5’-CGGAATTCAGAGGGTCAGCAGCCCGG-3’ For amplification of









* Restriction enzyme site is underlined.
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construct mini-CTX-PtsrA-lacZ was introduced into E. coli S17-1(?pir) and then
integrated into the chromosome of P. aeruginosa PAO1 as described in Chapter 2. The
resultant reporter strain was designated as PAO1pTsrAlacZ.
Deletion of the internal sequence of tsrA encoding the peptide from 37-aa to 299-
aa and that of vfr encoding 21-aa to 207-aa were carried out by allelic exchange
facilitated by the gene replacement vector pK18GT following the methods described in
Chapter 3. The resultant mutants ?tsrA, ?vfr, and ?tsrA?vfr, which contain in-frame
deletion of tsrA, vfr, and the tsrA/vfr double genes, respectively, were confirmed by PCR
analysis and DNA sequencing.
4.2.3 RNA Extraction and microarray analysis
The methods used for total RNA isolation and purification, cDNA synthesis,
labeling and hybridization, GeneChip arrays scanning and microarray data analysis were
the same as described in Chapter 3.
4.2.4 Extracellular protein isolation and western blotting analysis
Overnight bacterial cultures were inoculated at a 1:2000 ratio to fresh LB medium
supplemented with NTA and/or spermidine and incubated at 37°C for 16 hours for
extracellular protein isolation. The methods for harvesting extracellular proteins and
western blotting were the same as described in Chapter 3.
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4.2.5 Quantitative ?-galactosidase assay
Overnight bacterial cultures were diluted 1:100 to fresh LB medium
supplemented with NTA and/or spermidine as indicated. The growth was continued with
shaking at 37°C for 3 hours to allow OD600 reaching 1.0. ?-Galactosidase activity was
measured as described in Chapter 3.  The data presented were the averages from at least
three independent experiments and given as Miller units (MU).
4.2.6 HeLa cell culture and cytotoxicity assay
The cytotoxicity of different bacterial strains was determined by assaying LDH
released from HeLa cells. The methods for HeLa cells culture and cytotoxicity assay
were the same as described in Chapter 3, except that two sets of MOI (25, 50) were tested
in this study.
4.2.7 Purification of recombinant GST-TsrA
For purification of recombined protein GST-TsrA, the tsrA coding region from P.
aeruginosa PAO1 was amplified using primers pGEX-tsrA-F/pGEX-tsrA-R, and then
fused into the GST-fusion expression vector pGEX-6p-1 (GE Healthcare) digested with
EcoRI and XhoI. The resultant construct pGEX-tsrA was transformed into host strain E.
coli BL21 (DE3). After sequencing confirmation, GST-TsrA fusion protein was
expressed and purified with the Glutathione Sepharose 4B affinity column according to
the procedure recommended by GE Healthcare.
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4.2.8 Electrophoretic Mobility Shift Assay (EMSA)
5’-biotin labelled DNA probes containing the promoters Pvfr and  PtsrA were
generated using PCR by annealing 5’-biotin labelled oligonucleotide primers as described
in Table 4-2 and purified from an agarose gel (Qiagen). EMSA were performed using
LightShift® Chemiluminescent EMSA Kit (Pierce) following the manufacturer’s
instruction. Briefly, each reaction (10 µl) containing the biotin-labelled probe (0.1 pmol),
1 µg Poly (dI•dC) (2’-deoxyinosinic-2’-deoxycytidylic acid), and GST-TsrA protein (40
ng, 120 ng or 240 ng) as indicated. When necessary, non-labelled specific competitor
probe (0.4 pmol or 4 pmol), non-labelled unrelated competitor probe Plac (0.4 pmol or 4
pmol), spermidine (10 fmol, 100 fmol, or 1 pmol), putrescine (100 fmol or 1 pmol) and
ornithine (100 fmol or 1 pmol) were included in the reaction solution. The reactions were
incubated at 25°C for 20 minutes. Samples were immediately subjected to electrophoresis
on a 5% polyacrylamide 0.5 x TBE gel at 4°C. Detection of biotin-labelled DNA was
done by chemiluminescence following the manufacturer’s instruction.
4.2.9 Isothermal titration calorimetry (ITC) analysis
Titration calorimetric measurement was performed using a VP-ITC calorimeter
(Microcal Inc., Northampton, MA) following the manufacturer’s instruction. In brief, 2
µl aliquots of spermidine solution (1 mM) were added at an interval of 4 minutes between
injections via a 300-µl syringe to the sample cell containing 1.4 ml of GST-TsrA (50 nM)
with constant stirring at 290 rpm at 18°C, and heat changes accompanying these
additions were recorded. GST protein (50 nM) was used as a control in this experiment.
Glutathione and salts were removed from the protein samples using the HiPrep™ 26/10
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Desalting Column (GE Healthcare) and the GST-TsrA or GST protein was eluted from
the column in Tris Buffer (50 mM,  pH 8.0). Spermidine solution was prepared directly in
Tris Buffer (50 mM, pH8.0) and all titrant and titrate solutions were thoroughly degassed
under vacuum prior to loading in ITC. The titration experiment was repeated at least
twice  and  the  data  were  calibrated  with  the  buffer  control  and  fitted  using  the  one-site
model to determine the binding constant (Ka) using MicroCal ORIGIN v7.0 software.
4.3 Results
4.3.1 Deletion of tsrA (pa2432) encoding a putative transcription regulator in the
mutant ?spuE partially restores the expression level of exsCEBA
We have shown that mutation of the major spermidine uptake transporter
SpuDEFGH severely down-regulates the expression of 37 T3SS genes  and up-regulates
10 other genes in P. aeruginosa (Zhou et al., 2007) (Chapter 3). Among the 10 up-
regulated genes, 6 genes were up-regulated by 2-fold, and the remaining 4 genes were
moderately up-regulated by ? 2-fold but > 1.5 fold (Table 4-3). The gene pa2432 that
shows a 5.3-fold transcriptional increase in the mutant ?spuE attracted my attention. The
product of pa2432 was annotated as a putative regulatory protein belonging to the LysR
family  of  transcriptional  regulators  (http://www.pseudomonas.com, http://smart.embl-
heidelberg.de/), in agreement with our speculation that there could be transcription
factor(s)  in  the  spermidine  signaling  pathway.  RT-PCR  analysis  confirmed  that
expression of pa2432 was significantly up-regulated in the mutant ?spuE (Fig. 4-1).
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LysR proteins are coinducer-responsive regulators with sizes ranging from 250 to 350
residues and their
Table 4-3. The genes up-regulated in ?spuE
ID no. Gene Description Average foldchange ±S.E.
PA0572 Hypothetical, unclassified, unknown 3.23 1.09
PA1202 ycaC Putative enzymes 12.06 3.20
PA1203 Hypothetical, unclassified, unknown 4.30 0.42
PA1205 Hypothetical, unclassified, unknown 2.00 0.20
PA1206 Hypothetical, unclassified, unknown 1.81 0.27
PA1317 cyoA Energy metabolism 1.83 0.44
PA2432 Transcriptional regulator 5.33 1.04
PA2433 Hypothetical, unclassified, unknown 2.32 0.45
PA2698 Putative enzymes 2.56 0.38
PA5497 nrdJa Hypothetical, unclassified, unknown 1.52 0.15
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Fig. 4-1 RT-PCR analysis of tsrA transcription in wild type PAO1 and the deletion
mutant  ?spuE.  RT-PCR  was  performed  at  different  concentrations  of  RNA  samples  as
indicated. 16s rDNA was amplified as internal control to show equal loading of RNA
templates.
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N-terminus contains the helix-turn-helix DNA-binding motif, which is the most
conserved  portion  of  the  LysR-like  regulators.  Importantly,  it  is  well  known  that  most
LysR-type regulators interact with small specific signal molecules to modulate gene
expression (Schell, 1993). Therefore, it was intriguing to determine if this putative
transcriptional regulator is involved in the spermidine transporter dependent signaling
pathway. To this end, the ?spuE?pa2432 double in-frame deletion mutant was generated
and the reporter construct pC-lacZ was integrated into the genome of mutant
?spuE?pa2432 in the same way as described in Chapter 2. Quantitative analysis of lacZ
activity showed that deletion of pa2432 in the genetic background of mutant ?spuE
increased the expression level of exsCEBA 2-fold upon calcium depletion (Fig. 4-2A).
However, it was noted that the exsCEBA expression in this double deletion mutant was
lower  than  that  in  the  wild  type  PAO1 (Fig.  4-2A).   To  verify  the  finding, pa2432 was
cloned under the control of lac promoter in plasmid vector pDSK519 to generate the
expression construct pDSK-pa2432 and this construct was introduced into mutant
?spuE?pa2432 for complementation analysis. Somewhat unexpected, in trans expression
of pa2432 in ?spuE?pa2432 strongly suppressed the exsCEBA expression (Fig. 4-2A),
suggesting that this putative transcription regulator encoded by pa2432 is  involved  in
repression of T3SS gene expression in P. aeruginosa. The gene product of pa2432 was
hence designated as Type III Secretion Repressor A (TsrA).
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              A
               B
Fig. 4-2 TsrA modulates T3SS activity in P. aeruginosa.  (A) Deletion of tsrA (pa2432)
in ?spuE partially restored the low calcium-induced expression of exsCEBA (B) Deletion
of tsrA in PAO1 moderately enhanced exsCEBA expression, while in trans expression of
tsrA significantly repressed exsCEBA expression. Bacteria were grown in LB medium
with  or  without  7.5  mM NTA as  indicated.  The  experiment  was  repeated  twice  and  the
data are means of three replicates.
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4.3.2 In trans expression of tsrA down-regulated the expression of T3SS Genes
Given that deletion of SpuDEFHG transporter led to overexpression of tsrA, two
approaches were used to evaluate the impact of elevated repressor on levels on T3SS
gene expression in P. aeruginosa. Firstly, the in-frame deletion mutant ?tsrA was
generated using PAO1 as the parental strain and the reporter gene pC-lacZ was integrated
into the genome of resultant deletion mutant ?tsrA. Quantitative ?-galactosidase assay
showed that tsrA deletion led to about 40% increase in exsCEBA expression compared to
the wild type upon calcium depletion (Fig. 4-2B). Secondly, the tsrA gene was introduced
to both wild type PAO1 and the deletion mutant ?tsrA for in trans expression, and the
results showed that in trans expression of tsrA in these two strains substantially repressed
the expression of exsCEBA both  in  the  LB medium and LB NTA medium (Fig.  4-2B).
The  above  data  are  in  agreement  with  the  notion  that  TsrA acts  as  a  repressor  in  T3SS
regulation.
To investigate the influence of TsrA on T3SS gene expression, I examined the
global gene expression profiles of the strains PAO1(pDSK519) and PAO1(pDSK-
pa2432) under calcium-depletion conditions using whole genome microarray. The results
showed that 189 genes were down-regulated and 264 genes were up-regulated in
PAO1(pDSK-pa2432).  These 453 affected genes belonged to 21 functional groups (Fig.
4-3). Among them, 30 out of the 36 T3SS genes at the T3SS locus consistently showed
significantly decreased transcription (>2-fold) due to in trans expression  of tsrA in two
independent sets of microarray analysis (Fig. 4-4). The affected genes include those
encoding the T3SS secretion and translocation (pscNOPQRS, popN-pcr23D, pcrGVH-
popBD, pscCDEFGHIJKL), and regulation (exsCEBA, exsD). In addition, decreased
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transcriptional expression of 3 T3SS genes, i.e., pcr1, pcrR and pscL, were  detected  in
one set of microarray experiment (6.5-, 6.5- and 3.0-fold, respectively). But there are also
3 T3SS genes, i.e., pscU, pscT and pcr4, whose transcript levels were not affected by in
trans expression of tsrA based on two sets of microarray analysis. At this stage, it is not
clear whether these exceptions are due to microarray error or that they are not the
members of TsrA regulon. Furthermore, the transcriptional expression of three T3SS
effector genes and their chaperons (exoT, exoY, exoS, orf1 and pa3843),  which  are
located elsewhere on the chromosome, were markedly decreased by 14.6-, 6.9-, 19.9-,
11.5 and 11.3-fold, respectively, in strain PAO1(pDSK-pa2432). The microarray results
were  verified  by  RT-PCR  analysis  which  showed  that  expression  levels  of popN, exoS
and exoT were dramatically down regulated in strain PAO1(pDSK-pa2432) compared
with its wild type PAO1 (Fig. 4-5). The RT-PCR results also showed that the expression
levels of these representative T3SS genes in ?tsrA were marginally increased (Fig. 4-5),
which is consistent with the results from quantitative ?-galactosidase assay (Fig. 4-2B).
In addition to the influence on the T3SS genes, microarray analysis showed that in
trans expression of tsrA also caused decreased expression of 189 genes (Table 4-4).
Among them, 6 are involved in the biosynthesis of the PQS quinolone signal (pqsBCDE
and phnAB); 7 are involved in phenazine biosynthesis (phzC2D2E2F2G2, phzB1 and
phzS); 3 are involved in hydrogen cyanide synthesis (hcnABC); 3 are involved in the
biosynthesis of rhamnolipids (rhlAB and rhlC)  and 3 are involved in the biosynthesis of
secreted proteases (aprE, lasA and lasB) (Table 4-4). Noticeably, the gene products of
these TsrA-repressed genes are either virulence factors or the signal associated in
virulence regulation. Moreover, 6 genes encoding transcriptional regulators
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Fig. 4-3 Funtional groups of the genes up-regulated (grey bars) and down-regulated
(open bar) by in trans expressing tsrA as detected by microarray analysis. The genes were
categorized into functional classes based on the annotation available from the P.
aeruginosa genome sequence (www.pseudomonas.com).
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Table 4-4. The virulence genes (exclusive of T3SS genes) and transcriptional regulators
down-regulated by in trans expression of tsrA in PAO1
ID no. Gene Description Averagefold change ±S.E.
Biosynthesis of quinolone
PA0997 pqsB
Homologous to beta-keto-acyl-acyl-carrier protein
synthase -3.74 0.32
PA0998 pqsC
Homologous to beta-keto-acyl-acyl-carrier protein
synthase -3.60 1.38
PA0999 pqsD 3-oxoacyl-[acyl-carrier-protein] synthase III -3.54 1.46
PA1000 pqsE Quinolone signal response protein -4.09 2.07
PA1001 phnA anthranilate synthase component I -2.37 0.89
PA1002 phnB anthranilate synthase component II -1.97 0.49
Biosynthesis of phenazine
PA1901 phzC2 phenazine biosynthesis protein PhzC -14.28 2.96
PA1902 phzD2 phenazine biosynthesis protein PhzD -19.13 2.80
PA1903 phzE2 phenazine biosynthesis protein PhzE -17.25 1.59
PA1904 phzF2 probable phenazine biosynthesis protein -17.21 2.69
PA1905 phzG2 probable pyridoxamine 5'-phosphate oxidase -13.29 3.84
PA4211 phzB1 probable phenazine biosynthesis protein -25.59 6.04
PA4217 phzS flavin-containing monooxygenase -11.56 3.35
Biosynthesis of hydrogen cyanide
PA2193 hcnA hydrogen cyanide synthase HcnA -2.84 0.28
PA2194 hcnB hydrogen cyanide synthase HcnB -3.28 0.64
PA2195 hcnC hydrogen cyanide synthase HcnC -4.77 1.82
Biosynthesis of rhamnolipids
PA1130 rhlC rhamnosyltransferase 2 -3.00 1.41
PA3478 rhlB rhamnosyltransferase chain B -6.52 2.10
PA3479 rhlA rhamnosyltransferase chain A -6.74 1.78
Biosynthesis of secreted proteases
PA1247 aprE alkaline protease secretion protein AprE -3.30 1.39
PA1871 lasA LasA protease precursor -3.58 1.00
PA3724 lasB elastase LasB -4.66 1.99
Transcriptional regulators
PA0652 vfr transcriptional regulator Vfr -1.57 0.07
PA1663 probable transcriptional regulator -2.57 0.72
PA2016 liuR regulator of liu genes -1.71 0.41
PA3678 probable transcriptional regulator -1.76 0.34
PA3932 probable transcriptional regulator -5.30 1.26
PA4296 pprB two-component response regulator, PprB -1.94 0.74
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Fig. 4-4 In trans expression of tsrA leads to decreased transcription of T3SS genes.  Top
panel shows the relative location and size of the genes required for secretion,
translocation and T3SS-related regulatory activities, which are located contiguously on
the  chromosome  within  five  operons  (based  on  the  genome  sequence  data  of  strain
PAO1, http://prodoric.tu-bs.de/gsearch.php). The ExsA-dependent promoter and
transcriptional direction are indicated by diamond and arrow, respectively. Bottom panel
indicates the transcriptional fold changes of these T3SS genes in PAO1(pDSK-pa2432)
in comparison with the control strain PAO1(pDSK519). The transcriptional changes of
three effector genes, i.e., exoT, exoY, and exoS,  which  are  located  elsewhere  on  the
chromosome, were described in the text.
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Fig. 4-5 RT-PCR analysis of popN, exoS and exoT transcription in the P. aeruginosa
strains including PAO1, ?tsrA, and PAO1(pDSK-tsrA). RT-PCR was conducted using
two  concentrations  of  RNA  template  as  indicated.  16s  rDNA  was  amplified  as  the
internal control to show equal loading of RNA template.
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(vfr, pa1663, liuR, pa3678, pa3932 and pprB) were also detected to be moderately or
significantly down-regulated in the strain overexpressing tsrA (Table 4-4). The above
data suggest that in the absence of polyamine signal, enhanced expression of TsrA may
likely contribute to global regulation of virulence gene expression in P. aeruginosa.
4.3.3 Enhanced expression of tsrA reduced  the  production  of  T3SS  effector  ExoS
and attenuated T3SS-mediated cytotoxicity.
To determine the role of TsrA on secretion of T3SS effectors, extracellular
proteins were harvested from the culture supernatants of the mutant ?tsrA and strain
PAO1(pDSK-tsrA) for Western blot analysis. The results showed that deletion of tsrA in
wild type PAO1 led to a marginal increase in ExoS; while in trans expression of tsrA in
PAO1 reduced ExoS in supernatant to an undetectable level in the calcium depletion
medium (Fig. 4-6). In addition, in trans expression of tsrA in ?tsrA also reduced the level
of secreted ExoS as expected (Fig. 4-6). It was noticed that the ?spuE?tsrA double
deletion mutant and the ?spuE single deletion mutant displayed similar results; both of
them failed to secrete ExoS when grown under calcium depletion condition.
Given that enhanced expression of tsrA led to a significant down-regulation in
T3SS gene expression, the biological significance of the repressor TsrA was examined by
assaying the T3SS-dependent cytotoxicity towards the human epithelial HeLa cells.
Quantitative determination of lactate dehydrogenase (LDH) released 4 hour post infection
showed that deletion of tsrA increased the cytotoxicity by 20-30% compared with the
wild type PAO1 (Fig. 4-7A). Consistently, deletion of tsrA in the genetic background of
mutant  ?spuE  restored  the  cytotoxicity  of  ?spuE  to  a  level  similar  to  wild  type  PAO1
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(Fig. 4-7A). The effect of in trans expression of tsrA on cytotoxicity was also examined.
Quantitative analysis showed that PAO1(pDSK-tsrA) reduced its cytotoxicity to HeLa
cells by up to 70% compared with wild type PAO1 and the vector control
PAO1(pDSK519) (Fig. 4-7B). Similar results were also obtained by comparing the
cytotoxicity of the strains ?tsrA, ?tsrA(pDSK519) and ?tsrA(pDSK-tsrA) (Fig. 4-7B).
4.3.4 Vfr is involved in the TsrA regulatory pathway
Table 4-4 has shown that 6 transcriptional regulators were down-regulated in
strain  PAO1(pDSK-tsrA).  Among  them,  the  global  regulator  Vfr  is  the  only  known
regulatory protein implicated in T3SS modulation. As microarray data showed that in
trans expression of tsrA only moderately down-regulated vfr transcription by about ~1.5-
fold, RT-PCR analysis was conducted, which confirmed the finding of microarray
analysis (Fig. 4-8A). The results prompted me to recheck the microarray data which
compared  the  global  gene  expression  profiles  of  the  mutant  ?spuE  with  the  one  of  the
wild type PAO1 (Chapter 3), and found that deletion of spuE resulted  in vfr down-
regulation by 1.2- and 1.4-fold in the mutant ?spuE in two independent sets of
microarray  data.  Vfr  is  well  known  as  a  cAMP  receptor  protein  (Kanack et al., 2006),
which positively controls the expression of T3SS genes in conjunction with the adenylate
cyclases encoded by cyaA and cyaB (Wolfgang et al., 2003). Expression of cyaB is
induced by the calcium depletion signal, which in turn increases vfr transcription as well
as stabilizes Vfr protein and activates T3SS, probably by enhancing the activity of T3SS
master regulator ExsA as part of a transcriptional complex in P. aeruginosa (Wolfgang et
al., 2003; Yahr and Wolfgang, 2006).
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Fig. 4-6 Immunoblotting analysis of the role of TsrA in regulation of effector secretion.
Bacterial cultures were grown in LB NTA medium supplemented with or without
spermidine. The extracellular proteins were separated by 10% SDS-PAGE. The proteins
were transferred onto nitrocellulose membrane and blotted with anti-ExoS antibody. The
experiment was repeated for at least three times with similar results.
ExoS
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Fig. 4-7 Expression of tsrA attenuates the T3SS-mediated cytotoxicity. Cytotoxicity was
determined by the LDH release by the HeLa cells infected with two MOIs of 25 and 50.
(A) Deletion of tsrA enhanced bacterial cytotoxicity towards HeLa cells. (B) In trans
expression of tsrA attenuated bacterial cytotoxicity towards HeLa cells. Experiments
were performed in DMEM medium supplemented with 1% FBS and 2 mM glutamine.
The data are means of three replicates.
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Fig. 4-8 Vfr is a key component in the spermidine signaling pathway. (A) RT-PCR
analysis of vfr transcription. The RNA samples used as the reaction templates were
prepared at different concentrations as indicated. 16s rDNA was amplified as internal
control to show equal loading of RNA template. (B) Disruption of vfr resulted in reduced
expression of exsCEBA and overexpression of vfr using vector pDSK-vfr (indicated as
‘vfr’ in the bracket) in the ?spuE mutant results in a high level expression of exsCEBA.
The vector pDSK519 (indicated as ‘v’ in the bracket) was introduced to the strains as a
control. (C) Exogenous spermidine induction of the T3SS system was largely impaired
due to the mutation of vfr. The data are means of three replicates.
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The above findings suggest that TsrA might suppress T3SS gene expression
through down-regulation of the transcriptional regulator Vfr. To investigate this
possibility, vfr was  cloned  under  the  control  of lac promoter in the plasmid vector
pDSK519 for in trans expression in the deletion mutant ?spuEpClacZ. The expression
construct pDSK-vfr was also introduced to the transposon mutant vfr::Tn (pale4, Chapter
2) as a control. Quantitative analysis of lacZ activity showed that the decreased exsCEBA
expression in both mutants ?spuE and vfr::Tn could be restored by in trans expression of
vfr (Fig. 4-8B), suggesting that Vfr may act at downstream of the SpuDEFGH transporter
in the spermidine signaling pathway. The notion is further strengthened by the finding
that mutation of vfr resulted in a reduced response to exogenous spermidine (Fig. 4-8C).
Under calcium-depletion conditions with different amounts of NTA, exogenous addition
of spermidine at the final concentration of 1 mM merely enhanced the expression level of
exsCEBA by less than 20% in the mutant vfr::Tn relative to the blank control without
addition of spermidine.  In contrast, addition of spermidine to wild type strain PAO1 led
to 2- to 3-fold increase in exsCEBA expression over the corresponding blank control (Fig.
4-8C). To investigate how TsrA and Vfr interplay in the signaling pathway, the vfr gene
was deleted from the mutant ?tsrA to generate the double deletion mutant ?tsrA?vfr. As
a control, vfr was also  deleted  from strain  PAO1 to  produce  the  single  deletion  mutant
?vfr. The reporter pC-lacZ was integrated into the genome of these two mutants for
quantitative analysis. The results showed that the double deletion mutant ?tsrA?vfr
displayed a similar expression level of exsCEBA as the deletion mutant ?vfr (Fig. 4-9A).
In comparison with its parental strain PAO1 and the single deletion parental strain ?tsrA,
deletion in ?tsrA?vfr caused about 50% and 30% decrease in exsCEBA expression level
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(Fig. 4-9A). The data are in agreement with the notion that TsrA and Vfr are in the same
signaling pathway. Furthermore, exsCEBA expression in double deletion mutant
?tsrA?vfr was fully restored by in trans expression  of vfr but  not  by tsrA (Fig. 4-9A),
indicating that Vfr acts at the downstream of TsrA in this regulatory cascade.
The above findings were further confirmed by Western blotting analysis, which
showed that double deletion of vfr and tsrA resulted in a reduced level of secreted ExoS
in the low calcium conditions, which was similar to the single deletion mutant??vfr (Fig.
4-9B). As expected, in trans expression of vfr, but not tsrA, in mutant ?vfr?tsrA restored
the secreted ExoS to the wild type level (Fig. 4-9B).
4.3.5 Spermidine modulates the interaction between TsrA and the promoter of vfr
(Pvfr)
To  investigate  how  Vfr  is  regulated  by  TsrA,  the  GST-TsrA  fusion  protein  was
over-expressed and purified in E. coli by affinity column chromatography. In the attempts
to obtain TsrA protein by removing the GST tag from GST-TsrA fusion protein using the
PreScission Protease (GE Healthcare), degradation of TsrA appeared (data not shown).
Therefore, GST-TsrA fusion protein was used in the subsequent experiments with the
GST protein as a background control.
Electrophoretic Mobility Shift Assay (EMSA) for testing direct interaction
between  TsrA  and  the  promoter  of vfr (Pvfr) was performed using biotin labelled Pvfr.
The  results  showed that  GST-TsrA bound to  Pvfr to generate a band shift, whereas the
background control GST protein did not affect the electrophorectic mobility of the
promoter Pvfr (Fig. 4-10A), suggesting that the bandshift was caused by TsrA.
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Fig. 4-9 TsrA modulates T3SS gene expression by repressing vfr transcription. (A) The
double deletion mutant ?vfr?tsrA showed reduced expression of exsCEBA; while in
trans expression of vfr by pDSK-vfr (indicated as ‘vfr’ in the bracket), but not tsrA
(indicated as ‘tsrA’ in the bracket) in ?vfr?tsrA restored expression of exsCEBA. The
data are means of three replicates. (B) The ?vfr?tsrA double deletion mutant showed
reduced secretion of the type III effector protein ExoS but the phenotype was rescued by
expression of vfr but not tsrA. Bacterial cultures were grown overnight in LB medium
with 8 mM NTA and the extracellular proteins in supernatants were collected by
trichloroacetic acid precipitation and separated by 10% SDS-PAGE. The proteins were
transferred onto nitrocellulose membrane and blotted with anti-ExoS antibody.
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Fig. 4-10 TsrA suppresses vfr and tsrA expression through direct binding to the
corresponding promoters. (A) EMSA analysis of specific binding of GST-TsrA to the
promoter of vfr (Pvfr). Lane 1 & 5 (counted from left), the biotin labelled probe incubated
with GST protein as a control. Lane 2-4, the probe was incubated with purified GST-
TsrA protein with increased concentrations as indicated in the subsection 4.2.8. Lane 6 &
7, unlabelled probe of Pvfr was  incubated  with  GST-TsrA and  biotin  labelled  Pvfr with
increased concentrations for specific competition. Lane 8 & 9, unlabelled probe of Plac
was incubated with GST-TsrA and biotin labelled Pvfr with increased concentrations as a
nonspecific competition control. (B) EMSA analysis of specific binding of GST-TsrA to
the promoter of tsrA (PtsrA). (C) Spermidine dependent disassociation of GST-TsrA-
Pvfr complex. Lane 1, probe was incubated with GST protein as a negative control. Lane
2, probe was incubated with GST-TsrA as a positive control. Lane 3-5, probe and GST-
TsrA were incubated with increased amounts of spermidine (lane 3, 1 nM of spermidine;
lane 4, 10 nM of spermidine and lane 5, 1 µM of spermidine). Lane 6 & 7, GST-TsrA
was incubated with increased amounts of putrescine (lane 6, 10 nM of putrescine and
lane 7, 1 µM of putrescine). Lane 8 & 9, GST-TsrA were incubated with increased
amounts of ornithine (lane 8, 10 nM of ornithine and lane 7, 1 µM of ornithine). (D)
Association of TsrA- PtsrA was polyamine independent.
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Fig. 4-11 ITC analysis of spermidine binding to TsrA. The upper panel shows the ITC
titration of 50 µM GST-TsrA (A) or GST (B) with 2 µl aliquots of 1 mM spermidine in
Tris Buffer, pH 8.0, at 18 °C. The lower panel shows the binding isotherm for titration as
described  in  the  upper  panel  where  the  solid  line  is  the  best  fit  of  the  data  to  a  one-site
binding model.
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The specificity of the interaction between TsrA and Pvfr was tested by using the non-
labelled Pvfr probe and the nonspecific lac promoter  (Plac) as competitors in reaction
mixture, respectively. The results confirmed the specific interaction between TsrA with
Pvfr since such an interaction was only disrupted by the unlabelled specific competitor
Pvfr but not affected by the unrelated lac promoter  DNA  (Plac) (Fig. 4-10A). These
results suggest that TsrA represses the T3SS by modulating the expression of vfr through
direct interaction with its promoter.
Bearing in mind that most members of the LysR family transcriptional regulators
interact with small specific signal molecules (Schell, 1993), I decided to test whether
spermidine, which was shown previously as a specific signal in induction of T3SS gene
expression, is the cognate signal ligand of TsrA (Zhou et al., 2007) (Chapter 3). Two
polyamines which are not the T3SS signal, i.e., putrescine and ornithine (Zhou et al.,
2007) (Chapter 3), were used as nonspecific controls. The three polyamines were
separately added to the reaction mixture to perform EMSA assay. The results showed that
addition of putrescine or ornithine at a final concentration of 10 nM or 1 µM did not
interfere with the interaction between TsrA and Pvfr (Fig. 4-10C). However, addition of
spermidine at a concentration of as low as 1 nM abolished the interaction between TsrA
and Pvfr (Fig. 4-10C). The data suggest that spermidine may interact with TsrA or the vfr
promoter, which consequently abrogates the formation of protein-promoter complex.
To understand how spermidine interferes with the formation of TsrA-Pvfr
complex, the possibility of spermidine binding to TsrA was determined by ITC analysis.
Fig. 4-11A shows the titration calorimetry profile resulting from consecutive injection of
2 µl aliquots of 1 mM spermidine to 50 µM GST-TsrA at 18°C. The binding reaction was
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exothermic with a binding dissociation constant Kd equivalent to (2.46 ± 0.32) x 10-5
M1. As a control, no binding between GST and spermidine was detected by ITC analysis
under  the  same  conditions  (Fig.  4-11B),  demonstrating  the  specific  interaction  between
spermidine and TsrA.
4.3.6 Self repression of tsrA expression through direct binding between TsrA and
tsrA promoter (PtsrA)
Most  members  of  the  LysR  family  are  also  auto  regulatory  transcriptional
regulators which repress their own transcription to self-maintain a constant level  (Schell,
1993). To determine this possibility, the promoter of tsrA (PtsrA) was fused to the
promoterless reporter gene lacZ on the chromosomal integration vector mini-CTX-lacZ.
The resultant construct containing the fusion gene PtsrA-lacZ was then integrated at the
attB site of the wild type strain PAO1 and its derivatives ?tsrA and ?spuE. Quantitative
lacZ activity assays showed that deletion of spuE increased tsrA promoter activity, which
is consistent with the enhanced tsrA transcription in mutant ?spuE shown Fig. 4-1 and
Table 4-3. Importantly, deletion of tsrA resulted in an enhanced transcription from PtsrA
by about 1- to 2-fold compared with the mutant ?spuE and wild type PAO1, respectively
(Fig. 4-12), which confirms its role in negative autoregulation.
The interaction between TsrA and the promoter PtsrA was demonstrated by
EMSA. Fig. 4-10B shows that GST-TsrA bound to PtsrA to generate a band shift; while
the GST protein alone did not interact with PtsrA. The specificity of interaction between
TsrA and PtsrA was confirmed as the protein-DNA complex was disrupted by addition of
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Fig. 4-12 Auto-repression of tsrA transcription. Deletion of tsrA in ?spuE resulted in
enhanced expression of tsrA independent of calcium concentration. The experiment was
repeated twice and the data are means of three replicates.
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the unlabelled specific competitor PtsrA but not by the unrelated lac promoter (Plac)
(Fig. 4-10B).
EMSA and ITC results  have  shown that  TsrA interacts  with  spermidine  to  form
the TsrA-spermidine complex which interferes with the binding between TsrA and Pvfr
and hence de-represses vfr expression (Fig. 4-10C, Fig. 4-11). It was intriguing to find
out whether spermidine also interferes with the interaction between TsrA and its own
promoter PtsrA. To this end, the effects of 3 polyamines (spermidine, putrescine and
ornithine) on the interaction between TsrA and PtsrA were  tested  by  EMSA assay.  The
results showed that formation of the TsrA-PtsrA complex  occurred  regardless  of  the
presence or absence of 3 polyamines (Fig. 4-10D).
4.3.7 Deletion of tsrA partially attenuates the response of P. aeruginosa to exogenous
addition of spermidine
Previous data have shown that exogenous addition of spermidine induces the
exsCEBA expression of P. aeruginosa in a dosage-dependent manner (Fig. 3-7A) (Zhou
et al., 2007) (Chapter 3). To determine the relative role of TsrA in spermidine signaling
pathway, I tested the effect of tsrA and spuE/tsrA mutation on T3SS expression in P.
aeruginosa in response to exogenous addition of spermidine. The results showed that
deletion of tsrA did not abrogate the bacterial response to spermidine. By monitoring the
pC-lacZ reporter activity in response to exogenous addition of 1 mM of spermidine, the
expression level of exsCEBA of the mutant ?tsrA was found to be increased by about 2-
fold than the control without addition of spermidine (Fig. 4-13A). This level of induction
was similar to that of wild type strain PAO1 under the same growth conditions (Fig. 4-
151
13A). When the NTA concentration was increased to 2 mM or 5 mM in culture medium,
the response to spermidine by the deletion mutant ?tsrA and its wild type was maintained
but partially compromised (Fig. 4-13B; 4-13C). In contrast, exogenous addition of
spermidine to the double deletion mutant ?spuE?tsrA and the single deletion mutant
?spuE in  all  the  3  tested  media  resulted  in  similar  less  than  40%  increase  in exsCEBA
expression level (Fig. 4-13A, B & C).
4.4 Discussion
A Blast search showed that TsrA is novel LysR-type regulator, which is
conserved in various P. aeruginosa strains, including PACS2, PACS2, 2192, C3719,
LESB58, PA14 and PA7. In addition, TsrA homologs sharing more than 50% identity in
amino acid sequence are also found in other bacterial species, such as, Pseudomonas
mendocina, Ralstonia metallidurans, Ralstonia Eutropha, and Burkholderia multivorans.
However, the biological functions of these close homologues have not yet been reported.
The results from this chapter show that TsrA is a novel transcriptional repressor, which
represses T3SS gene expression and affects bacterial virulence in P. aeruginosa.   TsrA
was initially found to be up-regulated in the spermidine transporter mutant ?spuE (Table
4-3, Fig. 4-1) (Zhou et al., 2007). Several lines of evidence suggest that TsrA is a key
regulator in the spermidine signaling pathway. First, deletion of tsrA from either wild
type PAO1 or from the genetic background of ?spuE resulted in increased expression of
exsCEBA (Fig.  4-2A,  4-2B).  Second,  microarray  study  showed  that  increasing  TsrA





Fig. 4-13 Deletion of tsrA partially attenuated the exogenous spermidine induced
exsCEBA expression in the culture media with (A) 1 mM NTA, (B) 2 mM NTA, and (C)
5 mM NTA. Results are means of three replicates.
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the expression of T3SS genes as well as other virulence genes (Fig. 4-3, 4-4, 4-5; Table
4-4). Third, deletion of tsrA in the mutant ?spuE recovered the cytotoxicity of mutant
towards HeLa cells by 80% (Fig. 4-7A); and consistently, in trans expression of tsrA in
PAO1 significantly attenuated its cytotoxicity (Fig. 4-7B). Identification of TsrA as a
novel transcriptional regulator in spermidine signaling pathway facilitates our
understanding on the molecular mechanisms of host-pathogen interactions.
TsrA belongs to the LysR-type transcriptional regulator (LTTR) family, most
members of which are well known to be self-repressed, but function as transcriptional
activators in the presence of some small signal molecules (co-inducer) (Schell, 1993).
However, there are exceptions; a few members such as CatM (Neidle et al., 1989), AmpR
of Enterobacter cloacae (Honore et al., 1986), IciA (Thony et al., 1991) and RovM
(Heroven and Dersch, 2006a), have been shown to act mainly as repressors. The results
from this study show that TsrA belongs to the repressor subfamily, which inhibits T3SS
gene expression by suppressing transcriptional expression of the global regulator Vfr
(Table 4-4, Fig. 4-4). This repression was abolished in the presence of exogenous
spermidine (Fig. 4-6, 4-10B). It is worthy to note that deletion of tsrA from wild type
strain PAO1 only caused a moderate increment (about 40%) in exsCEBA expression (Fig.
4-2A). In contrast, severe repression of exsCEBA expression was achieved by
overexpression of TsrA (Fig. 4-2B).  A plausible explanation is due to the low expression
level of tsrA in wild type PAO1 under the experimental conditions used in this study as
shown  by  RT-PCR  analysis  (Fig.  4-1).   Expression  of  some  of  the  members  of  LTTR
family is known to under environmental control. For example, expression of leuO, which
encodes a LTTR implicated in the bacterial stringent responses and in the virulence of
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Salmonella enterica Serovar Typhi, is enhanced in stationary phase and by phosphorous
restriction (VanBogelen et  al., 1996; Fang et al., 2000; Hernandez-Lucas et  al., 2008).
Similarly, production of another LTTR protein, RovM, is also related to richness of
nutrition and more RovM was detected in the minimal media, such as MMA, RPMI and
M9, than in the rich medium (LB) (Heroven and Dersch, 2006b). Our data showed that
expression of tsrA was increased in the ?spuE mutant (Fig. 4-1, 4-12), in which uptake of
spermidine is abolished (Lu et al., 2002), indicating that expression of tsrA is likely to be
suppressed by exogenous spermidine. Therefore, the tsrA of wild type P. aeruginosa is
not expected to be highly expressed in LB medium, which was reported to contain about
0.3 mM each of spermidine and spermine (Ozawa et al.,  1993).  The  presence  of  these
polyamines in LB medium promotes T3SS expression, at least partially by inhibiting tsrA
transcription. Under such conditions, it appears logical that deletion of tsrA had  less
prominent influence on exsCEBA expression. Consistent with this notion, the double
deletion mutant ?spuE?tsrA, in which polyamine uptake is blocked, showed a 2-fold
increase in exsCEBA expression compared to the single deletion ?spuE mutant (Fig. 4-
2A). Furthermore, deletion of tsrA in ?spuE almost fully restored the cytotoxicity of
?spuE (Fig. 4-7A), suggesting that the attenuated cytotoxicity of mutant ?spuE is largely
due to TsrA, which is highly expressed in the mutant and thus represses T3SS gene
expression.
In this study, not only the LTTR type transcriptional factor TsrA was identified,
but the global regulator Vfr (virulence factor regulator) was also shown to be involved in
the spermidine signaling pathway. Vfr belongs to the family of cAMP receptor proteins
(CRPs), and it is a global regulator that is associated with a range of biological functions
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in P. aeruginosa, including activating the transcription of quorum sensing genes lasR and
rhlR (Albus et  al., 1997; Beatson et  al., 2002; Bertani et al., 2003), regulating the
production of several extracellular and cell-associated virulence factors, such as
exotoxinA and protease IV (West et al., 1994; Lory et al., 2004),  and modulating T3SS
gene expression (Wolfgang et al., 2003). CRP family members have been shown to be
intrinsically unstable and the level of cAMP is essential for the stability of CRP proteins
(Ohki et al., 1992). Similarly, the mutants unable to synthesize cAMP show reduced
expression of vfr by 2-fold (Wolfgang et  al., 2003), which is accompanied with a
disproportionate reduction in Vfr protein level, which is more than 10-fold (Yahr and
Wolfgang, 2006). Therefore, cAMP is a key factor influencing vfr transcription as well as
the protein stability of Vfr. In addition, a recent study shows that deletion of fimL leads to
a marginal reduction in the transcription of vfr by 30% to 50% (Whitchurch et al., 2005).
FimL is an unusual signaling protein and it shares a high degree of sequence similarity
with the amino-terminus of ChpA, which also regulates cAMP production (Whitchurch et
al., 2005; Yahr and Wolfgang, 2006). Therefore, it is likely that FimL influences the vfr
expression by modulating cAMP levels. Data provided in this chapter have presented
another signaling mechanism that controls vfr expression. Firstly, vfr was shown to be
down-regulated by in trans expression  of tsrA (Fig. 4-8A, Table 4-4). Secondly, the
results of EMSA and ITC assay suggest that TsrA interacts with the vfr promoter and
spermidine disrupts their interaction and hence de-represses vfr expression (Fig. 4-10A;
Fig. 4-10C, Fig. 4-11). As Vfr is associated with positive regulation of T3SS gene
expression (Wolfgang et al., 2003), it is plausible that TsrA controls T3SS expression by
modulating vfr expression. This hypothesis is supported by the finding that the deficiency
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of double deletion mutant ?tsrA?vfr in exsCEBA expression (Fig. 4-9A) and ExoS
secretion (Fig. 4-9B) was rescued by complementation with vfr but not tsrA.  The  data
presented in this chapter have also shown for the first time that Vfr is a key regulator in
the spermidine signaling pathway since deletion of vfr had largely impaired the response
of P. aeruginosa to exogenous spermidine (Fig. 4-8). As either mutation in the
spermidine uptaking transporter SpuDEFGH or in trans expression of the repressor tsrA
did not affect the transcriptional level of cyaA and cyaB (Zhou et al., 2007; Chapter 4,
Table 4-4), which encodes two adenylate cyclases for cAMP biosynthesis (Wolfgang et
al., 2003) it seems unlikely that spermidine modulates vfr transcription through changing
the level of cAMP.
Polyamines are known to play roles in numerous cellular processes, including
modulation of transcription and translation, protection against oxidative damage,
regulation of bacterial porins and eukaryotic ion channels, and mediation of biofilm
formation (Lopatin et al., 1994; Karatan et  al., 2005; Shah and Swiatlo, 2008). These
organic  polycations  function  by  direct  interaction  with  target  molecules  such  as  DNA,
RNA, and porin proteins, most likely through their protonated amine groups (Shah and
Swiatlo, 2008). In contrast, our previous results have shown that spermidine is a specific
signal that activates transcription of T3SS genes in P. aeruginosa through modulating the
transcriptional  expression  of  the  T3SS  master  regulator  ExsA  (Zhou et al., 2007)
(Chapter 3), which suggests the presence of a specific spermidine signaling pathway. In
this chapter, by dissecting this signaling pathway, we found that TsrA is a novel
spermidine effector. TsrA auto-regulates its own expression by direct binding to its own
promoter (PtsrA) (Fig. 4-10B), and suppresses T3SS expression by blocking the
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transcription of vfr (Fig. 4-8A, 4-10A). Importantly, spermidine binds to TsrA as shown
by ITC analysis (Fig. 4-11A), and such an association inactivates the ability of TsrA to
form a complex with the promoter of vfr (Pvfr) (Fig. 4-10C). To my knowledge, TsrA is
the first identified polyamine-dependent regulator, which plays a key role in modulation
of bacterial virulence. However, it remains puzzling that how this regulatory system
specifically responds to spermidine but not to other polyamines which share similar
structures and biochemical properties.
Taken together, the results from this and the previous chapter suggest a specific
spermidine signaling pathway that is essential for T3SS gene expression and virulence of
P. aeruginosa (Fig. 4-15). In this signaling pathway, the spermidine (including spermine)
signal from host cells is sensed and transported into bacterial cells by the transporter
SpuDEFGH, and the signal promotes vfr transcription by formation of a complex with
TsrA to prevent the repressor binding to the vfr promoter. Meanwhile, the TsrA-
spermidine complex binds to the promoter PtsrA and represses its own transcription,
which serves to further reduce the intracellular level of TsrA. As a consequence, Vfr
promotes T3SS gene expression by modulating ExsA with an unknown mechanism (Fig.
4-15). However, mutation in the spermidine transporter SpuDEFGH ceased uptaking of
exogenous spermidine into bacterial cell, which leaves TsrA free to repress vfr
expression, and hence less TsrA is available for auto-repression and results in increased
expression of tsrA. It is worthy to note that deletion of tsrA only partially attenuated the
response of P. aeruginosa to exogenous addition of spermidine (Fig. 4-13A, 4-13B, 4-
13C), whereas deletion of vfr completely blocked T3SS expression (Fig. 4-9A). These
data  suggest  that  TsrA  is  merely  one  of  the  regulatory  elements  downstream  of  the
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SpuDEFGH spermidine transporter in modulating T3SS gene transcription, and there
may be other factor(s) that could also transduce spermidine signal to the T3SS regulon
via Vfr independent of TsrA (Fig. 4-15).
In the previous chapter, it was found that de novo synthesis of spermidine did not
seem to  be  involved  in  the  regulation  of  T3SS since  deletion  of speD and speE had no
effect on T3SS gene expression. It becomes intriguing why endogenous spermidine has
no  interaction  with  TsrA.  One  of  the  possible  explanations  is  that  most  cellular
polyamines exist as a polyamine-RNA complex due to its polycationic property and the
available free polyamines are limited intracellularly (Igarashi and Kashiwagi, 2000). For
example, in E. coli ~95% spermidine binds to RNA or DNA and only 3.8% of spermidine
is free (Igarashi and Kashiwagi, 2000). Therefore, the limited available intracellular
spermidine and the weak association constant between spermidine and TsrA determine
that  the  formation  of  spermdine-TsrA  complex  for  de-repressing vfr expression and
consequently activating T3SS only happens only in the presence of high level of
exogenous spermidine which can be uptaken by the SpuDEFGH spermidine transporter.
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Fig. 4-14 Structures of common polyamines.
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Fig. 4-15 Proposed spermidine signaling pathway required for T3SS gene expression in
P. aeruginosa. Extracellular spermidine is sensed and transported into bacterial cell by
the spermidine transporter SpuDEFGH, which de-represses vfr transcription by forming a
TsrA-spermidine complex to prevent TsrA binding to Pvfr; while the TsrA-spermidine
complex  remains  to  bind  to  the  promoter  PtsrA and exerts auto-repression (left panel).
However, mutation of the spermidine transporter leads to stopped uptaking of exogenous
spermidine, leaving TsrA free to repress vfr expression, and hence reduced amount of
TsrA is available for auto-repression and gives rise to increased expression of tsrA (right
panel).
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Chapter 5 Protection against mice pulmonary pseudomonal infection by
active immunization with polyamine transport protein SpuD of P.
aeruginosa
5.1 Introduction
Pseudomonas aeruginosa is a metabolically versatile Gram-negative bacterium
that is capable of causing opportunistic infections in plants and mammals. In humans, P.
aeruginosa infections occur in gastrointestinal tract and respiratory system and in patients
with ocular infections, burn wounds, and cystic fibrosis (CF) (Lyczak et al., 2000).  The
characteristics of acute and chronic infections caused by P. aeruginosa are quite distinct
and are associated with selected expression of a certain subset of virulence factors. The
pathogenesis of acute infections, such as ventilator-associated pneumonia, is thought to
require the expression of a functional type III secretion system (T3SS), along with other
toxins and proteases (Yahr and Greenberg, 2004). These infections typically result in
systemic spread of P. aeruginosa in a mouse pulmonary challenge model and ultimately
mortality (Vance et al., 2005). The expression of a functional T3SS also correlates with
poor prognosis in clinical infections (Sawa et al., 1998; Roy-Burman et al., 2001).
The T3SS of P. aeruginosa consists of 43 genes, which encode the protein
components for assembly and generation of a needle-like structure to inject the effector
proteins  (ExoS,  ExoT,  ExoU  and  ExoY)  into  the  cytoplasm  of  eukaryotic  host  cells
(Dacheux et al., 2000; Dacheux et al., 2001). These effectors act by interfering with host
immune responses, including activation of host signaling cascades, triggering host pattern
162
recognition through extracellular and intracellular pattern recognition receptors (PRRs),
and suppression or evasion of innate and adaptive defenses (Coburn et al., 2007). For
example, the production of ExoS in the murine lungs infected with P. aeruginosa
activates TLR2 and TLR4, which are essential for production of complete inflammatory
responses (Epelman et al., 2004). Consistent with its key role in suppressing host immune
systems, null mutation of T3SS in P. aeruginosa resulted in significantly attenuated
virulence (Vallis et al., 1999; Rocha et al., 2003; Urbanowski et al. 2005; Urbanowski et
al. 2007).
Expression of T3SS genes is coordinately regulated by its master transcriptional
regulator ExsA (Frank, 1997).  ExsA-dependent promoters lie upstream of exoS, exoT,
exoY, exoU, pscU, popN, pcrG, exsC and exsD, which controls the transcription of all the
9 T3SS operons, including its own transcription (Brutinel et al., 2008). In addition, T3SS
gene expression is also coupled with the type III secretion activity. The translocator
proteins PopB, PopD, and the needle tip protein PcrV are secreted via the type III
secretion system and they are required for pore formation and translocation of effectors
across the host cell plasma membrane (Broms et al., 2003; Dacheux et al., 2004; Goure et
al., 2004; Goure et al, 2005). Secretion of PcrV, PopB and PopD allows the secretion of a
negative regulator of T3SS gene expression (ExsE) under the low calcium conditions and
thereby relieves the block on T3SS gene expression (McCaw et al., 2002; Urbanowski et
al., 2007) Furthermore, several upstream regulatory proteins are known to influence the
expression of T3SS genes, such as the global transcriptional regulator Vfr that positively
modulates T3SS expression with an unknown mechanism (Wolfgang et al., 2003). More
recently, we showed that a major spermidine transporter encoded by the spuDEFGH
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operon is also required for T3SS expression in P. aeruginosa. Null mutation of this
transporter leads to a defective production of effector proteins and attenuated cytotoxicity
toward HeLa cells (Zhou et al., 2007; Chapter 3).
 Our results also indicate that blocking the uptake of host polyamine signals could
prevent T3SS induction and as a consequence, attenuate P. aeruginosa cytotoxicity
against a human cell line (Zhou et al., 2007; Chapter 3). In this chapter, I will further
investigate the biological significance of the SpuDEFGH transporter in infection by using
the mouse pulmonary infection model and evaluate the immunogenicity and effect of
SpuD, which is one of the substrate binding proteins of the transporter that acts by
recruiting polyamine signals from extracellular environment, against P. aeruginosa
infection in this animal model.
5.2 Material and methods
5.2.1 Bacterial strains and growth conditions
The P. aeruginosa strains  used  in  this  study  were  wild  type  strain  PAO1
(Laboratory collection), the deletion mutant ?spuE (Chapter 3) and the transposon
insertion mutant exsA::Tn (Chapter 2). Strains were routinely maintained in LB broth at
37°C. The E. coli strain used in this study was BL21 (DE3) (F- ompT hsdS(rB- mB-)
dcm+ Tetr gal (DE3) endA, Stratagene), which was maintained in LB broth at 37°C with
addition of antibiotic ampicillin (Ap) (Sigma, U.S.A) at 100 µg/ml when necessary.
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5.2.2 Intra-tracheal challenge with P. aeruginosa
To prepare bacterial cells for infection, overnight bacterial cultures were diluted
1:100 to fresh LB medium for incubation at 37°C with shaking at 250 rpm for 3 hours,
allowing OD600 to reach 1.0. The bacterial cells were harvested and washed with PBS for
2 times and then the cells were resuspended in PBS buffer (123.2 mM NaCl, 10.4 mM
Na2HPO4 and 3.2 mM KH2PO4, pH 7.3) to obtain a cell density with colony forming
units (CFU) of 1x109 per ml. The bacterial solutions were further diluted 167 times or
500 times by PBS to obtain a CFU of 6x106 or 2x106 for infection of mouse. The
bacterial CFU counting was determined by plating serial dilutions of each inoculum on
LB agar plates.
To establish pulmonary infection, 8-10 week old FVB/N mice were anesthetized
with Hypnorm/Dormicum mixture, the trachea was exposed though anterior midline
incision.  Fifty microliters of prepared P. aeruginosa suspension was delivered just
beneath the cricoid’s cartilage. The incision was sealed by sterile surgical clips.
5.2.3 Quantification of P. aeruginosa load in mice lungs
To determine the clearance of P. aeruginosa in mice lungs after inoculation (3 x
105 bacteria/mouse), mice were killed by inhalation of carbon dioxide at specified time
points post P. aeruginosa infection as indicated. Tissue samples from lung were removed
aseptically, and samples were homogenized and supernatants were taken for
quantification of bacterial colony forming units (CFU). Animals were used following the
guidelines of the National Advisory Committee for Laboratory Animal Research
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(NACLAR), with protocols approved by the Institutional Animal Care and Use
Committee (IACUC), Singapore (Reference No: IACUC 50053).
5.2.4 Cytokine levels following infection with P. aeruginosa
BAL (bronchoalveolar) lavage fluid from each group of 4 mice was collected and
pooled at 22 hours post P. aeruginosa infection (3 x 105 bacteria/mouse). The cytokine
levels were evaluated by using RayBio? Mouse cytokine Antibody array following the
manufacturer’s instructions. The resultant images were processed by Image J
(http://rsb.info.nih.gov/ij/) to determine the signal intensities for quantitative analysis.
5.2.5 Purification of recombinant SpuD
For purification of the recombinant SpuD (from the 25th amino  acid  to  367th
amino acid), the spuD coding  region  (from the  76th nucleic acid to 1101st nucleic acid)
from P. aeruginosa PAO1 was amplified using primer pair, spuD25thAA-F-B (5’-
CTGGGATCCATGGCGGACAACAAGGTGCTG-3’) and spuDend-R-E (5’-
CGGGAATTCTCACTTGCCGGACTTGATC-3’), which contained engineered BamHI
site and EcoRI site (underlined) for cloning in the expression vector pGEX-6p-1 (GE
Healthcare). The start codon ATG and terminator codon TGA were included respectively
in the forward primer and reverse primer for correct expression of the recombinant SpuD.
The purified PCR product and vector were digested with BamHI and EcoRI, gel-purified,
and ligated together. The resultant construct pGEX-spuD was transformed into host strain
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E. coli BL21 (DE3) (Stratagene). After sequencing confirmation, the SpuD protein was
purified according to the manufacturer’s instruction (GE Healthcare).
5.2.6 Endotoxin removal from the SpuD protein solution
The regenerated Detoxi-Gel Endotoxin Removing Column (Pierce) was used to
remove potential lipopolysaccharides (LPS) from the purified SpuD protein samples. The
protein sample was applied to the column and incubated for 2 hours.  The flow-through
fractions were collected and separated by 10% SDS-PAGE for assessment of purity and
potential degradation. Bacterial endotoxin level of the SpuD protein samples collected
before and after endotoxin removal was quantitatively determined by Limulus
Amebocyte Lysate (LAL) Kinetic-QCL® (Lonza) following manufacturer’s instructions.
5.2.7 Immunogenicity assay of mice by ELISA analysis
Twenty-four 10-week old FVB/N mice were maintained on a standard diet with
free access to water. Among them, 12 mice were immunized with 100 µg SpuD antigen
subcutaneously. Complete Freund’s adjuvant (CFA, Sigma) was used in the primer
immunization on day 0 while incomplete Freund’s adjuvant (IFA, Sigma) was used in the
booster immunizations on day 21 and day 42. Both CFA and IFA were used according to
the manufacturer’s instruction. Serum samples were taken at day 0 and day 50 post
immunization, respectively, and assayed to determine the titers of total IgG proteins.
A ninety-six-well microplate was coated with 100 µl per well of SpuD antigen
solution,  which  was  prepared  at  a  concentration  of  0.5  µg/ml  in  coating  buffer  (50  mM
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carbonate buffer, pH9.6), and incubated overnight at 4°C. On the second day, the plates
were washed 3 times with PBST (PBS containing 0.05% tween 20) and followed by 3
times washing with PBS. Subsequently, the wells were treated with blocking buffer (5%
FBS in PBST) for 2 hours at 37°C, and washed 3 times with PBST and 3 times with PBS.
An aliquot of 50 ?l diluted mouse serum was added to each well and the plate was
incubated at 4°C overnight. On the third day, the plate was washed as previously
described. Fifty microliters of a 2500x dilution of HRP-conjugated goat anti mouse IgG
was added to each well and the plate was incubated at 37°C for 2 hours, followed by
washing. Detection was done by adding 50 ?l TMB substrate solution (Pierce) to each
well, and the reaction was stopped 5 minutes later by adding equal volume of 1M H2SO4.
The reaction products were quantified by reading OD450 in a microplate reader.
5.3 Results
5.3.1 Null mutation of spermidine uptake transporter in P. aeruginosa reduces the
host mortality in a mouse pulmonary infection model
Chapter 3 has shown that deletion of spuE decreased the host cell extract-induced
expression of T3SS genes and attenuated the T3SS-mediated cytotoxicity toward HeLa
cells. It was therefore intriguing to determine the impact of null mutation of the
SpuDEFGH transporter on in vivo virulence of P. aeruginosa. Prior to inoculation, the
effect of mutation on growth was evaluated.  The results shown in Fig. 5-1 show that the
wild type strain PAO1 and its mutant ?spuE had nearly identical growth curves under the
four tested conditions, suggesting that mutation in the SpuDEFGH transporter does not
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affect normal bacterial growth (Fig. 5-1). To examine the role of this spermidine
transporter in virulence under in vivo conditions, we used a mouse model of acute
pulmonary infection. FVB/N mice were infected with two dosages of bacterial cells, i.e.,
1 x 105 and 3 x 105 CFU per mouse, respectively. Surviving animals were counted daily
over  a  5-day  period.  At  a  low inoculum dosage  (CFU = 1  x  105 per ml), the wild type
PAO1 caused only 20% of mortality at the 3rd day post infection (Fig. 5-2A), whereas at a
high dosage (CFU = 3 x 105 per ml), PAO1 caused progressive death of infected mice
with a total mortality of 20%, 60% and 80% at day 2, 3 and 4, respectively (Fig. 5-2B). In
contrast, none of the mice infected with a low dosage of mutant ?spuE was killed (Fig. 5-
2A), and only 20% of mouse mortality occurred at 3rd day  post  infection  with  the  high
dosage of the mutant. Mice challenged with the T3SS null mutant exsA::Tn showed
100% survival after 5 days (Fig. 5-2A, 5-2B). The above findings indicate the
SpuDEFGH transporter plays a key role in modulation of T3SS-mediated acute infection
in the animal host.
5.3.2 The ?spuE mutant shows a slow lung clearance post infection
To determine whether the reduced mortality of mice infected with the mutant
?spuE was caused by the changed pattern of bacterial load in the infection court as a
consequence of host immune responses, the P. aeruginosa cell numbers in mice lungs
was counted at 1day post infection and 2 day post infection. One day after infection, the
wild type PAO1 survived marginally better than the mutants ?spuE and exsA::Tn in the
infected lungs (Fig. 5-3). However, at the day 2 post infection, PAO1 bacterial cells were
completely eliminated in mouse lungs, while persistence of the ?spuE mutant cells in
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mouse lungs was observed, which is similar to the control strain exsA::Tn (Fig. 5-3). As
T3SS plays a key role in inducing immune responses (Power et al., 2004), our results
suggest that wild type PAO1 may trigger a stronger immune response than the mutants
?spuE and exsA::Tn, which consequently leads to faster bacterial clearance.
5.3.3 Mice infected with ?spuE have reduced cytokine production
To determine the impact of spermidine transporter mutation on host immune
response, the cytokine production level in BAL lavage fluid which was collected 22
hours post P. aeruginosa infection (3 x 105 bacterial cells/mouse) was evaluated. As
show in Table 5-1, infection by wild type PAO1, significantly induced the production of
6 cytokines in mouse BAL lavage fluid compared with PBS control, including
interleukin-6 (IL-6) by 22.5-fold, tumor necrosis factor (TNF?) by 5.7-fold, keratinocyte
chemoattractant (KC) by 12.8-fold, soluble tumor necrosis factor receptor I (sTNFRI) by
2.6-fold, monocyte chemotactic protein-5 (MCP-5) by 1.9-fold and granulocyte colony-
stimulating factor (GCSF) by 18.6-fold. As predicted, mutation of the spermidine
transporter compromised the ability of P. aeruginosa to trigger the production of
cytokines, in particular, IL-6, KC and TNF? (Table 5-1). Reduced production of IL-6 and
TNF? was also observed in the mice infected with exsA::Tn, which is a T3SS-deficient
mutant. Moreover, production of MCP-5 was also decreased by 8.9-fold in those mice
compared with mice infected with PAO1. However, production of KC in the mice
infected with exsA::Tn, instead of decrease, was even increased slightly (0.8-fold)
compared with the mice infected with PAO1 (Table 5-1).
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Fig. 5-1 The growth patterns of PAO1 and ?spuE. Bacteria were grown at 37 °C with
agitation.  Growth  was  monitored  by  measuring  the  optical  density  of  the  culture  at  600
nm (OD600) determined by Bioscreen C (Oy Growth Curves Ab Ltd.). PAO1 (square)
and ?spuE (triangle) have almost identical growth curves in (A) LB medium, (B) LB
medium  supplemented  with  1mM  spermidine  (C)  LB  medium  with  7.5  mM  NTA,  and
(D) LB medium supplemented with 7.5 mM NTA and 1mM spermidine.
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Fig. 5-2 Survival plots of FVB/N mice infected by P. aeruginosa wild type strain PAO1
(blue circle), the ?spuE deletion mutant (red square), and the exsA::Tn transposon
insertion mutant (black diamond). Each mouse was challenged by 1x105 (A) or 3x105 (B)
bacterial cells through intra-tracheal infection.. Similar data were obtained in two
independent experiments.
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Fig. 5-3 P. aeruginosa clearance in mouse lung after intra-tracheal infection. FVB/N
mice were challenged intravenously with a defined dose of P. aeruginosa strains PAO1,
?spuE and exsA::Tn, and pathogen clearance was determined by assessment of CFU ml-1
of bacteria in lung 1 day post infection (open bars) and 2 day post infection (grey bars).
The data are means from two independent experiments.
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Table 5-1. Cytokines production changed in mouse BAL lavage fluid during P.
aeruginosa infection
Cytokines Fold change
PAO1 vs. PBS mock
interleukin-6 (IL-6) + 22.5
granulocyte colony-stimulating factor (GCSF) + 18.6
keratinocyte chemoattractant (KC) + 12.8
tumor necrosis factor (TNF?) + 5.7
soluble tumor necrosis factor receptor I (sTNFRI) + 2.6
monocyte chemotactic protein-5 (MCP-5) +1.9
PAO1 vs. ?spuE
interleukin-6 (IL-6) + 1.7
keratinocyte chemoattractant (KC) + 1.7
tumor necrosis factor (TNF?) + 2.7
monocyte chemotactic protein-5 (MCP-5) + 0.1
PAO1 vs. exsA::Tn
interleukin-6 (IL-6) + 12.3
keratinocyte chemoattractant (KC) - 0.8
tumor necrosis factor (TNF?) + 2.1
monocyte chemotactic protein-5 (MCP-5) + 8.9
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5.3.4 SpuD Immunization increased the chance for mice to survive in the Intra-
tracheal challenge model
Given that the spermidine transporter mutants are less virulent in mice (Fig. 5-2),
it was intriguing to test the possibility of immunization with the protein components of
this spermidine transporter complex for protection against P. aeruginosa infection. As
SpuD and SpuE are the putative extracellular polyamine-binding components, which are
located at the outer part of the transporter complex, these two proteins were considered as
potential antigens for immunization. SpuD was chosen for subsequent studies as
preliminary data showed that SpuD was expressed in higher quantity than SpuE under the
experimental conditions used in this study.
Domain analysis using SMART program (http://smart.embl-heidelberg.de/)
indicates that SpuD has a signal peptide at the N-terminus (1st – 24th aa),  followed by a
SBP-bac-1 (bacterial extracellular solute-binding protein) domain spanning from 27th –
303rd aa,  and  a  region  of  intrinsic  disorder  at  the  C-terminus  (343rd – 367th aa)  (Fig.  5-
4A).  To  avoid  retention  of  SpuD  in  membrane  fraction  due  to  existence  of  the  signal
peptide, I designed the SpuD expression construction pGEX-spuD which harbors the
coding region from 76th - 1101st nt  for  purification  of  the  truncated  SpuD  (from  25th -
367th aa), which was estimated to give a peptide with approximately 38 kDa in size (Fig.
5-4B).
As  lipopolysaccharides  (LPS)  are  abundant  molecules  in  the  outer  membrane  of
Gram-negative bacteria, acting as endotoxins to elicit strong immune responses in
animals (Pier, 2000; Priebe et al.,  2008),  contamination  of  LPS  in  the  protein  samples
will  activate  host  immune  system,  which  may  affect  evaluation  of  SpuD  as  a  potential
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antigen. Therefore, after purification of the SpuD protein from the E. coli strain  BL21
(DE3) by the GST-affinity column, LPS in the protein samples were removed by the use
of detoxi-gel endotoxin removing column, which significantly reduced the endotoxin
concentration of the SpuD protein sample from 210 EU (endotoxin unit)/ml to 7.5 EU/ml
(Fig. 5-5). The resulted LPS-free SpuD sample was used for mouse immunization. One
week after the 2nd booster immunization, sample sera were collected from 4 mice
immunized with SpuD and 2 mice without immunization as a blank control. The
collected sera were subjected to Elisa analysis to determine their titers. After plotting the
antibody titer graph (Fig. 5-6), the anti-spuD titers of the collected sera were estimated to
be within the range from 1 in 10000 to 1 in 80000.
Mice with (n = 10) and without SpuD immunization (n = 12) were subjected to P.
aeruginosa infection through intra-tracheal injection. Fig. 5-7 shows that mice with SpuD
immunization had a significantly higher survival rate than those without immunization 3
day post infection by wild type PAO1 (80% vs. 0%), which was as high as the mice
without SpuD immunization but challenged by the ?spuE deletion mutant. As expected,
immunization with SpuD did not further protect mice which were challenged by the
?spuE deletion mutant, since mice with or without SpuD immunization showed similar
survival rate (80% vs. 75%) 3 days post infection (Fig. 5-7). These data demonstrated
that immunization of SpuD to FVB/N mice significantly increases their survival chance
in this intra-tracheal infection model.
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Fig. 5-4 Expression of recombinant SpuD. (A) In silico domain organization of SpuD
was analysized using SMART program (http://smart.embl-heidelberg.de), which
predicted that SpuD was composed of signal peptide domain (1st – 24th amino acid , red
bar), the solute binding protein (SBP) domain (27th – 303rd amino acid, grey bar) and
intrinsic disorder region (343rd – 367th amino acid, blue bar). (B) SDS-PAGE analysis of
recombinant SpuD (25th – 367th amino acid) stained by coomassie blue. The left most
lane, prestained protein ladder (BioLabs). Lane 1-8, fractions of SpuD sample eluted
from Glutathione Sepharose™ 4B column after on column digestion by PreScission™
Protease. The right most lane, the GST-SpuD fusion protein eluted from Glutathione
Sepharose™ 4B column using reduced glutathione solution (10 mM, Sigma).
177
Fig. 5-5 Chromogenic LAL standard curve. Series of endotoxin dilutions (blue diamond)
from the kit were subjected for assay following manufacturer’s instruction. The trendline
was added and its equation and R-squared value were calculated by Microsoft Excel
software. Endotoxin concentrations of the SpuD protein sample before (20 times diluted,
green square) and after (5 times diluted, red circle) endotoxin removal were estimated as
210 EU/ml and 7.5 EU/ml, respectively.
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Fig. 5-6 Anti-SpuD titer graph. Absorbance at 450nm vs. serum dilution is plotted using
the mean and standard error for each triplicate set. Titer of the anti-SpuD serum (red
symbols and lines) from each FVB/N mice with immunization is interpolated by drawing
a line down from the inflection point of the post-immune graph to the X-axis. Sera from
mice without immunization are used as a control (black symbols and lines).
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Fig. 5-7 Effect of SpuD immunization on the mortality of FVB/N mice challenged by P.
aeruginosa intra-tracheal infection. The mice with SpuD immunization and without
immunization (WT) were inoculated with wild type strain PAO1 and mutant ?spuE,
respectively. Similar data were obtained in two independent experiments.
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5.4 Discussion
This chapter has shown that mice infected with the mutant ?spuE, similar to those
infected with the strain exsA::Tn, had significantly increased survival chance in the
mouse pulmonary infection model (Fig. 5-2), which is most likely due to the down-
regulation of T3SS in both ?spuE and exsA::Tn as described in Chapter 3. These data are
consistent with two previous findings that deletion of all the T3SS effector genes from P.
aeruginosa strains PA99 and 388 led to increased mouse survival rate in an acute
pneumonia and a burn infection model, respectively (Holder et al., 2001b; Shaver and
Hauser, 2004). Therefore, the attenuated virulence of the P. aeruginosa spermidine
transporter mutant ?spuE in this acute murine pulmonary infection model is due to down-
regulation of T3SS.
Effector proteins are known to play a role in maintenance of bacterial persistence
in host tissues. By engineering a series of P. aeruginosa strains  that  secrete  only  one
effector protein, Shaver and Hauser (2004) found that the engineered strain which
secretes ExoU or ExoS displayed higher bacterial persistence than the control strain
lacking effector genes in mouse lungs 18 hours post infection. But the experiment was
not extended to a longer time post infection. Similar to the above findings, at the day 1
post infection, we found that the wild type PAO1 survived better in mouse lungs than the
mutant ?spuE (Fig. 5-3), which is defective in secretion of effectors (Zhou et al., 2007;
Chapter 3). Intriguingly, however, contradictory to the results obtained at one day post
infection,  at  the  second  day  post  infection,  bacterial  cells  of  wild  type  PAO1  were
completed cleared from the lungs, whereas ?spuE bacterial cells were still present in
animal lungs. It is noteworthy that the T3SS-defective control exsA::Tn showed a similar
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trend of bacterial persistence as the spermidine transporter mutant. As discussed below,
these seemingly contradictory results are likely due to the interaction between T3SS
effectors and host immune systems.
It has been established that the normal host defense against pulmonary bacterial
infection includes both innate and acquired immune responses (Uthaisangsook et  al.,
2002). The primary function of innate immune response is the elimination of foreign
particles deposited on the surface of airways and rapid clearance of pathogens from
alveoli (Standiford et al., 1996). Innate immunity includes pattern recognition molecules
and receptors, complement, antimicrobial peptides, leukocytes (such as neutrophils and
monocytes/macrophages), and cytokines produced by leukocytes (Uthaisangsook et  al.,
2002; Manderscheid et al., 2004). The first line of phagocytic defense against pathogens
is the alveolar macrophages (Sibille and Reynolds, 1990). Pathogen-activated
phagocytes, in turn, produce cytokines which play a critical role in localization,
reinforcement, and resolution of the host defense response (Standiford et al., 1996). The
cytokines secreted by phagocytes in response to infection include TNF?, interleukin-1?
(IL-1?), IL-10, IL-12 and members of the C-X-C (such as IL-8 in humans and KC in
mice) and C-C (such as MCP-1 in humans and MCP-5 in mice) chemokine families,
which is critical for clearance of microbial agents (Moore and Standiford, 1998). Type III
effectors are known to induce inflammatory responses during P. aeruginosa infections.
The engineered strain PA99U that secrets effector ExoU induced much more profound
inflammatory infiltration in the mouse lung parenchyma than the strain PA99null that
secrets none of the effectors (Diaz et al.,  2008).  ExoS was  also  shown to  induce  TNF?
production via a MyD88-dependent pathway through activation of both TLR2 and TLR4
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(Epelman et al., 2004). The ability to activate cells expressing TLR2 was attributed to the
C terminus of ExoS, whereas the ability to activate TLR4/MD-2 complex was attributed
to  the  N  terminus  of  ExoS  (Epelman et al., 2004). In vivo administration of antibodies
against TNF? and gamma interferon (IFN-?) results in an increase in bacterial growth in
the organs, which ultimately leads to death, suggesting the crucial role of endogenous
production of TNF? and IFN-? in pathogen resistance (Nakane et al., 1989). Therefore,
the faster clearance of PAO1 in infected lungs observed 2 day post infection (Fig. 5-3)
was likely caused by an enhanced production of the pro-inflammatory cytokines,
including TNF? and the two TNF?-inducible cytokines, i.e., IL-6 and KC (Moore and
Standiford, 1998), as shown in Table 5-1.
Robust production of TNF? from pulmonary macrophages and neutrophils and
resulting extensive inflammatory response are also believed to be responsible, in part, for
the high mortality associated with nosocomial infection (Gordon and Read, 2002),  which
correlates well with our data  that mice infected by PAO1 got sick at 1 day post infection
and the mortality of this group of mice started at 2 day post infection (Fig. 5-2). Taken
together, by comparing with the two ExoS-deficient mutants ?spuE and exsA::Tn it can
be concluded the capability of PAO1 to secrete and translocate effectors, such as ExoS, to
infected mice, which led to an increased production of TNF?, as well as the TNF?
inducible cytokines IL-6 and KC (Moore and Standiford, 1998), should be largely
responsible for the high mortality of mice (Fig. 5-2). Vice versa, these data demonstrate
the key role of spermidine transporter-mediated signaling pathway in P. aeruginosa
virulence.
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P. aeruginosa is a leading cause of life-threatening infections in
immunocompromised individuals, and it also is listed among the most serious antibiotic-
resistant bacterial pathogens (Davies, 1996; Robinson, 1997), which warrants further
investigation for new disease control strategies including effective vaccines. Vaccination
has been shown to be efficacious against P. aeruginosa infection in a number of studies
using killed whole cells (Cripps et al., 1994), purified outer membrane preparations (Lee
et al., 2000a; Lee et  al., 2000b), isolated outer membranes (Gilleland, Jr. et  al., 1988),
protein fusions (Mansouri et al., 1999), synthetic peptides representing protective
epitopes (Gilleland and Gilleland, Jr., 1995; Gilleland et al.,  2000),  as  well  as  secreted
virulence proteins, such as Exotoxin A (Manafi et al., 2009), and PcrV, the needle tip
protein  of  the  T3SS  (Sawa et al., 1999; Shime et al., 2001; Goure et  al., 2005). It has
been shown previously that immunization of mice with PcrV, a type III protein associated
with the translocation of effectors, provides protection against lethal lung infection and
injury by P. aeruginosa in an acute mouse lung infection model (Sawa et al., 1999), and
enhanced mice survival in a burn infection model (Holder et al., 2001a). Sawa et al.
(1999) suggested that neutralization of PcrV by PcrV-specific antibody, may lead to
increased survival and decreased lung injury by blockade of translocation of toxic T3SS
effectors to macrophages, which increases macrophage survival and facilitate
phagocytosis of bacterial pathogens, and consequently enhances host survival.  In this
chapter, the potential of active immunization with SpuD, one of the substrate binding
components of the spermidine transporter complex, for protection of mice was evaluated.
SpuD appears to be potent antigen, which induced prominent rises in mouse antibody
titers ranging from 1 in 10000 to 1 in 80000 (Fig. 5-6). This active immunization of SpuD
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significantly enhanced the mice survival against infection with wild type P. aeruginosa
strain PAO1 (Fig. 5-7). These results, plus the findings in Chapter 3 that SpuDEFGH
transporter plays a key role in uptaking of spermidine signal for induction of T3SS gene
expression, suggest that SpuD-specific antibodies generated by immunization may
protect mice by blocking spermidine signal transportation, which prevents T3SS
activation and hence reduces the cytotoxicity of P. aeruginosa.
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Chapter 6 General Conclusions and Future Directions
6.1 General conclusions
Pseudomonas aeruginosa is a common environmental Gram-negative bacterium
which acts as an opportunistic pathogen under certain circumstances. Nearly all clinical
cases of P. aeruginosa infection are associated with compromised host defenses, such as
general immunosuppression in AIDS patients, chronic lung infection in cystic fibrosis
patients and bacteremia in severe burn victims (Lyczak et al., 2000). P. aeruginosa
infections are often severe and life threatening. Once infected, it is often hard to eliminate
the pathogen because of limited susceptibility to antimicriobial agents and the frequent
occurrence of antibiotic resistance during therapy (Garner et al., 1988; Carmeli et al.,
1999). A clinical research conducted recently in Israel has shown that multi-drug resistant
P. aeruginosa is associated with severe outcomes compared to matched controls, in terms
of increased mortality and increased length of hospital stay, as well as the need for more
procedures (Aloush et al., 2005) Because of its clinical importance, The pathogen has
been subjected to extensive studies, which lead to identification of various virulence
factors Among them, Type III Secretion System (T3SS), which is conserved in many
Gram-negative bacterial pathogens, has attracted particular interests. By utilizing this
system, pathogen is able to directly inject protein effectors into host cells across bacterial
and host membranes, where they manipulate host cellular functions to facilitate infections
(Coburn et al., 2007). Expression of this secretion system is induced by various
environmental cues including host contact, which has been reported in numerous
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publications in the past two decades. However, it is not clear whether the pathogen could
communicate with the host through chemical signal molecules to modulate T3SS gene
expression. Such studies may shed light on understanding the molecular mechanisms of
interaction between P. aeruginosa and its hosts, and promoting development of new
strategies against P. aeruginosa infections.
Regulation of T3SS of P. aeruginosa is in general through modulating the activity
of the master regulator ExsA whose expression is under the control of the exsCEBA
promoter (Frank, 1997; Yahr and Wolfgang, 2006). In this study, in order to identify the
new genes implicated in T3SS regulation, I used a new approach by integrating a single
copy of the pC-lacZ transcriptional fusion into the chromosom of P. aeruginosa strain
PAO1 for monitoring expression of exsCEBA.  Based on this reporter system, transposon
mutagenesis led to the identification of 71 genes, which are putatively involved in T3SS
regulation. Among them, 5 genes (exsA, vfr, cyaB, retS, and rhlI/rhlR)  are known to be
involved in T3SS regulation, and 5 genes (mucD/lepA, lepA, algZ, algC and rsaL) are
either functionally or physically related to known T3SS regulators, illustrating the
feasibility of using this approach to identify new T3SS regulatory components. Apart
from the above 10 T3SS-related regulators, sequence analysis of the remaining
transposon mutants showing decreased expression of exsCEBA led to identification of 3
genes  (fleN, pslA and fimX) associated with bacterial motility and EPS production, 13
genes (ppk, spoT, ilvA1, sahH, argH/pa5264, lysA, pa5412/ltaA, metF, desA, pgi, nuoB,
nuoC and speD) involved in metabolism, 8 genes involved in transport of small
molecules (spuE, spuF, spuG, spuGH, potA, mexH, corA and mtr),  9  genes  (era,
queA/pa3824.1, truB, miaA, tufA, nusA, cca, pa2840, and rluC/rne) involved in post-
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transcriptional or post-translational modification, 8 genes with other diverse functions,
such as non-coding RNA and membrane proteins, and 20 genes encoding hypothetical
proteins. While the involvement of these newly identified genes in T3SS regulation needs
to be verified by deletion and complementation analysis, these data suggest that
transcription of exsA is likely influenced by multiple regulatory mechanisms.
Of  particular  interest,  among  these  newly  identified  genes,  four  genes  (spuE,
spuF, spuG and spuH),  which  are  located  in  the spuABCDEFGH operon, together with
spuD, encode a major ABC-type transporte system for spermidine uptake (Lu et  al.,
2002). Our study showed that mutation of these genes abolished the expression of most
T3SS genes, including the exsCEBA operon, under T3SS inducing condition (low
calcium).  In  addition,  null  mutation  of  the  spermidine  uptake  transporter  resulted  in
decreased host cell extract-dependent induction of T3SS expression and attenuated
bacterial cytotoxicity towards HeLa cells. Consistently, exogenous addition of
spermidine to the wild type strain PAO1 enhanced the expression of exsCEBA and
induced  the  secretion  of  the  effector  ExoS.  To  determine  the  specificity  of  polyamines
which activate T3SS in P. aeruginosa, several polyamines were subjected to activity test,
and the results showed that only spermidine and spermine were the effective signals for
inducing the expression of T3SS genes with spermidine being the strongest inducer,
which is in agreement with the previous report that spermidine is the preferred ligand
molecule of the SpuDEFGH transporter system (Lu et  al., 2002). Consistently, deletion
of the transporter significantly attenuated the spermidine activity on induction of T3SS
genes and abrogated the production of T3SS effector proteins. These findings have
unequivocally demonstrated that the SpuDEFGH transporter system is required for influx
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of exogenous polyamine signals, in particular, spermidine and spermine, into the bacterial
cells and that a spermidine transporter-dependent signaling pathway is involved in
regulation of P. aeruginosa T3SS expression.
By deletion analysis of the genes up-regulated in spu transporter mutants, I
identified a LysR-type transcriptional regulator TsrA that suppresses T3SS expression.
Further studies using genetic approaches and microarray analysis showed that TsrA
negatively regulates T3SS expression through influencing the expression of
transcriptional regulator Vfr. A previous study shows that Vfr positively regulates the
expression of T3SS genes but the mechanism of regulation remains elusive (Wolfgang et
al., 2003). In this study, the direct molecular interaction between TsrA and the promoter
of vfr (Pvfr) was demonstrated in vitro. Moreover, the spermidine signal was shown to
interact  with  TsrA  to  prevent  the  binding  of  TsrA  to  Pvfr and  hence  de-repress  the
transcription of vfr. These original findings from this thesis, together with the previous
knowledge of Vfr and ExsA, have thus depicted a novel spermidine transporter-
dependent regulation cascade for the signal modulation of T3SS expression in P.
aeruginosa (Fig. 6-1). In this signaling pathway, extracellular spermidine from host or
environment is sensed and transported into bacterial cells by the spermidine transporter
SpuDEFGH; the signal de-represses vfr transcription by forming a TsrA-spermidine
complex to prevent TsrA binding to the promoter of vfr (Pvfr); the accumulated Vfr,
together with its ligand cAMP, positively controls exsA expression, which subsequently
induces the expression of T3SS genes. Meanwhile, TsrA-spermidine complex binds to
the promoter of tsrA (PtsrA) to represses its own transcription, which provides a second
mechanism for spermidine to reduce the cellular level of repressor.
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To evaluate the biological significance of the SpuDEFGH-mediated signaling
pathway under in vivo conditions, an acute murine pulmonary infection model was
established in this study. The capability of P. aeruginosa strain PAO1 to secrete and
translocate effectors including ExoS to infected mice led to increased production of a set
of cytokines, including TNF?, IL-6 and KC, and resulted in a high mortality of mice,
compared  to  the  T3SS-deficient  strain  ?spuE.  Moreover,  active  immunization  with  the
purified endotoxin-free SpuD protein protected mice against P. aeruginosa infection and
showed significantly enhanced mice survival rate in comparison with the unimmunized
mice control. Although the mechanism with which SpuD immunization enhances mice
survival rate remains to be experimentally verified, it is conceivable that potential
blockage of the SpuDEFGH transporter by the SpuD-specific antibodies may lead to
inaccessibility of the exogenous spermidine signal for T3SS activation and hence reduces
the virulence of P. aeruginosa. Cumulatively, these data demonstrate the key importance
of the spermidine signaling pathway in modulation of P. aeruginosa virulence.
Recent studies have shown that increased arginase activity detected in asthma,
chronic obstructive pulmonary disease and CF may contribute  to the airway remodeling
due to increased production of polyamines (Maarsingh et al., 2008b), implying that high
levels of polyamines in various pulmonary disorders may favor the opportunistic
pathogen P. aeruginosa to activate T3SS as a virulence determinant to establish infection
and escape from host immune system. In addition to acting as a T3SS activation signal,
our data suggest that exogenous spermidine may also alleviate the repression of calcium
on T3SS gene expression, considering host body fluid contains a millimolar range of
extracellular calcium (Hueck, 1998). In conclusion, our discovery of this signaling
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cascade has added a new dimension to the known complicated T3SS regulatory networks
(Yahr and Wolfgang, 2006), and has also provided interesting insights into the molecular
mechanisms of host-pathogen interactions.
6.2 Future directions
Apart from these novel findings, this project also raises some interesting questions
worthy for future investigations:
First, given that many bacterial pathogens appear to have T3SS and the
SpuDEFGH-like polyamine transporters (Hueck, 1998; Igarashi and Kashiwagi, 1999a;
Igarashi et al., 2001b; Lu et al., 2002; Shah and Swiatlo, 2008), it will be interesting to
investigate whether spermidine signaling pathway is conserved in other bacterial species,
the answer of which thus may raise an intriguing possibility of potential functional co-
evolution of this new signaling pathway with T3SS in bacterial pathogens.
Second, our data show that deletion of tsrA only partially compromises, but does
not  totally  abolish  the  bacterial  response  to  polyamine  signals,  which  seems  to  suggest
that in addition to TsrA, there is likely another regulatory element(s) that is modulated by
extracellular spermidine signal. This unknown factor(s) that functions in parallel to TsrA
need to be identified.
Third, microarray analysis showed in trans expression of tsrA had a great impact
on  virulence  gene  expression.  However,  the  molecular  mechanism  with  which  TsrA
coordinately controls these downstream virulence genes remains elusive.
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Fig. 6-1 Proposed spermidine dependent hierarchical regulatory cascades required for
T3SS gene expression in P. aeruginosa. (A) In the absence of spermidine, TsrA represses
vfr transcription and consequently suppresses T3SS expression. (B) When the spermidine
signal is available, it is sensed and transported in to the bacterial cell by the SpuDEFGH
spermidine up-take transporter. TsrA receives the spermidine signal as one of the
receptors and leads to the de-repression of vfr transcription, which in turn activates T3SS
transcription. Symbole: X, indicates the unknown factor that may regulate T3SS gene
expression by modulating vfr expression; A, ExsA; V, Vfr; spd, spermidine.
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Last, Chapter 5 showed that active immunization of SpuD significantly enhanced
the survival rate of mice challenged by PAO1. However, protection in animal models is
only a suggestion of potential effectiveness of the vaccine in humans. In addition, it will
be worthy to investigate if SpuD in combination with other antigens, such as PcrV (Sawa
et al., 1999; Holder et al., 2001a), OmpI and OmpF (von Specht et al., 1996; Knapp et
al., 1999; Price et al., 2001), or elastase epitopes (Sokol et al., 2000), could augment the
effectiveness of immunization for protection against P. aeruginosa infections.
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